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NSBP1 Nucleosomal Binding Protein 1 
nt Nucleotides 
OD600 Optical density measured at 600 nm 
OE Overexpression 
ON Overnight 
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PAA Polyacrylamid 
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PARD3 Par-3 Family Cell Polarity Regulator 
PARP1 Poly [ADP-ribose] polymerase 1 
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Pc Polycomb 
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RNA Ribonucleic acid 
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RPL30 Ribosomal Protein L30 
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SDS Sodium dodecyl sulfate 
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TTF-I Transcription Termination Factor I 
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WB Western blot 
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1 Summary 
 
The modulation of higher order structure of chromatin has profound 
implications in the regulation of nuclear processes, like transcription, replication, 
recombination or DNA repair. Those processes require accessible DNA to recruit 
large protein complexes to function.  
In humans, the architectural proteins of the “high mobility group nucleosomal binding 
domain” (HMGN) family participate in the opening of chromatin structure and the 
regulation of gene expression. HMGN proteins bind the nucleosome particle through 
a conserved nucleosomal binding domain (NBD) and compete with H1 for the binding 
to chromatin. 
Of all HMGN family members, HMGN5 has the biggest effect on transcriptional 
regulation in mouse and human cells. Moreover, HMGN5 is also able to induce large-
scale chromatin decondensation in vivo.  
In the present work we study the functional role of HMGN5 in the opening of higher-
order structure of chromatin and gene expression by biochemical and genome-wide 
methods.  
We identified a novel and specific RNA binding domain overlapping with the NBD of 
HMGN5. Moreover, by in vitro competition assays we demonstrated that HMGN5 
exhibits exclusive binding to nucleosomes or to RNA. Furthermore, we showed that 
the RNA binding activity is a feature of other HMGN members as well, highlighting a 
novel function for those proteins.   
The overexpression and knockdown of HMGN5 in human cell lines affect the 
expression of about 3000 genes respectively, with 1287 overlapping target genes. 
ChIP-seq analysis of HMGN5 revealed that HMGN5 mainly associates with active 
regulatory genomic regions, like promoters and CpG islands, and it localizes to 
DNase I hypersensitive sites (DHSs). Moreover, we found that the actively regulated 
target genes belong to the group of genes involved in RNA metabolic processes. 
HMGN5 binding overlaps with RNA polymerase II binding sites. CLIP-seq analysis of 
HMGN5-bound RNAs revealed that HMGN5 is able to bind nascent transcripts. In the 
light of the biochemical results, we propose that HMGN5 participates in the regulation 
of RNA metabolism by a dual mechanism that enables HMGN5 binding either 
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chromatin or RNA since the HMGN5-bound RNAs have no functional relationship 
with the chromatin function of HMGN5.  
Interestingly, by using quantitative mass spectrometry we identified CTCF, BANF1 
and seven proteins associated with the pre-ribosomal RNA processing.  
Strikingly, our ChIP-seq data revealed that HMGN5 co-localizes with HMGN5. As 
CTCF constitutes the major organizer of chromatin architecture, the results 
presented here suggest a cooperative role of both proteins in the organization of 
higher-order structure of chromatin.  
Further functional characterization of the potential HMGN5-CTCF complex, may shed 
light on the regulation of higher-order chromatin organization. 
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2 Introduction 
 
 
2.1 Chromatin as functional organizer of DNA in the 
nucleus 
 
    In eukaryotic cells, the DNA molecule needs to be tightly packed to fit into the 
nucleus which has a diameter of 10µm, and yet be accessible to allow regulation of 
processes like transcription, replication or DNA repair. This is possible trough the 
highly specialized and dynamic packaging of DNA in the chromatin fiber. Chromatin 
was first discovered and named by Walther Flemming in the 19th century as a 
stainable fibrous structure within the nucleus of cells. Later, in 1928 the German 
botanist Emil Heitz made the first categorization of chromatin by discriminating the 
chromosomes in euchromatin (genetically active) and heterochromatin (genetically 
inactive) based on its staining properties under the light microscope (Passarge, 
1979). 
Besides the general categorization in euchromatin and heterochromatin, the 
chromatin is organized in specialized, spatiotemporal changing compartments that 
are required for the proper function of all DNA-dependent processes.  
Several regulatory mechanisms like ATP-dependent chromatin remodelers, 
posttranslational modification of histone, DNA modification or regulatory RNAs have 
been described –globally termed epigenetic mechanisms-, that control the fate of 
gene expression, by modulating locally (at nucleosomal level) or globally (by long 
distance chromatin interactions) chromatin accessibility (Bartkuhn & Renkawitz, 
2008). This highlights the crucial role of the coordinated and dynamic regulation of 
chromatin organization on the transcriptional regulation of genes. 
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2.2 DNA packaging and higher-order chromatin 
organization 
 
The nucleosome corresponds to the basic level of chromatin organization, and is 
composed of a nucleosome core particle (NCP) a linker DNA. The nucleosome core 
particle is composed of 147 bp of two tight 1.65 left handed superhelical turns of DNA 
wrapped around a histone octamer (Figure 1) which is composed of two copies of the 
histones H2A, H2B, H3 and H4 (Luger, 2003). In the NCP, the core histones are 
assembled into four heterodimers, two H2A/H2B and two H3–H4 dimers (Luger, 
Mäder, Richmond, Sargent, & Richmond, 1997; A. L. Olins & Olins, 1974; Woodcock, 
Safer, & Stanchfield, 1976). The core histones are evolutionary conserved basic 
small proteins (ranging between 11-16kDa), that have 2 characteristic functional 
domains; a histone fold domain mediating histone-DNA and histone-histone 
interactions required to form the nucleosome particle, and the N-terminal histone tails 
(and C-terminal tail in H2A and H2B) that are disordered, flexible and accessible 
structures protruding from the nucleosome core particle (Downs, Nussenzweig, & 
Nussenzweig, 2007). The histone tails are hotspots of regulatory posttranslational 
modifications. 
 
 
 
 
 
 
 
 
 
 
Figure 1. Structure of nucleosome core particle.  
Scheme of the nucleosomal structure at the 2.8 Å resolution level obtained from X-ray 
crystal structure. A) Front view of the nucleosome particle, formed by 147bp of double-
stranded DNA (in light blue) wrapped around a histone octamer composed of the histone 
H2A (yellow), H2B (red), H3 (blue) and H4 (green). The respective histone tails extensions 
are shown. Red star indicates site of ubiquitination in yeast. B) Side view of the nucleosome 
with a 90° rotation in the vertical axis. Image obtained after (Luger, 2003). 
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Histones interact with DNA through different mechanisms including salt bridges, 
hydrogen bonds with DNA, non-polar contacts with the deoxyribose, electrostatic 
interactions between the positively charged N-terminal tails with the DNA phosphates 
and base-specific contacts (Widom, 1998). 
The nucleosome core are separated by a flexible DNA linker–with a variable length 
between 20-80bp depending on the species and the cell type (Felsenfeld & 
Groudine, 2003)-. This array of nucleosomes forms the so called “10 nm fiber” that 
resembles a “beads-on-a-string” structure under electron microscopy (Figure 2) at 
low salt conditions (A. L. Olins & Olins, 1974; Woodcock et al., 1976). A diploid 
human cell that contains about 6x109 nucleotide pairs (with a total average length of 
2m), DNA is packaged on average into 30 millions nucleosome cores. 
 
 
 
 
 
 
 
 
 
 
Figure 2. Electron micrograph of the chromatin “beads-on-a-string” structure. 
Decondensed "beads-on-a-string" form of purified chromatin visualized by electron 
microscopy. Picture adapted from Molecular Biology of the Cell. 3rd edition. (Alberts et al., 
1994) 
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2.3 Higher-order chromatin organization 
 
Inside the cell nucleus, chromatin is not linear in structure, but it is rather organized 
into 3-dimentional higher-order structures. This higher-oder organzation plays critical 
roles for the regulation of nuclear functions.  
At a first level, the binding of the linker histone (H1 and H5) helps the packaging of 
nucleosomes into the chromatosome core particle (Harshman, Young, Parthun, & 
Freitas, 2013; Simpson, 1978). Linker histones are composed of a tripartite structure, 
consisting of a flexible and short N-terminal tail, a conserved central globular domain, 
and a long (100 amino acids) intrinsically disordered and basic C-terminal domain 
(Allan, Hartman, Crane-Robinson, & Aviles, 1980). 
By using cryo-microscopy (cryo-EM) and crystal structures it was recently shown that 
the C-terminal domain of H1 associates primarily with a single linker in the 
nucleosome, while the globular domain interacts with both DNA linkers and the 
nucleosome dyad, resulting in a reduction of the flexibility of linker DNA and a more 
compact nucleosome conformation (Bednar et al., 2017). It has been shown that 
depletion of H1 is lethal in mice (Fan et al., 2003) and Drosophila (Lu et al., 2009). 
Moreover, H1 depletion alters the proper folding of chromosmes during mitosis 
(Maresca, Freedman, & Heald, 2005) highliting its role in the higher-order chromatin 
conformation. 
 
2.3.1 Classical view of chromatin higher-order organization 
 
It has been described that chromatin is highly packaged into a hierarchical higher-
order structure. In the classcial text-book view of chromatin organization (Figure 3), 
the nucleosomal array is folded into thought to fold into intermediate fibers of 
increasing diameter of 30, 120 300 and 700 nm diameter, to finally form the mitotic 
chromosome, eye-visible under the light microscope.  
Two competing models have been proposed to explain the formation of the 30 nm 
fiber. The solenoid model, in which consecutive nucleosomes are located adjacent to 
one another in the fiber, and fold into a simple “one-start helix“ (Finch & Klug, 1976), 
and the zig-zag model, which assumes an arrangement of the nucleosomes in a 
zigzag manner in which two rows of nucleosomes form a “two-start helix” so that 
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alternate nucleosomes interacts with the neighbor nucleosome of the other row  
(Dorigo et al., 2004; Horowitz et al., 1994; Worcel et al., 1981). Both models assume 
a selective internucleosomal interaction of close neigbors nucleosomes on the DNA 
strand (Maeshima, Imai, Tamura, & Nozaki, 2014). 
Despite that for many years the hierarchical folding of chromatin has been widely 
accepted, the chromatin folding in vivo is still a controversial topic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Hierarchical higher-order compaction of chromatin. 
DNA is wrapped around histone octamers forming nucleosomes. Individual nucleosomes 
are separated by free linker DNA and associate with histone H1. The 10 nm fiber twists into 
a large coil, generating the condensed, supercoiled 30 nm fiber. The coils form loops (300-
nm fiber) and the loops coil further, producing the metaphase chromosome as highest 
condensation level of DNA in eukaryotes (image and description taken from Alberts, 3rd 
edition.) 
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2.3.2 A new concept of higher-order chromatin structure 
 
Over years, the formation of the 30 nm fiber has been supported by several 
biophisical studies, including X-ray crystallography, or small-angle X-ray scattering 
(SAXS), and the 30 nm chromatin conformation has been the reference for many 
studies in the chromatin field. However, despite all the efforts made to unravel the 
specific conformation of chromatin in vivo it is still not clear if the 30 nm fiber really 
exist in vivo (Fussner et al., 2011; Luger, Dechassa, & Tremethick, 2012; Maeshima, 
Hihara, & Eltsov, 2010; Nozaki et al., 2014). This is because the classical methods 
have technical limitations, as they are mainly based on in vitro structure of 
reconstituted chromatin from DNA and histones (P. J. J. Robinson., 2006; Schalch et 
al., 2005), or based on chromatin purified from permeabilized cells (Belmont & Bruce, 
1994; Horowitz et al., 1994; Worcel et al., 1981), lacking many components of the 
physiological chromatin context. 
By the use of cryo-electron microscopy (cryo-EM) analysis of vitrified chromosomes it 
was suggested, already three decades ago, that chromatin was irregularly folded in 
vivo (McDowall et al., 1986). 
Furthermore, the latest evidence in the field strongly argues against the existence of 
the 30 nm fiber in vivo (Bouchet-Marquis, et al., 2006; Eltsov et al., 2008; Nishino et 
al., 2012; Ou et al., 2017).  
By using a sofisticated method that combines electron microscopy tomography and 
labeling methods (ChromEMT), the 3D chromatin ultrastructure in the nucleus of 
living human cells was analyzed for the first time. In the study performed by Ou and 
colleagues it was revealed that chromatin is organized as irregular polymers with 
diameters of 5 to 24 nm in interphase and mitotic chromosomes (Ou et al., 2017), 
instead of the classically described higher-order structures. 
Those results are in agreement with the recently proposed "polymer melt model" 
(Figure 4), in which chromatin is organized as flexible and disordered dynamic folded 
10 nm fiber similar to a “polymer melt” (Maeshima et al., 2010). In this model, at low 
nucleosome concentration, nucleosome fibers can form 30 nm fibers mediated by 
intra nucleosome interactions, which can explain the observed in vitro formation of 
the 30 nm fibers. However, as the nucleosome content increases  nucleosomes form 
inter fiber associations (due to increased cation concentration or molecular crowding 
effect) leading to the formation of a polymer-like structure (Nishino et al., 2012). The 
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"polymer melt" model represents several advantages in determining accessibility of 
the DNA to the recruiting of regulatory machineries and for the formation of functional 
chromatin domains through long-distance chromatin interactions. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Classical and new model of higher order chromatin folding. 
Comparison between the classical view of a hierarchical chromatin folding (left), and the 
new model of irregularly folded nucleosome fibers (“polymer melt”). In the classical view, 
nucleosomes are organized in regular fibers of 30 nm, which are subsequently packaged to 
get a highly compacted mitotic chromosome inside the nucleus. In the novel model, 
chromatin is organized as irregular folded 10 nm fiber which implies a flexible and less 
constrained chromatin organization. 
Picture taken from: 
 https://www.nig.ac.jp/labs/MacroMol/e-more_detailed_description.html (Maeshima et al., 
2014) 
 
 
Introduction 
29 
2.4 Mechanisms regulating chromatin structure 
 
 
Epigenetic regulatory mechanisms involve posttranslational modification of histones, 
canonical histone replacement by histone variants, DNA methylation, non-coding 
RNA and ATP dependent chromatin remodeling. Each mechanism has been 
extensively studied, revealing that they are highly coordinated, functionally interacting 
and influencing each other (Armstrong, 2013). The actors in the epigenetic marking 
system, have been classified as “writers”, “erasers”, and “readers” due to their ability 
to add, remove or recognize, respectively, histones or DNA chemical modifications 
(marks) to establish the gene expression program of the cell (Torres & Fujimori, 
2015). 
 
 
2.4.1 Histone posttranslational modification 
 
Histones are marked by a large number of posttranslational modifications (PTMs), 
including acetylation, methylation, phosphorylation, ubiquitination, citrullination, 
sumoylation, ADP-ribosylation and proline isomerization (Rothbart & Strahl, 2014). 
Most of the modifications are located in the unstructured N-terminal and C-terminal 
tails that protrude from the nucleosome particle. However, some modifications have 
been found in the histone-fold domain, required for nucleosome unwrapping and 
disassembly (Simon et al., 2011). 
PTMs have been associated with specific functions, but they are mainly found in 
combinations, suggesting a “histone code” that finally define a specific chromatin 
state (Strahl & Allis, 2000) by the recruitment of modifying enzymes, such as histone 
acetyltransferases (HATs), histone methyltransferases (HMTs,) or histone 
deacetylases (HDACs), among others, that alter the structure of the surrounding 
chromatin environment. 
Of the PTMs, the mostly described histone modification is lysine methylation. Lysine 
can be mono-, di- or tri-methylated, and these modifications can be associated with 
either gene activation or silencing depending on possition and the cross-talk with 
other PTMs (Torres & Fujimori, 2015). As an example, mono- and trimethylation of 
the lysine 4 from histone H3 (H3K4) as well the H3 lysine 36 trimethylation 
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(H3K36me3) are associated with transcription activity, whereas H3K27me3 and 
H3K9me2 have been associated with transcriptional repression (Woo, Ha, Lee, 
Buratowski, & Kim, 2017). Specific combinations of histone modifications are 
hallmarks of the active/inactive regulatory genomic elements like promoters, 
enhancers, or intron/exon boundaries (V. W. Zhou, Goren, & Bernstein, 2010). A 
summary of the different histone marks and their associated functions is depicted in 
(Figure 5). 
. 
 
 
Figure 5. PTMs associated with different chromatin states. 
A) At promoters, PTMs contribute to fine-tune gene activity from active to poised to inactive 
states. B) At gene bodies, they discriminate between active and inactive conformations. C) At 
distal sites, histone marks correlate with levels of enhancer activity. D) On a global scale they 
may confer repression of varying stabilities and be associated with different genomic 
features. For example, lamina-associated domains (LADs) in the case of stable repression 
and Polycomb (Pc) bodies in the case of context-specific repression. DNAme, DNA 
methylation; LOCK, large organized chromatin K modification. Figure and description legend 
obtained after Zhou et al., 2011. 
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2.4.2 Histone variants 
 
Additionally to the histone PTMs, chromatin can be regulated by the replacement of 
canonical histones by histone variants.  
Histone variants are non-allelic isoforms of the canonical histones that have a 
specific expression, localization, specie specific distribution pattern (Kamakaka & 
Biggins, 2005) and play determinant roles in regulating chromatin structure. 
Different than canonical histones, that are produced during the DNA synthesis (S) 
phase of the cell cycle, histone variants are expressed throughout the cell cycle, and 
are incorporated to chromatin in a replication-independent manner by specific histone 
chaperones (Biterge & Schneider, 2014). 
The genes coding for the (known) histone variants contain intronic sequences, the 
pre-mRNAs are polyadenylated and can undergo alternative splicing (Biterge & 
Schneider, 2014). 
It is believed that the deposition of histone variants alters the stability of the 
nucleosome, affecting the interactions between histones and with the DNA, thus 
helping to modify the chromatin conformation (Gautier et al., 2004; Park, Dyer, 
Tremethick, & Luger, 2004) 
Histone variants can differ from their canonical counterparts by minor modifications 
(as one amino acid change in the H3 variants H3.1 and H3.2) to drastic structural 
modifications as in the H2A variant macroH2A (E. Bernstein & Hake, 2006). 
To datel, all histones, with the exception of H4 have described histone variants. The 
most studied histone variants belong to the H2A family and they are involved in 
diverse cellular processes, associated with activation or repression of transcription, 
as DNA damage response and centromeres formation (E. Bernstein & Hake, 2006). 
Among them, H2a.Bbd (associated with active transcription), H2A.X (involved in DNA 
repair and genome integrity), H2A.Z (activation and repression of transcription and 
chromosome segregation) and macroH2A which have been associated with X-
chromosome inactivation and transcriptional repression (Biterge & Schneider, 2014; 
Sarma & Reinberg, 2005). 
The number of histone H3 variants differs among species. In mammals there are four 
main isoforms, H3.1, H3.2, H3.3 and CENPA (found at centromeric chromatin) 
(Filipescu, Mueller, & Almouzni, 2014). However, recent studies have revealed an 
extended group of H3 variants that possess a tissue-specific and specie-specific 
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expression pattern. Those variants include the testis-specific histones H3.4, and 
H3.5, and the histone H3.Y which is conserved among primates (Filipescu et al., 
2014). 
For many of the histone variants, posttranslational modifications have been 
described, contributing to the modulation of gene expression (Biterge & Schneider, 
2014). 
 
 
2.4.3 DNA methylation 
 
In vertebrates, DNA methylation is key for regulation of different processes, like gene 
expression, genomic imprinting, silencing of transposable elements or X-
chromosome inactivation. This modification occurs extensively in CpG dinucleotides 
and is mediated by a group of enzymes called DNA methyltransferases (DNMTs) that 
catalyze the methylation at the carbon-5 position of cytosine residue at the CpG 
dinucleotide to form 5-methylcytosine (5-mC) (Prokhortchouk & Defossez, 2008). 
Methylation of DNA is essential for development and viability in mammals (Jackson-
Grusby et al., 2001; Okano, Bell, Haber, & Li, 1999). In humans the CpG methylation 
patterns can be categorized in two groups; the first group, covering the vast majority 
of the genome (98%), possesses low CpG frequency (1 each 100bp) but highly 
methylated. Those CpGs are generally associated with transcriptionally repressed 
chromatin. In the second group (covering 2% of the genome) the CpGs are highly 
concentrated in the so-called CpG islands (CGIs), found in a ratio of 1 CpG every 
10bp in DNA stretched of about 1000bp (Illingworth et al., 2008). The human genome 
contains about ~30000 CGIs and most of them (around 21000) are found close to 
transcription start sites (TSSs) of genes and remain unmethylated which correlates 
with transcriptional activity. However, about 9000 CGIs are found at gene body, and 
the methylation at those sites have been associated with enhanced gene expression 
levels (Ball et al., 2009; Illingworth et al., 2008; Krinner et al., 2014) indicating that 
DNA methylation is a versatile mark with functions that depend on the genomic 
context. It has been described that the silencing mediated by DNA methylation can 
occur by two different mechanisms; DNA methylation can act by masking the 
genome and therefore preventing the binding of transcription factors, or the 
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methylation readout can be performed by methyl-binding proteins (“readers”) like 
Methyl-CpG Binding Domain Proteins (MBD1, MBD2 and MBD4), and Methyl-CpG 
Binding Protein 2 (MeCP2) that can recruit chromatin remodeling complexes, DNA 
methyltransferases or histone deacetylases, that lead to transcriptional repression 
(Baubec, Ivanek, Lienert, & Schuebeler, 2013). 
It has been lately shown that besides CpG, cytosines followed by adenine, thymine 
or another cytosine can also be methylated. The methylation of those cytosines is 
known as Non-CpG methylation and is prevalent in human embryonic stem cells 
(Ramsahoye et al., 2000) or brain development (Guo et al., 2014; Lister et al., 2013), 
however, the specific functions of those modifications are still unclear. 
 
 
2.4.4 ATP dependent remodeling complexes 
 
To allow the binding of regulatory machineries to specific genomic sites, the 
chromatin needs to be dynamically changed. This active process is mediated by 
chromatin remodeling complexes, which use ATP-hydrolysis to move, destabilize, 
eject or restructure nucleosomes (Clapier & Cairns, 2009; Erdel, Krug, Längst, & 
Rippe, 2011), thereby regulating the accessibility of DNA regulatory factors. 
The chromatin remodeling complexes have ATPases, that belong to the SF2 
helicase superfamily, and accessory regulatory subunits which are required for 
targeting and regulation of nucleosome remodelling (Erdel et al., 2011; Längst & 
Manelyte, 2015). 
The remodelers can be classified into four families, the SWI/SNF (SWItch/Sucrose 
Non-Fermentable), CHD (chromodomain, helicase, DNA binding), ISWI (imitation 
switch) and INO80 (inositol requiring 80) family (Längst & Manelyte, 2015).  
The activity of chromatin remodeling complexes and their targeting to specific 
genomic regions can be regulated by the interplay with different chromatin signals 
like DNA sequence, DNA structure, methylation, histone modifications, histone 
variants, and they can interact with chromatin associated proteins and complexes, as 
transcription factors (reviewed in Erdel et al., 2011), structural proteins that regulate 
chromatin compaction as H1 (Hill & Imbalzano, 2000) or HMG chromatin binding 
proteins (Bonaldi, et al., 2002; Heppet al., 2014; Rattner, Yusufzai, & Kadonaga, 
2009). Chromatin remodeling complexes can also interact with regulatory RNAs 
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(Längst & Manelyte, 2015). Those interactions will help to determine the accessibility 
of chromatin required for the regulation of gene expression. 
 
 
2.4.5 Regulatory RNAs 
 
In the last years there have been cumulative evidence showing that non-coding 
RNAs (ncRNAs) are essential for regulation of chromatin architecture and gene 
expression. ncRNA have been classified according to their size, biogenesis and 
function. According to size, they are commonly (and loosely) classified into two sub-
categories, small ncRNA, with an average length of less than 200nt, and long non-
coding RNAs (lncRNA) with a size of >200nt (Patil, Zhou, & Rana, 2013).  
Non-coding RNAs play a role in the regulation of different processes, including gene 
regulation, translation, splicing, cell cycle control, genome defense and chromosome 
structure (Brown, Mitchell, & Neill, 2011).  
The mechanisms by which ncRNA participate in gene regulation include interactions 
with different epigenetic regulatory machineries. As an example, they can guide and 
modulate the activity of transcription factors, direct DNA methylation, recruit histone 
modifying enzymes to either activate or silence gene expression (main mechanisms 
described in Mattick, Amaral, Dinger, Mercer, & Mehler, 2009) or they can directly 
interact with DNA to modulate recruitment of transcriptional regulatory machineries 
(Schmitz, Mayer, Postepska, & Grummt, 2010).  
It was shown already four decades ago that RNA is stably associated with chromatin 
in different species (Holoubek, et al., 1983; R. C. Huang & Huang, 1969; Huang & 
Bonner, 1965). 
Furthermore it has been shown that RNA also plays a structural role contributing to 
the higher-order chromatin organization (Caudron-Herger et al., 2011; Rodriguez-
Campos & Azorin, 2007; Schubert et al., 2012). 
The group of Karsten Rippe demonstrated the existence of RNA transcripts 
associated with chromatin -which they called “chromatin-interlinking” RNAs or 
ciRNAs- that were responsible for maintaining chromatin in a decondensed and 
active state during interphase in human and mouse cell lines (Caudron-Herger et al., 
2011). 
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Moreover, in our laboratory it was shown that the small nucleolar RNAs (snoRNAs) 
constitute the mayor fraction of chromatin-associated RNAs in Drosophila and human 
cells, and it was demonstrated that they are required to keep the higher-order 
structure of chromatin in an open state in Drosophila (Schubert et al., 2012), 
indicating that RNA is a key player in the global reorganization of chromatin 
architecture. 
A well-studied example of ncRNAs involved in modulating chromatin conformation is 
the dosage compensation in mammas and in fly. In female mammals, the lncRNA 
Xist RNA controls the developmentally regulated chromatin-mediated X chromosome 
inactivation (XCI) by recruiting silencing complexes in cis, thus generating a compact 
heterocromatinized global chromatin architecture in one of the X-chromosomes 
(Pandya-Jones & Plath, 2016). In Drosophila melanogaster on the other hand, the 
roX RNAs (RNA on the X) are required for balancing dosage by increasing the 
transcription levels in the single male X-chromosome. This is mainly done by the 
recruitment of the male-specific lethal (MSL) complex that regulates nucleosome 
positioning at High-Affinity Sites (HAS) from topological associated domains (TADs), 
from which the complex is spread leading to the global activation of the male X-
chromosome (Ramírez et al., 2015). 
To date, a huge number of non-coding RNAs have been discovered –including short 
ncRNAs and lncRNAs- and many of them have been shown to be required for 
different nuclear processes -reviewed elsewhere-, however, for most of them, the 
mechanisms underlying their function still need to be elucidated.  
Indeed the main concept that defines the functional borders between coding and 
non-coding RNA needs to be re-defined, as it has been shown that some non-coding 
RNAs have coding potential (Andrews & Rothnagel, 2014; Ruiz-Orera, Messeguer, 
Subirana, & Alba, 2014), and also some classically defined messenger RNAs 
(mRNAs) have been shown to possess non-coding functions (Kumari & Sampath, 
2015; Poliseno et al., 2010; Sampath & Ephrussi, 2016) for which a dual coding/non-
coding function have been proposed (Nam, Choi, & You, 2016). 
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2.5 Nuclear architecture and gene regulation 
 
In the interphase nuclei the chromatin is dynamically compartmentalized. Beyond the 
global separation between euchromatin and heterochromatin, it has been shown that 
each chromosome occupies non-random territory (Bodnar & Spector, 2013) called 
“chromosome territories” (CTs) (Figure 6A and B). By the use of dedicated 
microscopy methods, together with chromosome conformation capture techniques 
(from 3C to Hi-C), it was demonstrated that the chromosome territories are further 
organized into sub-domains called Topologically Associated Domains (TADs) that 
are formed by long-distance regulatory interactions between the promoters and their 
regulatory enhancers which are often located hundred of kilobases up to megabases 
away (Kaiser & Semple, 2017). TADs are delimited by sharp boundaries that are 
enriched in housekeeping genes and insulator sites that are bound by architectural 
proteins as the CCCTC-binding factor (CTCF) or cohesins that have been shown to 
be required for the establishment of TADs through promoter-enhancers interactions 
through the formation of intrachromosomic loops and in less extent interchromosomal 
interactions (Dixon et al., 2012; Gonzalez-Sandoval & Gasser, 2016). 
This compartmentalization allows the functional clustering of gene-rich (associated 
with euchromatin) or gene-poor chromatin regions (heterochromatin), keeping them 
apart from each other, and thereby contributing to the coordinated regulation of 
transcription of specific set of genes (Meaburn & Misteli, 2007). The gene-rich 
chromatin is generally located in the nuclear interior while the heterochromatin (like 
centromeric and pericentromeric chromatin) is clustered in the nuclear periphery 
generally associated to the nuclear lamina (NL), forming the Lamina-Associated 
Domains (LADs). LADs comprise large chromatin domains, ranging from 100kb to 
10Mb in length and covering around 40% of the genome, that are in close contact 
with the nuclear lamina in the inner membrane of the nucleus (Guelen et al., 2008; 
Pickersgill et al., 2006). 
TADs are highly conserved between species, and invariant between cell types. It has 
been shown that the disruption of the boundaries in engineered mouse models 
recapitulates human developmental disorders (Kaiser & Semple, 2017). Moreover in 
different limb genetic malformation in Human and Mouse, TADs appear disrupted 
with altered promoter-enhancer interactions and misexpression (Lupiáñez et al., 
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2015) which highlights that gene positioning trough higher-order chromatin 
organization is crucial for the control of transcriptional fate of the cell. 
Besides chromosomal territories, functional nuclear substructures have been 
characterized, including Cajal bodies, nuclear speckles, promyeolocytic leukemia 
nuclear bodies (PML NBs) and the nucleolus (Figure 6B); those self-organizing 
structures are formed by dynamic nucleoprotein complexes that play vital roles in the 
regulation of the nuclear homeostasis. Cajal bodies, for example, play a role in 
posttranscriptional modification of spliceosomal components, as the maturation of 
snRNPs (small nuclear ribonucleoproteins) and snRNA (small nuclear RNAs). 
Nuclear speckles have been described as sites for splicing factor storage and 
modification (reviewed in Wood, Garza-Gongora, & Kosak, 2014). 
 
 
Figure 6. Spatiotemporal organization of nuclear architecture. 
A) 24-Color 3D FISH representation and classification of chromosomes in a human G0 
fibroblst nucleus. All visible chromosomes in the section are represented with false colors 
after classification with the program goldFISH. Image modified after Bolzer et al., 2005. B) 
Diagram depicting the compartmentalization of fuctional nuclear components. Chromosome 
territories (CTs), nucleolus, nuclear speckles, nuclear pores, Cajal bodies, nuclear lamina, 
PML bodies and Nuclear envelope are indicated in the figure. Image after Lanctôt et al., 
2007. 
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Of all functional nuclear compartments, the best-characterized example is the 
nucleolus, where the rRNA transcription, processing and assembly of ribosomal 
particles take place. The nucleolus is built around the rRNA genes at specific 
chromosomal loci called “nucleolar organizer regions” (NOR) on the short arms of the 
acrocentric chromosomes (Nemeth & Längst, 2011). Inside the nucleolus there are 
specific chromatin conformations associated to the transcriptional activity of the rRNA 
genes. On the active rRNA genes there have been described specific long-range 
interactions between promoter and terminator sequences. It has been shown that 
those interactions are mediated by TTF-I (Transcription Termination Factor), 
subdividing the rRNA transcription unit into functional chromatin domains (Németh et 
al., 2008). 
Nuclear transcription is carried out by specialized “transcription factories” in which the 
transcription machinery –like transcription factors, remodeling complexes, 
coregulators or RNA polymerases- is concentrated and fixed while the DNA template 
moves relative to the polymerization site (Papantonis & Cook, 2013). In the 
nucleolus, as an example, the RNA is transcribed by “factories” containing up to 30 
active RNA polymerases each (Jackson, Iborra, Manders, & Cook, 1998). 
Although in the last years many efforts have been made to understand the 
mechanisms that regulate chromatin dynamics, it is still not known how the functional 
organization of the genome into higher-order structures can orchestrate the 
regulation of transcription. 
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2.6 HMGN5 regulates higher-order structure of 
chromatin 
 
 
The “High Mobility Group” (HMG) proteins constitute another group of players that 
participate in the regulation of chromatin structure. The HMG super family is divided 
into three non-related subfamilies, the HMGA (characterized by the AT-hook motif), 
HMGB (characterized by the HMG-box motif) and HMGN (High mobility group 
nucleosome-binding) which are non-histone architectural proteins that were shown 
play roles in the regulation of transcription, replication and DNA repair (Reeves, 
2010).  
The HMGN family -described so far only in vertebrates- participate in the modulation 
of higher-order structures of chromatin by direct interaction with the nucleosome 
through a highly conserved “nucleosomal binding domain” (NBD) (Postnikov & 
Bustin, 2010).  
The HMGN family consists of five members, HMGN1, HMGN2, HMGN3, HMGN4 
and HMGN5 (Figure 7), all of them sharing the conserved N-terminal domain 
containing the Nuclear Localization Signal (NLS) and the NBD, including a conserved 
octapeptide “RSARLSA”. This motif is required for the recruitment of HMGN to the 
core nucleosome particle, to decompact chromatin architecture, locally and globally, 
by competing with the binding of linker histone H1 to chromatin (Kugler, Deng, & 
Bustin, 2012). 
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Figure 7. Schematic diagram of HMGN family. 
Cartoon depicting the HMGN functional domains; the bipartite nuclear localization signal 
(NLS) is depicted in red; the conserved Nucleosome Binding Domain (NBD) is indicated in 
Cyan; the NBD core octapeptide is indicated in blue and the C-terminal chromatin regulatory 
domain (RD) is indicated in orange. The regulatory serines from the NBD core are 
highlighted in red. 
 
 
 
HMGN5, formerly known as NSBP1 or NBP-45, is the last discovered member of the 
HMGN family (Shirakawa, Landsman, Postnikov, & Bustin, 2000). It is a highly 
abundant protein and shares the functional domain NBD with the other members of 
the family, as well as the ability of counteracting the binding of H1 to chromatin, by a 
mechanism involving the interaction of the C-terminal tails of both proteins (Rochman 
et al., 2009). But differentIn contrast to the other HMGNs, HMGN5 is characterized 
by the presence of a very long negatively charged and unstructured C-terminal 
domain, of about 300 amino acids in mouse (Shirakawa et al., 2000) and 200 amino 
acids in humans (King & Francomano, 2001; Rochman et al., 2009). The C-terminal 
tail of both, mouse and human proteins is enriched in aspartic and glutamic acid and 
organized in repeated motifs. The acidic motif EDGKE is repeated 11 times in mouse 
HMGN5 and 4 times in the human protein, but its functional relevance is unknown so 
far. It was reported that the C-terminal tail is responsible for the specific chromatin 
location of HMGN5. In mouse, HMGN5 is tethered to euchromatin (Rochman et al., 
2009) and in human cells it was shown associated to both, euchromatin and 
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heterochromatin (Malicetet al., 2011). Moreover, deregulation of HMGN5 lead to 
changes in the expression of a large set of genes in cells and mouse models (Kugler 
et al., 2013; Malicet et al., 2011; Rochman et al., 2009; 2011) being the HMGN 
protein with the strongest effect on transcriptional regulation. 
It has been shown that HMGN5 induces large-scale chromatin decondensation in 
vivo -(Rochman et al., 2009) and our own work presented in this dissertation-, and it 
was suggested that the global chromatin reorganization observed in vivo is mediated 
by the unstructured C-terminal tail. These results highlight the relevance of this 
protein in the regulation of higher-order structure of chromatin and the cellular 
transcriptional identity. 
Interestingly, several studies have reported an oncogenic role of HMGN5 in various 
types of cancer (Chen et al., 2012; Yang et al., 2014). Moreover, HMGN5 has an 
important function in embryonal development, demonstrating that transcriptional 
changes during differentiation were a result of the induced changes in the global 
chromatin architecture mediated by HMGN5 (Shirakawa et al., 2009).  
It is known that HMGN5, as all HMGNs, is a target of posttranslational modifications. 
Phosphorylation and acetylation of the NBD control the cell-cycle dependent binding 
of the protein to chromatin in vivo (Moretti et al., 2015; Pogna, Clayton, & 
Mahadevan, 2010). Furthermore, the recent evidences suggest a role of HMGN5 in 
the tethering of chromatin to the Nuclear Lamina (NL) (Zhang et al., 2013). However, 
the mechanism by which HMGN5 can regulate the opening of chromatin structure is 
far from been understood. 
Interestingly, the functional homolog of HMGN5 in the Drosophila system, the 
decondensation factor 31 (Df31) which is also required for opening higher order-
structures of chromatin, is tethered to chromatin in an RNA-dependent manner 
(Schubert et al., 2012; Schubert & Längst, 2013), hinting the possibility of a 
conserved RNA-dependent mechanism involved in the regulation of higher-order 
structures of chromatin in the human system. 
Due to the role of HMGN5 in the organization of chromatin architecture and its impact 
on transcriptional regulation, studying the dynamics and function of HMGN5 may 
help to understand the contribution of chromatin architecture to the maintenance of 
cell homeostasis.  
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3 Objectives 
 
Here we proposed to use the human HMGN5 protein as a model protein to study the 
dynamics of opening of higher-order structure of chromatin and its contribution to the 
regulation of transcription, by using integrative genome-wide analysis. 
For that purpose, we will analyze the genomic distribution of HMGN5, and study the 
effects of HMGN5 deregulation on the global transcription pattern. The integration of 
this data will shed light on the influence of the binding of HMGN5 at specific genomic 
loci on the transcriptional levels of the associated genes. We will try to determine the 
functional role of HMGN5 by analyzing its genome-wide association with regulatory 
elements and characterized chromatin hallmarks, like the histone PTMs H3K27ac 
and H3K4me3, or RNA polymerase II distribution, and others.  
To test the hypothesis of the involvement of RNA in the regulatory mechanism 
mediated by HMGN5, we will characterize the in vitro RNA binding properties of the 
protein, and we will try to identify the potential RNA interacting partners in vivo. The 
data obtained will be integrated with the genomic distribution of HMGN5 and the 
transcriptome profile to get more insight into a possible functional mechanism. 
In parallel, we will perform quantitative mass spectrometry to analyze the global 
HMGN5-protein interactome with the aim to reveal potential physiological binding 
partners that may help to delineate the role of HMGN5 in the regulation of higher-
order structure of chromatin. 
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4 Results 
 
 
4.1 HMGN5 decompacts chromatin 
 
It was already shown that HMGN5 induces large-scale chromatin decompaction 
(Rochman et al., 2009). As proof of these results, we tested the global chromatin 
decompaction in vivo by using the LacI/LacO tethering system (Figure 8). This 
method allows the targeting of a protein to an array of a tandem repeat (256 copies) 
of the Lac operon (LacO) sequence which is inserted in a highly compacted telomeric 
region in U2OS cells (Jegou et al., 2009). The HMGN5 protein is fused with a GFP-
LacI construct, in which the LacI repressor allows the recruitment to the LacO 
sequence, and GFP fluorescence is used for in vivo visualization. The hHMGN5-
GFP-LacI construct (vector psV2_HMGN5-GFP-LacI) was used for transient 
transfection of U2OS cells containing the LacO array, and GFP fluorescence was 
monitored by confocal microscopy. When HMGN5 was tethered to the LacO array, 
large-scale chromatin decompaction induced by HMGN5 was observed, as the LacO 
array appears decondensed compared with the GFP control, in which a highly 
condensed chromatin structure is observed (Figure 9). We also tested the human 
Parathymosin (PTMS) protein (construct pSV2-PTMS-GFP-LacI), which, like 
HMGN5, is an acidic and unstructured protein with a nuclear and nucleolar 
localization and that was described to counteract the binding of H1 to chromatin 
(Martic, 2005) and to decompacts chromatin. As shown in Figure 10, the recruitment 
of PTMS to the LacO array does not decondense chromatin in our system, indicating 
the functional specificity of HMGN5 in the global chromatin reorganization. 
 
 
 
 
 
 
 
Results 
44 
 
 
 
 
 
 
 
 
 
Figure 8. Representation of HMGN5 tethering to LacO array 
The diagram illustrates the LacI/LacO tethering system. The fusion protein containing 
HMGN5-GFP-LacI is tethered through the LacI repressor (depicted in blue in the left 
diagram) to a tandem array (256 copies) of the LacO sequence, which is stable integrated in 
a telomeric region is the U2OS cell line. Using confocal microscopy the effect of HMGN5 in 
LacO array decompaction is visualized by the distribution of GFP signal from the fusion 
protein. In the right drawing a cartoon of a cell containing the stable integration of the LacO 
array is indicated. 
 Image adapted from: 
 https://malone.bioquant.uni-heidelberg.de/methods/single_cell/single_cell.html. 
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Figure 9. HMGN5-mediated chromatin decondensation. 
U2OS cells containing a stable integration of the LacO array were transfected with the 
construct pSV2_GFP_LacI_HMGN5 or with the control plasmid pSV2_GFP_LacI for 
transient expression of HMGN5_GFP_LacI or GFP_LacI respectively, to analyze the 
tethering to the LacO array. 24 h post transfection the cells were fixed with 4% PFA and the 
DNA was counterstained with DAPI. Cells were visualized by confocal microscopy using a 
Leica SP8 device. The arrows indicate the tethered protein (seen by GFP fluorescence). The 
lower panel shows selected example cells transfected with HMGN5. Insets show magnified 
areas indicated by the arrows. In the merged images, DNA is shown in red and the GFP 
signal in green. Scale bars represent 2µm. 
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Figure 10. PTMS tethering to the LacO array.  
A construct containing PTMS-GFP-LacI (vector pSV2_GFP_LacI_PTMS) was transiently 
transfected to U2OS cells containing the LacO array. 24 h after transfection the cells were 
fixed with 4% PFA and the DNA was counterstained with DAPI. Cells were analyzed by 
confocal microscopy using a Leica SP8 device. The picture shows a representative cell 
transfected with PTMS. In the merged image the DNA is shown in red and the GFP signal in 
green. Scale bar represents 5µm. 
 
 
 
 
4.2 HMGN5 is a specific RNA binding protein 
 
 
It was previously demonstrated in our laboratory that the Drosophila protein Df31 
(decondensation factor 31), which is a functional homolog of HMGN5, specifically 
interacts with RNA forming a ribonucleoprotein complex that maintain accessible 
higher-order structures of chromatin (Schubert et al., 2012). 
To explore the potential role of HMGN5 in RNA binding, we tested the in vitro 
interaction of the full-length recombinant human HMGN5, expressed as GST tagged 
protein (Figure 11), with various fluorescently labeled short single-stranded nucleic 
acid sequences (Table 1). The interaction was analyzed by electrophoretic mobility 
shift assays (EMSA) and microscale thermophoresis analysis (MST).  
A serial dilution of the protein was performed in a 2:1 ratio and incubated with 50nM 
of the respective nucleic acid (details in section 7.2.4.2). We used for binding two 
ssRNA with predicted secondary structure, the snoRNA2T2 (38nt) and snoRNA2T1 
(33nt), two RNA without predicted secondary structure, the U-rich En3_TFO_RNA 
5µm
GFPDAPI Merge
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(29nt) and its complementary A-rich RNA sequence En3_RNA_rev (29nt). As control 
of specificity we used two ssDNA, the En3_TFO_DNA, with the same sequence 
composition than the En3_TFO_RNA and its complementary DNA En3_DNA_rev, 
both 29nt long. 
Interestingly, HMGN5 is able to specifically interact with RNA as observed by the 
formation of specific high molecular weight complexes in EMSA with the structured 
RNA samples snoRNA2T2, snoRNA2T1, and with the unstructured En3_RNA_rev 
and En3_TFO_RNA (Figure 12A).  
We analyzed the binding affinities of the protein to the nucleic acids using Microscale 
Thermophoresis (MST). Due to technical limitations with fluorescence detection, the 
analysis could only be performed for the nucleic acids En3_TFO_DNA, 
EN3_TFO_RNA, snoRNA2T1 and snoRNA2T2. As it was observed in EMSA, the 
MST analysis showed a higher affinity of HMGN5 for ssRNA over ssDNA (Figure 
12B). 
When comparing the binding affinity of HMGN5 to the nucleic acids En3_TFO_DNA 
and En3_TFO_RNA -both having the same sequence- HMGN5 shows a clear 
preference for binding the RNA over the DNA, as seen by EMSA and after MST 
analysis (Figure 12A and B) with an EC50 value of 100nM for the binding to 
En3_TFO_RNA, and 741nM for En3_TFO_DNA. This difference is even more 
dramatic when comparing the binding to the nucleic acids En3_RNA_rev and 
En3_DNA_rev, which correspond to the complementary sequences of the 
En3_TFO_RNA and En3_TFO_DNA respectively, in which the protein showed clear 
binding for the RNA molecule in EMSA but it does not bind the DNA molecule at the 
given protein concentrations. It is important to notice that there is no apparent 
influence of the secondary structure of the RNA in the in vitro binding affinity of 
HMGN5, as judged by the similar binding pattern of the three ssRNA analyzed. 
Those results suggest a biological function of the RNA binding of HMGN5, and a 
possible involvement of RNA in the HMGN5 mediated chromatin decondensation.  
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Figure 11. Purification of recombinant HMGN5 
A) Schematic representation of the full-length human HMGN5 protein. The red box 
represents the nuclear localization signal (NLS); the nucleosomal binding domain (NBD) 
containing the core sequence RRSARLSA is represented in cyan, and the green boxes 
represent the repetition sequence EDGKE (the serines at position 20 and 24 from this 
sequence are marked in red). B) The human recombinant HMGN5 was expressed in E.coli 
as a GST-tagged construct. 1µg of purified protein was analyzed by denaturing 
polyacrylamide gel electrophoresis (SDS-PAGE) containing 12% PAA. PageRuler 
Prestained Protein Ladder Plus was used as a reference for molecular weight. The 70kDa 
band is indicated. 
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Table 1. Single-stranded nucleic acids used in EMSA and MST. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Four single-stranded RNA and two single-stranded DNA molecules were used for EMSA 
and MST experiments. The sequences, structure predictions, fluorescent label and length 
are shown for each nucleic acid. The secondary structure prediction was performed with 
the RNAfold web tool. 
GAGUUUA
UUACU
AAUC
U
U U C G
G G U A U G A A A U U C
GC
UAGCGUGA
UAA
UGAU
U U C A A C U
U C A C U G C U G A C C
A
G
GGAGGAAAAAAGAAAAAAAAAA
AAAAAGA
CCTCCTTTTTTCTTTTTTTTTTTT
TTTCT
CCUCCUUUUUUCUUUUUUUUU
UUUUUUCU
GCUAGCGUGAUAAUGAUUUCA
ACUUCACUGCUGACCAG
GAGUUUAUUACUAAUCUUUCG
GGUAUGAAAUUC
En3 DNA rev
En3 TFO DNA
En3 TFO RNA
snoRNA2T2
snoRNA2T1
Not predicted
Not predicted
Not predicted
     Nucleic acid                      Sequence                  Structure      Label
GGAGGAAAAAAGAAAAAAAAAA
AAAAAGA
En3 RNA rev Not predicted
Cy5
Fam
Fam
Cy5
Cy3
Fam
Length (nt)
33
38
29
29
29
29
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Figure 12. HMGN5 interaction with nucleic acids. 
A) HMGN5-nucleic acid interaction analyzed by EMSA. Each fluorescently labeled nucleic 
acid was kept at a constant concentration of 50nM and a 2:1 dilution of the protein was used 
starting with 2µM. B) Binding interaction determined by MST. The protein-nucleic acid 
interactions were quantified by Microscale thermophoresis using the same conditions 
described for EMSAs. The fluorescence was normalized to fraction bound after adjusting the 
binding curve with the Hill equation and the EC50 value for each interaction was determined 
(in Lowe box EC50 +/- standard deviation). The binding interaction by MST was measured 
for the ssRNAs En3_TFO_RNA, snoRNA2T1, snoRNA2T2 and the ssDNA En3_TFO_DNA. 
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4.3 The nucleosome-binding domain is required but 
not sufficient for RNA binding 
 
 
Since HMGN5 is a highly acidic and unstructured protein, there is no available data 
regarding the presence of any common RNA binding motif, therefore we focus in the 
structural characterization according to the nucleosomal binding function of the 
protein. In HMGN5, like in the other members of the HMGN family, the canonical 
nucleosomal binding domain (NBD) is crucial for the binding of the protein to 
nucleosomes. Specifically, NBD contains two serines (S20 and S24 in human 
HMGN5), that are phosphorylated during mitosis; the phoshorilation was shown to 
decrease the association of the protein to chromatin (Prymakowska-Bosak et al., 
2001; Rochman et al., 2009; Malicet et al., 2011). In order to verify which part of the 
protein is responsible for the RNA binding ability and test the contribution of the NBD 
to the RNA binding, we created a set of deletion mutants (as GST-tagged constructs) 
and three phosphomimetic mutants (Figure 13A and B) -to mimic phosphorylation of 
HMGN5 during mitosis-, and tested the binding to the Cy5 labeled RNA snoRNA2T2 
with which the full length protein showed a specific interaction.  
The analysis of interaction reveals that the protein mutant lacking the first 19 amino 
acids (∆N19) still forms the RNA-protein complex (Figure 13C), but even at the 
highest protein concentration (2µM) only less than 50% of RNA is bound to HMGN5, 
indicating that those amino acids contribute to the high binding affinity of the protein. 
When the first 20 amino acids are deleted (mutant ∆N20) the RNA binding activity is 
almost completely lost. Furthermore, when deleting the first 24 amino acids (∆N24), 
containing parts of the NBD including the two serines responsible for the nucleosome 
binding activity, the RNA interaction is completely abolished. These results indicate 
that the N-terminal region containing the first 24 amino acids, are required for RNA 
binding. Interestingly, the deletion mutant ∆C27 that contains only the first 26 amino 
acids, including the NBD, has also a reduced RNA affinity compared with the wild 
type and the formation of a defined complex is not observed, but rater a smear at the 
three higher protein concentration. Moreover, the NBD mutant that contains only the 
amino acids from the nucleosome-binding domain completely loses the RNA binding 
ability, indicating that this region is required but not sufficient by itself for RNA 
binding. This result is confirmed by the RNA binding of the phosphomimetic mutants 
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(Figure 13D). Here, the serines at position 20 and 24 are replaced by glutamic acid. 
The mutant S24E shows a similar binding pattern as the ∆N19, while the mutant 
S20E shows a more pronounced decrease in RNA binding, but still, in both cases, a 
stable protein-RNA complex is observed. The replacement of both serines by 
glutamic acid (S20,24E) produces a binding pattern similar to ∆C27, with smeary 
bands, indicating the formation of intermediate binding species or instable binding. 
This results show that the serines 20 and 24 have a clear contribution to the RNA 
binding properties of HMGN5, and it suggests that the C-terminal part of the protein -
judged by the binding of the ∆C27 mutant- contribute to stabilize the RNA-protein 
complexes. 
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Figure 13. Interaction of deletion and phosphomimetic mutants of HMGN5 with 
RNA. 
A) Schematic representation of HMGN5 deletion and phosphomimetic mutants. The amino 
acids 1-36 including the nucleosomal binding domain are shown. Red lines represent the 
deleted amino acids; black lines correspond to non-shown amino acids. The phosphomimetic 
point mutations S20E, S24E and S20,24E are colored in green. B) Coomassie stained 
polyacrylamide gel of the recombinant GST-tagged mutants. 1µg of each purified protein was 
loaded on a 12% denaturing polyacrylamide gel electrophoresis (SDS-PAGE). The 70kDa 
and 25 kDa bands of the pre-stained protein marker (PageRuler Prestained Protein Ladder 
Plus) are indicated as molecular weight reference. C) Interaction of HMGN5 deletion mutants 
and D) HMGN5 phosphomimetic mutants with RNA. The interactions were done using 50nM 
of the Cy5 labeled snoRNA2T2 and the proteins were serial diluted in a ratio 2:1 starting at 
2µM and measured by EMSA assays. Free RNA and the formation of the complex are 
indicated. A control without protein was loaded in each gel. The interactions were loaded on 
a 6% native polyacrylamide electrophoresis with 0.4X TBE and visualized and documented 
using the Typhoon FLA 9500 (GE Healthcare). 
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4.3.1 Stabilization of RNA-complexes by intramolecular 
interaction of HMGN5 
 
It has ben shown that several intrinsically disordered proteins (IDPs) fold upon 
binding of their interacting partners to form a defined structure (Staby et al., 2017)  
(Mitrea & Kriwacki, 2013). As our previous data suggests that the N-terminal part of 
HMGN5 is responsible for the RNA-binding and the C-terminal part of the protein 
may help stabilizing the complexes, we wanted to test if the contribution of the C-
terminal domain is determined by the “folding upon binding” hypothesis. In order to 
do that, we mixed the deletion mutant ∆C27 -containing the N-terminal domain of 
HMGN5 (which does not show a major specific protein-RNA complex) with equimolar 
concentrations of the deletion mutant ∆N24 (non-binding mutant) to complement the 
full-length sequence of HMGN5 and analyze the interaction with RNA. For the 
interactions, the snoRNA2T2 was kept at a constant concentration of 50nM, while 
both proteins were serial diluted in a 2:1 ratio starting with 2µM as the highest 
concentration (See methods 7.2.4.2). Interestingly, the RNA binding activity is 
recovered when both proteins are mixed as judged by the formation of the specific 
protein-RNA complexes (Figure 14) compared with the binding of the independent 
proteins with RNA (∆C27 and ∆N24 EMSA pictures taken from Figure 13), indicating 
that there is a specific interaction between both protein domains that allow the 
formation of a stable RNA-protein complex. Altogether those results suggest that the 
RNA binding is mediated by the N-terminal domain of HMGN5, with special influence 
of the serines 20 and 24 from the NBD, and stabilized by intramolecular interactions 
with the C-terminal domain upon binding of the RNA. 
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Figure 14. The RNA binding is stabilized by protein intramolecular interactions. 
The Cy5-labeled ssRNA snoRNA2T2 was used at a constant concentration of 50nM. 
Proteins were mixed in equimolar concentration and serial diluted in a 2:1 ratio starting with 
2µM. EMSAs corresponding to interaction of mutant ∆C27 and ∆N24 were taken from figure 
13. Under each EMSA experiment a schematic representation of the deletion mutants used 
is shown. The first and last amino acid of each protein is indicated in the schemes. For each 
experiment a negative binding control without protein was performed. The interactions were 
loaded in a 6% native PAGE and visualized and documented with a Typhoon FLA 9500 (GE 
Healthcare). 
 
 
 
4.4 The ability to bind RNA is a characteristic of the 
HMGN family 
 
The N-terminal domain containing the NBD in HMGN5 is a conserved region among 
all the members of the HMGN family. As this domain is responsible for nucleosome 
and RNA binding activity in HMGN5, we wanted to test whether this is a general 
feature of HMGN proteins. Therefore, we expressed, purified and tested the protein 
HMGN2 and compared the putative RNA binding ability with HMGN5. HMGN2 is 
composed of 90 amino acids in humans, three times shorter than the human HMGN5 
but the minimum binding sequence RRSARLSA from the NBD is conserved (Figure 
15).  
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Figure 15. Comparison between HMGN5 and HMGN2 protein features. 
Cartoon depicting the HMGN5 and HMGN2 features. The nuclear localization signal (NLS) 
is indicated in a red box (one NLS in HMGN5 and a bipartite NLS in HMGN2). The 
nucleosomal binding domain (NBD) and the NBD core containing the conserved octapeptide 
RRSARLSA are represented in cyan and blue boxes respectively. The two serines of this 
sequence (responsible for nucleosome binding) are highlighted in red. The orange box in 
HMGN2 represents the chromatin-unfolding domain, and the green boxes represent the 
repetitive sequence EDGKE in HMGN5. The last amino acid of HMGN5 (amino acid 282) 
and HMGN2 (amino acid 90) are indicated in the cartoon. 
 
 
 
We created a recombinant human HMGN2 as GST tagged construct (Figure 16A). 
We prepared a serial dilution of the protein in a 2:1 ratio (Methods 7.2.4.2) and 
performed the interaction with 50nM of the RNA snoRNA2T2. The interaction was 
analyzed by EMSA and MST measurement. The result from Figure 16B shows that 
HMGN2 is also able to specifically interact with RNA, as a clear high molecular 
weight complex is formed (lanes 6-10). The MST analysis (Figure 16C) shows that 
HMGN2 binds the RNA with an affinity of 844±7.7nM (EC50 value), while HMGN5 
shows, nevertheless, a better binding to the snoRNA2T2, with an affinity of 368nM. 
This is also visible in the EMSA experiments, in which HMGN5 produces a complete 
shift of the RNA (as already seen in Figure 12A and Figure 13C), while for HMGN2, 
even at the highest concentration there is RNA in a free state (Figure 16B).  
Additionally, we compared the RNA binding of HMGN5 with HMGB1, member of the 
HMGB family, characterized by a conserved HMG-box motif. Like HMGN proteins, 
HMGB1 is able to interact with chromatin and to regulate nuclear processes like 
transcription, replication or DNA repair (Bustin, 1999). HMGB1 recognizes 
specifically pre-bent or distorted DNA, and it is able to interact with branched RNA 
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substrates (A. J. Bell, Chauhan, Woodson, & Kallenbach, 2008). To compare the 
specificity of HMGN5 binding to the HMGB1-RNA interaction, we measured the RNA 
binding ability of a recombinant HMGB1 from rattus norvegicus, which shares 99% 
sequence identity with the human HMGB1. The protein was kindly provided by Dr. 
Klaus Grasser from the University of Regensburg.  
The recombinant protein (Figure 16D) was used in the interaction assay in the same 
way than in HMGN5 and HMGN2 interactions (Materials and methods 7.2.4.2), and 
we used snoRNA2T2 for binding assays at 50nM concentration. Interestingly, we can 
observe that at the same concentrations used for HMGN-RNA interactions, HMGB1 
does not show RNA binding in the EMSA assay (Figure 16E), since no RNA-protein 
complex is formed. This result reinforces the specificity of the RNA binding of the 
HMGN proteins. 
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Figure 16. HMGN2 and HMGB1 interactions with RNA. 
A) Purification of the recombinant GST-tagged human HMGN2 protein. 1µg of purified 
protein was loaded on a 12% denaturing polyacrylamide gel electrophoresis (SDS-PAGE) 
and stained with Coomassie. The 35kDa band of the protein marker is indicated as 
reference of molecular weight (Lane 1). B) Interaction of HMGN2 with the Cy5-labeled 
snoRNA2T2 analyzed by EMSA. HMGN5 was serial diluted in a ratio of 2:1 starting with 
2µm as highest concentration (Lane 10) and the RNA used in a concentration of 50nM. C) 
Analysis of HMGN2-RNA interaction by MST. The binding curve was determined according 
to the Hill equation and the EC50 value was calculated (indicated in the nM range ± 
standard deviation). The binding was compared to the HMGN5-snoRNA2T2 interaction. D) 
Recombinant HMGB1 from rattus norvegicus. 1µg of recombinant protein was loaded on a 
12% SDS-PAGE and stained with Coomassie (Lane 2). Lane 1 indicates the molecular 
marker (PageRuler Plus prestained protein Ladder) E) Interaction of HMGB1 with 
snoRNA2T2. The protein-RNA interaction was prepared with the conditions indicated in (B). 
Lane 1 in (B) and (E) correspond to a negative control without protein. 
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4.5 Establishment of inducible stable HMGN5 cell 
line 
 
 
The in vitro analyses revealed the specific binding of HMGN5 to RNA. In order to 
unravel the biological significance of these interactions and to identify physiological 
RNA substrates it is necessary to study the interactions in an in vivo context. One 
possibility to achieve that is to immunoprecipitate the endogenous protein from cells 
using very specific antibodies to isolate the interacting partners and analyze the 
function of the protein in vivo. We tested several commercial antibodies from different 
companies to test the endogenous protein, and performed immunoprecipitation from 
HeLa cells. Unluckily none of them was suitable for protein immunoprecipitation (data 
not shown). Therefore, we created stable cell lines using the Flp-In system from 
Invitrogen (based on the T-REx™-293 cell line) to generate a stable inducible 
expression of HMGN5, as a GFP tagged construct (Section 7.2.5.2) for 
immunoprecipitation with anti-GFP antibodies.  
The advantage of producing stable cell lines with the Flp-In system, is the generation 
of isogenic cell population, with low inter-assay variation and homogeneous 
expression, due to the tetracycline-regulated protein expression (Savage, Wootten, 
Christopoulos, Sexton, & Furness, 2013).  
Figure 17 shows the successful establishment of the HMGN5-FlpIn cell line. After 24 
hours of induction, HMGN5 localizes in the nucleus, correlating with the localization 
of the endogenous HMGN5 (see Dox+ images in the Figure 17). It can be observed 
an homogeneus population of cells expressing the protein. In the non-induced cells 
(Dox-) we do not observe leaky protein expression. 
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Figure 17. Establishment of HMGN5 FlpIn inducible cell line.   
Selected stable clones were seeded in 6-well plates. After 24 h of induction with Doxycycline 
(Dox+) or without induction (Dox-), cells were fixed with 4% PFA and analyzed with confocal 
microscopy on a Leica SP8 device. DNA was counterstained with DAPI. HMGN5 expression 
was visualized by GFP fluorescence. In the merged images the DNA is shown in red and the 
HMGN5 protein expression in green. Lower images show 10 times magnified captures (2µm 
scale bar). 
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To estimate kinetics and levels of protein expression, a time course of HMGN5 
induction was performed. Figure 18 shows a western blot after the induction of 
HMGN5 with Doxycycline, from 0 to 24 h. Between 6-9 hours there are detectable 
protein levels, without an excess of protein degradation, therefore those time points 
were selected for the downstream experiments.   
 
 
 
 
 
 
 
 
 
 
Figure 18. Time course of HMGN5 expression. 
 Western blot showing the expression of the construct HMGN5-GFP after inducing the cells 
with Doxycycline. Total protein extracts were prepared after inducing the HMGN5 FlpIn cells 
with 1µg/ml Doxyciclyne for 0, 3, 6, 9, 16 and 24 h. 20µg of protein extracts were loaded per 
lane on a 12% SDS-PAGE and transferred to a PDVF membrane for western blot. HMGN5 
was detected using the anti-HMGN5 antibody HPA000511 (Sigma). The 70kDa band of the 
marker is indicated as reference of molecular weight. 
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4.6 Effect of HMGN5 deregulation in the global 
transcriptome pattern 
 
 
It has been shown that the loss or overexpression of HMGN5 affects the global 
transcriptome profile of the cells, in a tissue-specific manner (Kugler et al., 2013; 
Rochman et al., 2009). To analyze the role of the human HMGN5 protein in the 
transcriptional regulation in our system, we performed an RNA-seq profile and did a 
comparative expression analysis of genes after 24 h overexpression or knockdown of 
the protein in the stable cell line (HMGN5_FlpIn). For the knockdown HMGN5_FlpIn 
cells without selection antibiotics were seeded in 10cm plates per triplicate and 
transfected with smartpool siRNA complementary to the HMGN5 RNA for 24 h (see 
Figure 42 in the appendix for knockdown standardization). Two of the three biological 
replicates were selected for RNA sequencing per condition. Two replicates of un-
induced cells were used as control for baseline RNA expression. After treatment, the 
RNA was extracted (section 7.2.2.11), the libraries were prepared and RNA 
sequenced (7.2.7.1). Following quality analysis, the raw data was mapped to the 
hg19 human genome using the STAR aligner. A differential gene expression was 
performed to estimate the effects of HMGN5 overexpression and knockdown.  
The analysis highlights that the up- and down regulation of HMGN5 leads to 
transcriptional changes in 2999 and 3049 genes respectively (Figure 19A). A large 
set of genes (1287), corresponding to one third of the total transcripts affected is 
overlapped between the two conditions. Interestingly, only 90 genes from this set are 
reciprocally regulated. Detailed comparison of the two groups of genes affected 
indicates similar number of genes up or down regulated in both conditions, and for 
most of the genes, Log2 fold change were smaller than 2 (Figure 19B). Principal 
component analysis of the HMGN5 expression exhibits a correlation of the 
expression in the biological replicates analyzed for each condition: overexpression, 
knockdown and control cells (Figure 19C), indicating a good reproducibility of the 
data.  
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Figure 19. Modulation of global transcriptome profile by HMGN5 misregulation. 
A) Venn diagram depicting the overlapped transcriptional changes upon overexpression (OE) 
and knockdown (Kd) of HMGN5 in the HMGN5_FlpIn cell line (24 h of induction). A threshold 
of adjusted p-value <0.05 was used. B) MA plot of differential expression analysis. Points 
representing RNAs with significant differential expression compared with the control samples 
are marked in red. Gene expression changes were normalized to Log2 fold-change ratios. 
(C) PlotCount graph showing the normalized count of the HMGN5 transcript from the RNA-
seq in the non-treated cells (Control), knockdown and overexpression of HMGN5 (OE). Each 
dot in the groups represents individual biological replicates. 
 
 
 
We selected four candidate genes with affected transcription levels in the RNA-seq 
analysis for validation in qPCR. One of them ZCCHC12 (Zinc Finger CCHC-Type 
Containing 12) was 2 fold down-regulated after knockdown of HMGN5, and 0.6 fold 
up-regulated after HMGN5 overexpression. VGF (VGF Nerve Growth Factor 
Inducible) showed increased expression in both conditions (4-fold and 1.5-fold after 
knockdown and overexpression respectively). The genes coding for RPL30 
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(Ribosomal Protein L30) and EGR1 (Early Growth Response 1) changed their 
expression levels only after one treatment. RPL30 had a Log2FC of -2 after HMGN5 
Kd and EGR1 is up-regulated with Log2FC of 1.8 after HMGN5 OE. qPCR validation 
for all four candidates was performed on three independent biological replicates. The 
results obtained from the validation were normalized to log2FC and a student t-test 
was applied for statistical significance. As shown in Figure 20 there is a strict 
correlation between the log2FC obtained from qPCR for each candidate gene and 
the one obtained from the RNA-seq analysis, which further validate the RNA-seq 
analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. qPCR validation of 4 candidate genes. 
Log2 fold-change comparisons between qPCR and RNA-seq analysis for four selected 
candidates that showed differential expression between the treatments. Log2FC in qPCR 
estimates relative RNA enrichment in the treated cells (overexpression and knockdown of 
HMGN5) over non-treated control cells. Standard deviation from 3 independent biological 
replicates applies only to qPCR results. GAPDH was used for normalization of expression. 
Two-way ANOVA and Dunett´s post-test were used to define statistical differences of mRNA 
levels between groups. Kd: knockdown; OE: overexpression of HMGN5. ZCCHC12: Zinc 
Finger CCHC-Type Containing 12; VGF: Nerve Growth Factor Inducible; RPL30: Ribosomal 
Protein L30; EGR1: Early Growth Response 1. 
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We performed gene ontology (GO) enrichment analysis of genes that change their 
transcription levels after up- and down-regulation of HMGN5. Gene sets were 
functionally clustered by molecular function and biological process using the ClueGo 
plug-in (Bindea et al., 2009) of the Cytoscape Network (Cline et al., 2007). Statistical 
enrichment analysis reveals that mainly genes associated with cell cycle regulation 
and telomere elongation are down regulated in both conditions (Figure 21B and 
Figure 22B). HMGN5 overexpression leads to up-regulation of genes classified as 
“negative regulation of gene expression” (Figure 21A), in which several transcription 
factors are clustered. We also find upregulated genes associated with the apoptotic 
process and “cellular protein metabolic process”. The results showing that genes 
associated with cell cycle progression are affected, correlates with the role of 
HMGN5 in cell cycle regulation and cancer cell growth, previously shown in the 
literature (reviewed in Shi, Tang, Wu, & Sun, 2015).  
Additionally, genes associated to “RNA biosynthetic process”, “translation” and 
“negative regulation of gene expression” are up-regulated after a loss of HMGN5 
(Figure 22A), indicating that HMGN5 is important for controlling gene expression. 
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Figure 21. Gene set enrichment analysis after HMGN5 overexpression. 
Detailed GO term enriched in genes affected by HMGN5 overexpression is represented as a 
pie chart. Genes with increased expression levels (A) and with decreased expression levels 
(B) are analyzed. The groups are organized from higher (up) to lower (bottom) number of 
genes per group in the color legend, and displayed consecutively in the chart. The analysis 
was performed using the ClueGo software. Significance of enrichment was estimated with a 
two-sided hypergeometric test and the p-value correction was performed appliying the 
Bonferroni step-down method. The leading term correspond to the most significant term in 
the group. Only term with PValue <0.005 are shown. 
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Figure 22. Gene set enrichment analysis after HMGN5 knockdown. 
Detailed GO term enriched in genes affected by HMGN5 knockdown is represented as a pie 
chart. Genes with increased expression levels (A) and with decreased expression levels (B) 
are analyzed. The groups are organized from higher (up) to lower (bottom) number of genes 
per group in the color legend, and displayed consecutively in the chart. The analysis was 
performed using the ClueGo software. Significance of enrichment was estimated with a two-
sided hypergeometric test and the p-value correction was performed appliying the 
Bonferroni step-down method. The leading term correspond to the most significant term in 
the group. Only term with PValue <0.005 are shown. 
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When analyzing the 1287 genes overlapped between up- and down-regulation of 
HMGN5, a similar group of GO terms are overrepresented (Figure 23) in comparison 
with the separate datasets. Here, again, genes related to cell cycle regulation are 
mostly affected. It can be observed that genes related to RNA metabolism and 
processing, as gene associated with protein transport to Cajal bodies are also 
enriched. Since the subnuclear compartments Cajal bodies are associated with 
biogenesis, maturation and recycling of small RNAs (Nizami, Deryusheva, & Gall, 
2010), those results further confirm that HMGN5 plays a role in the regulation of RNA 
metabolism. 
 
 
 
Figure 23. Gene set enrichment analysis of the overlapped genes between 
overexpression and knockdown of HMGN5. 
Detailed GO term enriched in the genes affected by overexpression and knockdown of 
HMGN5 is represented as pie chart. The groups are organized from higher (up) to lower 
(bottom) number of genes per group in the color legend, and displayed consecutively in the 
chart. The analysis was done with the ClueGo software; significance of enrichment was 
estimated with a two-sided hypergeometric test and the p-value correction with the 
Bonferroni step-down method. The leading term correspond to the most significant term in 
the group. Only term with p-value <0.005 are shown. 
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4.7 HMGN5 UV-crosslinking immunoprecipitation 
 
 
To identify potential in vivo RNA targets of HMGN5, we performed an RNA 
immunoprecipitation after UV crosslinking (CLIP), using the HMGN5_FlpIn cell line. 
As control we performed the immunoprecipitation using a GFP_FlpIn cell line 
available at our laboratory. Protein immunoprecipitation after UV crosslinking is 
generally used to identify genome-wide RNA-protein interactions in vivo. The method 
(described in Ule, Jensen, Mele, & Darnell, 2005) has the advantage of generating 
good signal:noise ratio compared with the classical RNA immunoprecipitation method 
(RIP), and allows the identification of binding sites in the target RNAs (Darnell, 2010). 
First, cells are treated with UV at 254nm to create covalent bonds between proteins 
and their interacting RNAs in vivo. Afterwards, the complexes are 
immunoprecipitated from cell lysates while a partial RNase A/T1 digestion on beads 
is performed. The protein-bound RNAs are subsequently radiolabeled and 
transferred to a nitrocellulose membrane for isolation. Then, the protein is removed 
with proteinase K, and RNA linkers added to the isolated RNA to generate the 
libraries for high throughput sequencing. 
 Since HMGN5 is a protein that strongly binds chromatin, the original protocol of 
CLIP, applied for soluble proteins cannot be directly used. Therefore, we modified the 
protocol by introducing a sonication step to fragment genomic DNA, before 
immunoprecipitation (workflow in Figure 24A). First we analyzed the efficiency of UV 
crosslinking in our samples. Cells from the HMGN5_FlpIn cell line and the control 
GFP_FlpIn, were treated for 8 h with (Dox+) or without (Dox-) Doxycycline to induce 
protein expression. Cells were treated with or without crosslinking with 150mJ/cm2 of 
UV at 254nm followed by protein co-immunoprecipitation. Figure 24B shows the 
efficiency of HMGN5 crosslinking and immunoprecipitation. For both HMGN5 and 
GFP, the immunoprecipitation is highly efficient, as judged by the high yield of the 
specific proteins. HMGN5 corresponds to the prominent band identified at 80-90kDa 
(Figure 24B, lanes 3-4) and GFP corresponds to the 26kDa band in lanes 6-7 in the 
figure 24B. Due to its ability of binding nucleosomes, the efficiency of crosslinking 
between HMGN5 and RNA can be followed by the co-immunoprecipitation of 
histones. In both induced HMGN5 samples (Lanes 3-4) the core histones are visible, 
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at a molecular weight between 10 and 15kDa, but when UV crosslinking is applied 
the amount of co-purified histones increases more than twice, with an observed 
approximate ratio 1:1 to HMGN5 (Figure 24B, lane 3). Linker histone H1 is also 
visible after UV crosslinking of HMGN5 samples. When comparing with the GFP 
control after induction and UV crosslinking, none of those bands are observed (figure 
24B lanes 6-7), indicating that the co-purification of histones is not background but 
rather mediated by specific interaction of HMGN5 with nucleosomes which is 
stabilized by UV crosslinking.  
 
 
Figure 24. HMGN5 CLIP standardization. 
A) Workflow of CLIP protocol to immunoprecipitate HMGN5-bound RNAs. After cells lysis a 
sonication step is performed for chromatin fragmentation. After immunoprecipitation with 
GFP_Trap magnetic beads, an on-bead partial RNA digestion is performed with RNAse 
A/T1. To isolate interacting RNAs, a DNAse and proteinase K treatment is performed to 
remove DNA and proteins respectively. Purified RNAs are used to prepare libraries for high 
throughput sequencing. B) Efficiency test of UV crosslinking. Cells grown in 15cm plate (from 
HMGN5-FlpIn and GFP-FlpIn), are treated with or without induction (Dox+ /Dox-), and 
subjected to UV crosslinking by applying 150mJ/cm2 UV at 254nm (UV+), or without UV 
treatment (UV-). Samples were used for protein Co-IP using the GFP_Trap agarose beads. 
10% of the immunoprecipitated samples were loaded on a 12% SDS-PAGE and visualized 
after Coomassie staining. PageRuler Prestained Protein Ladder Plus was used as a 
reference for molecular weight. The 70, 25 and 15 kDa bands are indicated in the figure. 
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As already mentioned, in our protocol we applied sonication to shear the chromatin 
and reduce unspecific background RNAs that were associated to chromatin. We 
tested the effect of sonication on the RNA quality by performing a sonication time 
course in the cells. After 20 min of intense sonication (sufficient to shear the 
chromatin) the total RNA content is mainly intact (Figure 25A, lane 5), as judged by 
the integrity of the 28S and 18S ribosomal RNA. 
Figure 25B shows the RNA partial digestion in lysed cells using the RNase A/T1 
cocktail (Thermo Scientific). For downstream experiments we selected the dilution 
1:50 (lane 3) in which RNA is digested to fragments up to 600nt approximately. 
 
 
 
Figure 25. Sonication and RNase treatment for CLIP. 
A) Effect of sonication on total RNA quality. Cells grown in 15 cm plate were lysed and 
sonicated at 0 (-) 5, 10, 15 and 20 min and total RNA was extracted and analyzed on a 4% 
denaturing urea gel. RNA was visualized by Ethidium bromide (EtBr) staining. The 28S and 
18S ribosomal RNA bands are indicated. The RiboRuler Low Range RNA Ladder was used 
as molecular weight reference (M: Marker). The 1000nt and 100nt bands are indicated in the 
figure. B) Partial RNA digestion with RNase A/T1. Lysed cells from 15 cm plates were treated 
with a cocktail of RNase A/T1 at the following dilutions: 1:500, 1:100, 1:50, 1:10, undiluted 
(UD), and no treatment (-). Per sample 1µg of isolated RNA were loaded on a 4% denaturing 
urea gel and visualized after EtBr staining. The 28S and 18S ribosomal RNA bands are 
indicated. The RiboRuler Low Range RNA Ladder was used as molecular weight reference. 
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4.8 HMGN5 binds RNA in vivo 
 
HMGN5-associated RNAs were isolated using the modified CLIP-seq protocol 
(results 4.7 and methods7.2.6.2). After purifying the RNAs, a stranded library was 
prepared for sequencing using the Ovation universal RNA-seq kit (Nugen). The 
quality of the libraries for sequencing is described in Figure 44 of the appendix. The 
higher throughput sequencing of the barcoded libraries was performed at the KFB 
Regensburg in an Illumina HiSeq device, using the specific barcodes from the 
adapters to combine 6 samples in one lane, three HMGN5 biological replicates and 
three GFP control samples. The sequencing gave a total of 152117704 million reads 
yielding an average of 25 million per sample. The reads detail of the demultiplexed 
data is listed in Table 2. 
 
 
Table 2. Demultiplexed reads from CLIP libraries sequencing. 
Sample Name of raw data sample Index #Reads 
GFP1 GFP1_GCACTA_L002_R1_001 GCACTA 26.530.237 
GFP2 GFP2_ACCTCA_L002_R1_001 ACCTCA 23.277.975 
GFP3 GFP3_GTGCTT_L002_R1_001 GTGCTT 23.586.035 
HMGN51 HMGN51_AACCAG_L002_R1_001 AACCAG 20.685.221 
HMGN52 HMGN52_TGGTGA_L002_R1_001 TGGTGA 33.310.255 
HMGN53 HMGN53_AGTGAG_L002_R1_001 AGTGAG 24.727.981 
 
For each sample, the name of the raw data, specific barcode (Index) used from the 
Ovation Universal-RNA seq kit and the reads obtained after sequencing are shown. 
 
 
 
The single-end reads were mapped to the hg38 reference genome using Bowtie 
(methods section 7.2.7.3). To get the enriched RNA on the HMGN5 samples a 
differential gene expression analysis (DGE) was done using the edgeR package from 
R. Due to technical problems with the quality of reads from GFP1 sample, the 
analysis with the control GFP was performed using only GFP2 and GFP3 samples. 
For DGE a combination of all alignments from all three HMGN5 samples was used, 
and as background a combined alignment of GFP2 and GFP3 was used. The reads 
were normalized to counts per million (CPM) to control for differences in library size 
between samples, and filtered using a 5 CPM threshold (each gene should have a 
minimum count of 5-10 CPM in a library to be considered expressed). The reads 
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count was performed in two different ways, by counting exons or introns obtained 
from genes, or obtained from transcripts. When performing DGE using exons coming 
from genes, we obtained a list of 23 RNAs enriched in the HMGN5 samples (FDR 
cutoff of 0.05) (Table 3).  
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Table 3. HMGN5-associated transcripts. 
Gene ID Gene name logFC logCPM p-value FDR 
79366 HMGN5 -4.49449498 9.637634792 5.54E-19 5.67E-15 
1053 CEBPE 3.958698057 6.628945597 1.65E-16 8.43E-13 
57505 AARS2 -6.639625238 4.672186956 4.71E-10 1.61E-06 
3508 IGHMBP2 -10.42058477 4.212379836 1.81E-08 4.63E-05 
9851 KIAA0753 -10.19893051 3.99528672 4.08E-07 0.000834356 
10079 ATP9A -10.08259598 3.881664093 1.59E-06 0.002707243 
8398 PLA2G6 -10.08461392 3.883657698 2.52E-06 0.003683113 
79877 DCAKD -10.04290033 3.842892724 3.38E-06 0.004092192 
58496 LY6G5B -10.02638367 3.826942295 3.60E-06 0.004092192 
8452 CUL3 -10.01797036 3.818571999 4.30E-06 0.004399785 
41 ASIC1 -9.998895224 3.800061671 4.73E-06 0.004399785 
51603 METTL13 -9.961141771 3.763299862 7.63E-06 0.006510971 
8318 CDC45 -9.940726861 3.743386566 8.66E-06 0.006580009 
84498 FAM120B -6.83765804 4.009313143 9.28E-06 0.006580009 
157313 CDCA2 -9.932440179 3.735407464 9.64E-06 0.006580009 
52 ACP1 -9.918149108 3.721273131 1.36E-05 0.008676717 
26205 GMEB2 -9.836435056 3.641983308 2.47E-05 0.014699186 
80742 PRR3 -9.861485796 3.666656761 2.59E-05 0.014699186 
49855 SCAPER -9.801153022 3.60811899 4.58E-05 0.024650247 
25825 BACE2 -7.471101614 3.696949114 5.26E-05 0.026898461 
23216 TBC1D1 -7.472213128 3.696984403 6.50E-05 0.031676287 
3707 ITPKB -9.753532537 3.561352804 6.99E-05 0.032528457 
4337 MOCS1 -9.751324205 3.559154194 7.59E-05 0.033016902 
84447 SYVN1 -9.700511834 3.510182665 7.74E-05 0.033016902 
8854 ALDH1A2 -9.710588785 3.52029618 8.11E-05 0.033196156 
201158 TVP23C -9.673225334 3.483877758 9.77E-05 0.038449166 
56980 PRDM10 -9.648199646 3.459755756 0.000117533 0.044553581 
84326 METTL26 -9.642116562 3.453527431 0.000124256 0.045420042 
85313 PPIL4 -9.655885047 3.467047841 0.000137691 0.048595546 
85476 GFM1 -9.687933405 3.49804815 0.000143435 0.048935262 
List of RNAs generated by counting exons obtained from genes. The Gene ID, name of 
gene, log fold change (LogFC), normalized Log counts per million (LogCPM), p-value and 
adjusted false discovery rate (FDR) are shown in the list. FDR cutoff: 0.05. The negative 
LogFC values correspond to enrichment of HMGN5 over GFP. 
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Some examples from the list are shown in Figure 26. Peaks are distributed along the 
RNA body in the transcripts from the genes AARS2 (Alanyl-TRNA Synthetase 2, 
Mitochondrial), KIAA0753 (OFD1 And FOPNL Interacting Protein) and ASIC1 (Acid 
Sensing Ion Channel Subunit 1), and enriched in comparison with the GFP samples. 
The peaks are observed widely distributed in exons and introns. 
 
 
Figure 26. Examples of HMGN5-bound RNAs. 
IGV screenshot depicting representative HMGN5-interacting RNAs. HMGN5 peak track 
(red) and GFP control (green) are indicated. Peak high was normalized to 30 for all 
samples. Each track represents the merged alignment from the biological replicates (three 
HMGN5 and two GFP). AARS2: Alanyl-TRNA Synthetase 2, Mitochondrial; KIAA0753: 
OFD1 And FOPNL Interacting Protein; ASIC1: Acid Sensing Ion Channel Subunit 1. The 
respective genes are represented under the GFP track for each example. Exons are 
represented as blue boxes. Lines represent introns, and the arrows in the introns represent 
direction of the transcript. 
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When DGE analysis was performed by counting reads of exons coming from 
transcripts, we were able to identify 150 bound exonic fragments, corresponding to 
81 transcripts (Supplementary Table 9). This indicates that HMGN5 does not bind to 
the complete transcript, but rather to specific motifs in the target RNAs. An example 
is shown in Figure 27, in which the protein is enriched in exons 16, 17 and 18 in the 
transcript of SEC31B (SEC31 Homolog B, COPII Coat Complex Component) but not 
in Exon 14. 
 
 
 
 
Figure 27. Distribution of HMGN5 peaks in the SEC31B transcript. 
IGV snapshot of HMGN5 CLIP-seq peaks in the SEC31B RNA. Peaks from the merged 
HMGN5 samples (red) and GFP samples (green) are shown. Peaks coming from biological 
replicates are merged in the figure. The respective gene is represented under the GFP track. 
Exons are represented as blue boxes and enumerated accordingly to the annotation in the 
hg38 reference genome. A fragment of the gene from Exon 14 (E14) to Exon18 (E18) is 
shown. Lines represent introns, and the arrows represent the direction of the transcript. 
SEC31B: SEC31 Homolog B, COPII Coat Complex Component. 
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We analyzed the distribution of HMGN5 in the intronic sequences of transcripts, and 
we found a set of 251 intronic regions associated with the protein. The top 30 intronic 
transcript regions associated with HMGN5 are listed in Table 4. An example of the 
distribution is presented in Figure 28 where the HMGN5 peaks are widely distributed 
in the intronic regions of the gene NFIA (Nuclear Factor I A), with a 7-fold enrichment 
in comparison to the GFP samples. This result suggests that HMGN5 could be 
binding to the newly transcribed RNAs. 
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Table 4. Top 30 HMGN5-associated intronic regions from RNAs 
Intron ID Gene name logFC logCPM p-value FDR 
16397 EPHA6 2.36536253 5.079924622 3.86E-12 9.68E-08 
62341 CEBPE 3.969194718 3.276891285 6.87E-11 8.62E-07 
28963 CSNK2B -10.57284844 2.602688125 2.00E-10 1.67E-06 
28962 CSNK2B -10.32288718 2.359067287 4.61E-09 2.89E-05 
16398 EPHA6 1.899411654 5.485641471 1.29E-08 6.47E-05 
62340 Unidentified 7.136547677 1.936530155 1.58E-08 6.59E-05 
70418 TOX3 -7.618927237 2.39595837 4.01E-08 0.00014371 
4830 LRRC47 1.815717525 6.181099348 5.59E-08 0.000162901 
51553 MOB2 -10.12201589 2.163675689 5.84E-08 0.000162901 
28960 LY6G5B -10.06003812 2.104242312 8.85E-08 0.000209141 
25675 G3BP1 -5.1776663 2.731225356 1.08E-07 0.000209141 
25674 G3BP1 -5.177663497 2.731225356 1.08E-07 0.000209141 
25673 G3BP1 -5.177660694 2.731225356 1.08E-07 0.000209141 
67488 WDR90 -10.06870594 2.111911219 1.38E-07 0.000246887 
28961 LY6G5B -9.932080302 1.980545806 1.56E-07 0.000246887 
4914 ENO1 -4.060905817 2.989744799 1.57E-07 0.000246887 
42278 AKAP2 -3.618873362 3.102655176 2.34E-07 0.000317207 
42277 AKAP2 -3.61887332 3.102655176 2.34E-07 0.000317207 
56763 GRIN2B 3.885392665 2.701879921 2.40E-07 0.000317207 
18061 ZNF385D 2.187543531 4.07306081 3.24E-07 0.000406409 
1577 NFIA -7.238771966 1.916972301 5.72E-07 0.00065174 
1578 NFIA -7.238785294 1.916972301 5.74E-07 0.00065174 
43457 TLN1 -9.589848183 1.651615196 5.97E-07 0.00065174 
20638 TAPT1-AS1 -3.222021858 3.680936008 6.59E-07 0.000662033 
20639 TAPT1-AS1 -3.222020606 3.680936008 6.59E-07 0.000662033 
16428 ST3GAL6 -4.203696894 2.717764913 7.83E-07 0.000755889 
17381 NAALADL2 1.913529548 4.185663806 8.35E-07 0.00077614 
4915 ENO1 -3.991224239 2.866444377 8.73E-07 0.000782529 
17380 NAALADL2 1.773638979 4.441169751 9.22E-07 0.000797771 
List of RNAs generated by counting introns obtained from transcripts. The Intron ID, name of 
associated gene, log fold change (LogFC), Log normalized counts per million (LogCPM), p-
value and adjusted false discovery rate (FDR) are shown in the list. FDR cutoff: 0.05. The 
negative LogFC values correspond to enrichment of HMGN5 over GFP. Genes for DGE 
analysis were extracted from TxDb.Hsapiens.UCSC.hg38.knownGene database of hg38 
human reference genome. 
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Figure 28. Distribution of HMGN5 peaks in an intronic region of gene NFIA. 
The peaks from the merged HMGN5 samples in upper track (red) and GFP samples (lower 
track in green) in the NFIA transcript are shown. The track height was set at 40 for each 
sample. The tracks correspond to the overlapped peaks from the independent biological 
replicates. The NFIA gene is represented under the GFP track. Exons are represented as 
blue boxes. Lines represent introns and the arrows represent the direction of the transcript. 
NFIA: Nuclear Factor I A. 
 
 
We performed genome ontology analysis to evaluate the distribution of HMGN5 on 
annotated genomic features associated with transcripts. Table 5 summarizes the 
HMGN5 distribution associated with basic genomic features. When we analyze the 
overlapped peaks in bp (strict overlap), HMGN5 is mostly found associated with 
introns (46671bp), intergenic regions (31153bp) exons (20020bp) and protein coding 
(18374bp). However, when the distribution is normalized according to the coverage 
of each feature in the genome (LogRE= Log ratio enrichment) we can observe an 
enrichment in 5’ UTR, CpG islands, coding genes, exons, protein-coding and non-
coding RNA. Figure 29 shows the enrichment of HMGN5 in some basic genomic 
features, according to the Log ratio enrichment.  
We combined the list of associated transcripts obtained with the different strategies 
mentioned before (Table 3, Table 9 and Table 10) and we performed GO enrichment 
analysis. We found that the genes cannot be statistically grouped, indicating that the 
HMGN5-bound RNAs are not related with each other.  
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Table 5. Global distribution of HMGN5 in transcript-associated genomic 
features 
Feature Coverage feature (bp) 
Overlap 
(#peaks) 
Overlap 
(bp) 
Expected 
Overlap 
(bp) 
Log Ratio 
Enrichment p-value 
Log 
p-value 
exons 84831605 73 20020 4103 1.59 5.14E-26 -58.23 
protein-
coding 73804459 66 18374 3570 1.64 2.83E-25 -56.53 
coding 52471711 67 15453 2538 1.81 5.27E-24 -53.6 
Cpg Island 23610399 29 7775 1142 1.92 1.86E-13 -29.31 
utr5 7089273 16 2839 342 2.12 2.63E-06 -12.85 
ncRNA 8518253 6 1972 412 1.57 2.61E-03 -5.95 
introns 1302962824 186 46671 63031 -0.3 5.49E-10 21.32 
gaps 159950299 0 0 7737 -8.95 3.34E-12 26.42 
intergenic 1781725049 107 31153 86191 -1.02 1.68E-127 291.91 
Genome ontology analysis of HMGN5 CLIP-seq. Expected overlap was estimated based on a 
genome size of 2.00e+09 bp. p-value cutoff 0.05. Negative log p-value= significantly 
associated; positive log p-value= significantly NOT associated. LogRE: Log ratio enrichment. 
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Figure 29. HMGN5 global CLIP peaks distribution. 
Genome ontology analysis of the HMGN5-enriched peaks from CLIP-seq analysis. The 
graph shows the Log ratio enrichment of peaks in the selected genomic features (utr5: 5’ 
untranslated; ncRNA: non coding RNA).  
 
 
We performed a motif finding against the hg38 genome using 'findMotifsGenome.pl' 
from Homer to search for specific motif sequences recognized by HMGN5 within the 
RNAs. 
We found a list of eight enriched de novo motifs (Figure 30). Interestingly, two of 
those motifs correspond to poly A and poly U tract, with an enrichment of 30.28% 
and 24.61% in the target sequences respectively, compared to 12.81% and 9.8% 
abundance in the background sequences. Remarkably, those two motifs are highly 
similar to the A-rich (En3_RNA_rev) and U-rich (En3_TFO_RNA) RNAs (Table 1) to 
which HMGN5 shows a specific and high affinity binding in vitro (Figure 12), thus 
validating the in vivo HMGN5-bound RNAs. Moreover, the preference of HMGN5 
binding for A rich sequences together with the fact that we mainly identified mRNA 
with the CLIP-seq suggest that HMGN5 could be binding the polyA tail of mRNA thus 
participating in the regulation of mRNA metabolism by direct targeting the RNA. 
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Figure 30. Significantly enriched HMGN5 de novo motifs. 
Top eight enriched motifs are shown ranked by p-value. Motif finding was performed with 
the Homer software using the hg38 reference genome. 
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4.9 HMGN5 forms distinct complexes either with 
nucleosomes or with RNA 
 
To compare the binding ability of HMGN5 toward RNA and nucleosomes, and to get 
insight into the binding mechanism, we performed a competition assay of HMGN5 
with RNA and nucleosome by using EMSA assays. First we assembled 
mononucleosomes in vitro, using a Cy3 labeled DNA sequence that contains the 
strong positioning sequence 601 (Lowary & Widom, 1998) as described in 7.2.4.1. 
The protein was serial diluted in a 2:1 ratio, starting from 2µM and the concentration 
of the nucleosome and RNA were kept constant (50ng and 50nM respectively). The 
result of Figure 31A reveals that HMGN5 interacts either with nucleosome or with the 
RNA since two distinct complexes are formed, and a super-shift representing 
HMGN5-RNA-nucleosome complex was not observed. Moreover, the protein binds 
both molecules with similar affinity, and a complete shift of RNA and nucleosome is 
observed at a protein concentration of 2µM (Fig 31A, lane 10). Interestingly, the 
presence of the RNA induces a decrease in the mobility of the HMGN5-nuclesome, 
as judged by comparison with the HMGN5-nucleosome sample (lane 2). This 
retardation in the mobility is more pronounced when the HMGN5-nucleosome 
interaction is prepared in presence of an excess of fragmented total RNA. Total RNA 
extracted from HeLa cells was subjected to MgCl2-dependent fragmentation 
(AbouHaidar & Ivanov, 1999), as described in section 7.2.2.14. Figure 31B shows the 
RNA competition, in which the protein-nucleosome complex was kept constant (lanes 
6-9), and increasing concentrations of non-labeled fragmented total RNA were added 
ranging from 300ng to 2µg. It can be observed that when RNA concentration 
increases, the mobility of the protein-nucleosome complex is retarded in a RNA 
concentration-dependent manner. This effect is not visible when only RNA and 
nucleosome are mixed (lane 10), indicating that the RNA has a specific effect in the 
HMGN5-nucleosome interaction that tends to displace the binding with the protein. 
Taken together, those results suggest that HMGN5 might have a dual function, as 
seen by the specific interaction with RNA and nucleosome. 
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Figure 31. RNA-nucleosome competition assay. 
A) Competitive EMSA to compare specificity of HMGN5 to nucleosome and RNA. 50 nM of 
Cy5 labeled snoRNA2T2 (green) and 50ng of Cy3 labeled mononucleosomes (red) were 
incubated with increasing concentrations of recombinant HMGN5 up to 2µM (titration in a 
2:1 ratio). The interaction was monitored in a 6% Native PAGE and visualized in a Typhoon 
9500 device. Controls of only RNA+nucleosome (Lane 1), Protein+nucleosome (lane 2) and 
protein+RNA (lane3) are shown. Nuc: nucleosome. B) The HMGN5-nucleosome interaction 
was prepared in presence of an excess of frragmented non-labeled total RNA extracted 
from HeLa cells. Lane 1, 50ng of Cy3 labeled mononucleosome; lanes 2-5 HMGN5-
nucleosome interaction. Lanes 6-9 competition with 300ng, 700ng, 1µg and 2µg of 
fragmented RNA. Lane 10, 50ng of mononucleosome mixed with 2µg of total RNA. The 
interactions were loaded in 6% Native PAGE and visualized in a Typhoon 9500 device. 
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4.10 HMGN5 bind preferentially to regulatory regions 
and regulates RNA metabolic genes 
 
Based on immunofluorescence analysis, it was previously shown that the human 
HMGN5 is mainly localized in heterochromatic regions (Malicet et al., 2011), unlike 
the mouse protein that localizes to euchromatin (Rochman et al., 2009). However the 
detailed identification of its binding across the genome is not known and is critical to 
understand its role in the global gene regulation and RNA metabolism. 
To analyze the genome-wide distribution of HMGN5, we performed ChIP-seq 
analysis on the HMGN5-FlpIn cell line with and without induction with Doxycycline 
and on induced GFP-FlpIn cell as control (7.2.6.1). 
After sequencing and quality check, a trimming step was performed using Homer 
tools to remove corresponding Illumina adapter sequences (methods 7.2.7.2 and 
appendix section 9.3.1). The reads were mapped to the hg19 human reference 
genome using Bowtie2. Peak finding and motif analysis were performed with Homer 
(v4.7). After inspection of the alignments, peaks of varying sizes were found, spread 
over larger distances, then a 1000bp size peak was assumed for motif finding 
(Histone style parameter). The enrichment of peaks over control was performed 
using each GFP sample as background separately for each individual HMGN5 
sample, and the resulting peaks were merged. Only peaks present on both HMGN5 
biological replicates with literal overlap were kept in the analysis. 
The result generated after ChIP-seq anaylsis reveal 6277 specific HMGN5 peaks. 
The Figure 32 shows the genomic distribution of HMGN5 at three different example 
locus. It can be seen an enrichment of HMGN5 in comparison with the GFP samples 
and the background non-induced HMGN5 cell line (Samples H-1 and H-2). A high 
correlation is observed between HMGN5 peaks and the genomic enrichment of 
H3K27ac at the given positions (bottom track in figure 32). 
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Figure 32. UCSC genome browser tracks depicting the HMGN5 distribution at 
three different example locus.  
Blue tracks represent the GFP control cell line (G- for non-induced GFP expression, and G+ 
for overexpressed GFP); green tracks represent two independent biological replicates of 
non-induced HMGN5 control (H-1 and H-2), and in red the overexpressed HMGN5 samples 
(H+1 and H+2). The genome tracks of the histone mark H3K27Ac and the DNase I 
hypersensitive sites are also shown. Locus shown: CATSPERG (Cation Channel Sperm 
Associated Auxiliary Subunit Gamma); KMT2E (Lysine Methyltransferase 2E); SDE2 
(SDE2 Telomere Maintenance Homolog). 
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Of the HMGN5 peaks annotated in the genome, almost 30% are located in promoters 
and 25% in intronic regions (Figure 33A). We performed Genome Ontology analysis 
on HMGN5 ChIP-seq to analyze the enrichment of HMGN5 in genomic element by 
normalizing the data according to the coverage (in bp) of feature in the genome. 
Strikingly, we found that the protein is highly enriched at promoters close to 
transcription start sites (TSSs) (Figure 33B, Table 6), corresponding to a Log 
enrichment of 2.88 in this feature (Log p-value -3863.96) compared with the expected 
random distribution. Similarly, we observe a strong enrichment in CpG islands and 
5’UTR (3.1 and 3.25 Log ratio enrichment respectively), all of them representing 
regulatory genomic regions. Even though a great number of peaks were found at 
introns and intergenic regions, as they are highly represented in the genome, the 
enrichment analysis indicates that HMGN5 is mainly depleted from those genomic 
attributes. 
 
Table 6. Genome ontology of HMGN5 ChIP-seq peaks 
Annotation 
Feature 
coverage 
(bp) 
Overlap 
(bp) 
Expected 
Overlap (bp) 
Log Ratio 
Enrichment 
Log  
p-value 
Promoters-
TSS 32837752 2340668 131932 2.88 -3863.96 
CpG islands 21842742 1946823 87757 3.1 -3512.42 
5’UTR 5995417 622375 24087 3.25 -1159.19 
Exons 77105916 1231945 309789 1.38 -660.95 
Protein-
coding 68356105 1099718 274635 1.39 -590.79 
ncRNA 6791910 135252 27287 1.6 -87.98 
TTS 30830670 291625 123868 0.86 -68.15 
Introns 1230652329 3812530 4944412 -0.26 260.01 
Intergenic 1799344491 1867135 7229256 -1.35 7899.65 
Ranked list of genomic features associated with HMGN5. Feature coverage: correspond to 
the total size in base pairs of the respective feature in the hg19 reference genome. Overlap: 
literal overlap of HMGN5 peaks in base pair in the respective genomic feature. Expected 
overlap: overlap expected by chance based on the proportion of each attribute in the 
genome. The Log ratio enrichment is obtained from the HMGN5 peaks overlap (bp) over the 
expected overlap (bp). The representative selected features are ranked according to the Log 
p-value. Negative Log P-value corresponds to significant association, and positive p-value 
corresponds to significantly NOT associated regions. 
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Figure 33. Genome-wide HMGN5 occupancy. 
(A) Distribution of total number of identified HMGN5 peaks at annotated genomic regions. 
Reference percentages are indicated in the pie chart. The name of the respective features is 
indicated in the color legend. B) Enrichment of HMGN5 in the selected genomic features. 
The overlap of HMGN5 (in bp) was normalized according to the expected random 
enrichment at each genomic attribute. The enrichment is represented as Log values (Log 
ratio enrichment). 
 
 
As it was shown in the previous result, HMGN5 binds preferentially to regulatory 
regions. Here we compared the distribution of the protein with the histone marks 
H3K27ac and H3K4me3, respectively enriched at promoters and enhancer of actively 
transcribed genes (discussed in Shlyueva, Stampfel, & Stark, 2014). Likewise, we 
analyzed the correlation of HMGN5 binding with DNase I hypersensitive sites (HS), 
with RNA polymerase II and CTCF distribution. We obtained the data from public 
ChIP-seq in the background cell line HEK293T available at the ENCODE project 
(methods section 7.1.7). 
We observe a correlation in the distribution pattern of the activation histone marks 
H3K27ac (Figure 34A) and H3K4me3 (Figure 34B) with HMGN5 occupancy in the 
genome, in which the marks are spread close to the center of HMGN5 binding site 
with a peak flanking at less than 1000bp from the peak center.  
Moreover, HMGN5 highly correlates with DNaseI hypersensitive (HS) sites (Figure 
34C), hallmark of active chromatin (Boyle et al., 2008; Gross & Garrard, 1988). 
Furthermore we also find a correlation of HMGN5 peaks with the RNA polymerase II 
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occupancy (Figure 34D), which marks transcription initiation, altogether 
demonstrating a role of HMGN5 in transcriptional activation.  
Interestingly, we found a strong correlation of HMGN5 binding with the CTCF 
genomic distribution (Figure 34E). CTCF distribution is observed as a narrow peak 
close to the center of HMGN5 binding site.  
CTCF is a well-characterized transcription factor that can act as transcriptional 
activator, repressor or insulator and helps to the 3D organization of chromatin by 
mediating long-range chromatin interactions (Ghirlando & Felsenfeld, 2016). CTCF 
has been found distributed at domain boundaries acting as barrier that demarcates 
active from repressive domains (Cuddapah et al., 2008). Taking into account that 
HMGN5 is a protein that globally decompacts chromatin, this data suggest the either 
both proteins recognizes the same sequences genome-wide, and then can co-
localize, or (and) they have a cooperative function, being part of a complex regulating 
chromatin architecture so far not described. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
90 
 
Figure 34. Motif distribution around HMGN5 ChIP-seq peaks. 
Correlation of HMGN5 occupancy with the distribution of H3K27Ac (A) H3K4me3 (B), DNase 
I hypersensitive sites (C), RNA Polymerase II (D), and CTCF binding (E). The average 
genomic distribution of the corresponding signal from the marks was plotted relative to the 
center of the HMGN5 binding sites (from -2000 to 2000 bp). Datasets were obtained from 
public available database in the human HEK293T cell line at the ENCODE project. 
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4.11 HMGN5-dependent transcriptional changes at 
the DNA-binding sites 
 
We further analyze the HMGN5-dependent transcriptional changes at the DNA-
binding sites to test the effect of HMGN5 binding at regulatory elements on the global 
transcriptional regulation. Figure 35A depicts the overlap between the HMGN5-
dependent transcriptional changes and the HMGN5 genomic binding sites at 
regulatory regions, including all peaks found at promoters, CpG islands and 5’UTR. 
From the 2394 peaks found at regulatory region, in 882 a transcriptional change is 
observed in the associated gene, 326 of them only when HMGN5 is overexpressed 
and 306 exclusively after HGMN5 knockdown. The remaining 250 genes are affected 
in both conditions. It can be observed a slight tendency to a down-regulation of the 
transcripts of HMGN5-bound genes compared with non-bound genes in both 
overexpression and knockdown of HMGN5 (Figure 35B). 
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Figure 35. Correlation of HMGN5 dependent transcriptional changes and DNA-
binding sites. 
(A) Venn diagram depicting the overlapped set of genes affected after overexpression (OE) 
and knockdown (Kd) of HMGN5, with the identified HMGN5 binding sites at regulatory 
regions. The Venn diagram was made with the BioVenn online tool 
(http://www.biovenn.nl/index.php) (B) Cumulative distribution of HMGN5-dependent 
transcriptional changes at the HMGN5-bound genes. The x-axis shows the log2 fold change 
(Log2 FC) values of the transcripts and the y-axis shows the cumulative distribution. 
 
 
Interestingly, when performing Gene Ontology analysis (GO) of the genes with an 
enrichment of HMGN5 at regulatory regions, we can observe that they are mainly 
associated with RNA metabolic processes (Figure 36A), being “RNA metabolic 
process”, “translation” and “RNA processing” the most enriched terms in the 
analyzed dataset. Likewise, when analyzing the subset of HMGN5-bound genes at 
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of HMGN5, the genes are functionally clustered as  “posttranscriptional regulation of 
gene expression”,  “sequence-specific mRNA binding”, and rRNA metabolic process” 
(Figure 36B and C). 
This result strictly correlates with our findings showing that the transcription of genes 
involved in RNA metabolism is mainly affected by a loss or overexpression of 
HMGN5, demonstrating a direct role of HMGN5 in the regulation of the RNA 
metabolism. For a great number of genes the effect could be explained by a direct 
influence of HMGN5 binding at the associated regulatory elements. Nevertheless, 
from this evidence is not possible to conclude that the effect is due to a direct change 
in the chromatin architecture mediated by HMGN5 binding, or is due to the 
interaction with unknown factors. 
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Figure 36. GO analysis of HMGN5-bound genes at regulatory regions. 
A) Statistical overrepresentation analysis of gene ontology terms shown as pie chart, from 
the 2394 genes with HMGN5 enriched at regulatory regions (including promoters, CpG and 
5’UTR). The groups are organized from higher (up) to lower (bottom) number of genes per 
group in the color legend, and displayed consecutively in the pie chart. B) GO analysis of the 
subset of genes with HMGN5 associated with promoters and that show transcriptional 
changes after HMGN5 overexpression and knockdown, represented as a pie chart and as a 
network in (C). The analysis was performed with the ClueGo software, and the significance 
of the enrichment was performed with a hypergeometric test. p-value correction was 
estimated sing the Bonferroni step-down method. The leading term correspond to the most 
significant term in the group. Only term with p-value <0.005 are shown. 
 
 
 
 
 
 
 
 
B
sequence-specific 
mRNA binding
rRNA metabolic 
process
posttranscriptional 
regulation 
of gene expression
 
 
 
 
posttranscriptional 
regulation of gene 
expression 
rRNA metabolic 
process 
 
 
sequence-specific
   mRNA binding
C
A
translation
RNA processing
mitotic celly cycle phase transition
posttranscriptional regulation of gene expression
RNA metabolic process
Intracellular protein transport
}Other fuctions
Results 
95 
4.12 HMGN5 preferentially binds CTCF recognition 
motif genome-wide 
 
It has been widely accepted that HMGN5, as the other HMGN proteins binds the 
nucleosome without specificity for the underlying sequence (Bustin, 2001). As the 
ChIP-seq analysis shows that HMGN5 is enriched at regulatory active regions, we 
hypothesized that the protein indeed has a preference for binding specific DNA 
motifs. Using the mapped reads from ChIP-seq we performed de novo motif search 
using the 'findMotifsGenome.pl' command from Homer on hg19 reference genome. 
We did the analysis assuming a 1000bp region for motif finding, since in the 
alignment of reads to the reference genome HMGN5 was distributed in broad 
regions, containing peaks of varying size (200/250/300/350/400/450/500bp).   
The motif analysis demonstrates that, different than previously thought, HMGN5 
binds specific DNA consensus sequences. In the Figure 37 a list with the five most 
enriched de novo motifs is shown, ranked according to the p-value. 
 
 
 
 
 
Figure 37. De novo motif analysis 
in HMGN5 ChIP-seq peaks.  
Top five most enriched motifs in the 
HMGN5 ChIP-seq dataset are ranked 
according to the p-value. The motifs 
were searched using the Homer software 
assuming a peak size distribution of 
1000bp. 
 
 
 
 
 
 
 
G
T
A
C
G
A
C
G
C
T
A
T
A
G
C
G
A
C
T
C
T
A
C
A
G
T
A
G
T
G
A
G
T
G
T
A
C
T
ATGATGATAGTAGGGACG
T
C
A
G
A
G
C
G
CGAGAATCGA
G
A
T
C
C
G
T
G
A
C
A
T
C
G
G
A
C
T
C
A
T
G
A
G
C
T
A
A
G
G
A
CG
A
C
G
T
C
A
A
C
G
TGCTGTCTGCATCAG
de novo motif P-value
1e-141
1e-77
1e-76
1e-75
1e-64
Results 
96 
Remarkably, the most enriched motif in the list, corresponds to the recognition 
sequence of CTCF (Figure 38) –and the paralog CTCFL- conserved in different 
human cell lines (Cuddapah et al., 2008; Essien et al., 2009). The motif was found in 
17% of the HMGN5 peaks analyzed. It can be noticed that the 12bp HMGN5 motif, is 
identical to the core sequence of CTCF canonical motif, indicating that both proteins 
could be co-localizing in the genome. However an interaction between both proteins 
has not been described in the literature. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38. CTCF binding site is the most enriched motif in HMGN5 ChIP-seq 
data.  
Most enriched HMGN5 de novo motif (p-value 1e-141) compared with the canonical CTCF 
motif obtained from Jaspar database. In the red box the canonical core of the CTCF motif is 
indicated. 
 
For comparison, we repeated the analysis using a 200bp peak size for motif finding, 
which correspond to the pre-defined setting from the Homer software, standard for 
transcription factor peaks, and is based on the assumption that most of the motifs are 
found +/- 50-75 bp from the peak center (see description of “findMotifsGenome.pl” 
command from the Homer software). The analysis shows that the motif for CTCF is 
also the most significantly enriched motif for HMGN5 using this parameter, with a p-
value of 1e-96 thus demonstrating the robustness of the analysis. 
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4.13 Identification of HMGN5-interacting partners 
 
As already known in the literature, HMGN5 can destabilize chromatin compaction by 
directly interacting with H1 and H5 and thus counteracting their binding to chromatin 
(Rochman et al., 2009). It was also recently shown that the human HMGN5 is able to 
interact with the lamina-associated protein Lap2α (Lamina-associated polypeptide 2, 
isoform alpha) (Zhang et al., 2013). However, a global HMGN5-protein interactome 
that reveals potential physiological binding partners has not been described so far 
and is critical to better understand the function of HMGN5 and its role in the 
regulation of RNA metabolism. 
Taking advantage of our established HMGN5_FlpIn cell line, we performed HMGN5 
Co-immunoprecipitation (Co-IP) to identify potential HMGN5-interacting partners by 
quantitative mass spectrometry. 
Since HMGN5 binds tightly to chromatin, the identification of interacting partners that 
binds through direct physical contact requires the fractionation of the associated 
DNA. Therefore, to perform Co-IP we first tested two different conditions to digest the 
DNA from the chromatin (standardized protocol in section 7.2.6.5). We performed a 
Micrococcal nuclease (MNase) digestion to generate mono-nucleosomes and a 
treatment with MNase plus Benzonase. The last treatment should completely 
degrade the DNA present in the lysed samples since the genetically engineered 
endonuclease Benzonase degrades the nucleic acids to <8bp fragments (according 
to the manufacturer). Figure 39A shows a silver-stained SDS-PAGE of 
immunoprecipitated HMGN5, and the control GFP, using both treatments, MNase 
(M) and MNase plus Benzonase (M+B) on two biological replicates each. We can 
see that for both proteins, the immunoprecipitation is highly efficient and the 
respective treatment does not affect the affinity of the antibody (GFP-Trap) for GFP, 
as the proteins are efficiently immunoprecipitated (indicated with a red star in the gel, 
at about 100kDa for HMGN5 and about 30kDa for GFP). When comparing both 
treatments in each sample, it can be observed that the treatment with MNase plus 
Benzonase produced cleaner results, since the contaminant background associated 
to chromatin is reduced. We repeated the Co-IP after both treatments for two new 
biological replicates, including two technical replicates per condition. The western 
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blot of the Figure 39B shows that the method is reproducible, since similar levels of 
HMGN5-GFP are detected with the antibody against HMGN5 after 
immunoprecipitation in all HMGN5 samples.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39. HMGN5 co-IP-standardization for mass spectrometry. 
A) Silverstaining of test Co-IP samples. The Co-IP was done with 15µl of GFP_Trap 
Magnetic beads using different treatments. M corresponds to MNase digested samples 
and M+B corresponds to a treatment with MNase and Benzonase. 2 independent 
replicates were used per condition. 10% of the beads used for IP were loaded in each 
lane. The red star indicates the overexpressed proteins, HMGN5 at around 100kDa, and 
GFP at around 30 kDa. HMGN5 input was loaded as reference. B) HMGN5 western blot 
after CoIP. After immunoprecipitation the samples were subjected to western blot using an 
antibody against HMGN5 (HPA000511). Each lane corresponds to 10% of the beads from 
the CoIP. Two independent biological replicates were used per cell line (HMGN5-1 and 
HMGN5-2; GFP-1 and GFP-2), with two technical replicate per treatment. 
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4.14 HMGN5 binds CTCF in vivo and proteins 
regulating the pre-rRNA processing 
 
After the Co-IP was standardized, three biological replicates per condition (from 
HMGN5_FlpIn and GFP_FlpIn cells as background control) were prepared and 
subjected to label-free quantitative proteomics (section 7.2.6.5.1) by liquid 
chromatography-tandem mass spectrometry (LCMS/MS), in collaboration with the 
laboratory of Axel Imhof, at the protein analysis unit of the Biomedical Center from 
the Ludwig Maximilian University. To identify the HMGN5-binding partners, the 
intensities of the found proteins were normalized with the ‘intensity-based absolute 
quantification’ (iBAQ) algorithm, which allows measurement of protein abundance 
and direct comparison between proteins. The enrichment of the protein in the three 
HMGN5 samples over the GFP control was calculated (log2 FC IBAQ HMGN5-GFP) 
and the significance tested with t-test and limma test. Figure 40 shows a volcano plot 
of logFC vs–log10 p-value, and the significant differentially bound proteins with more 
than 2 fold change (logFC=2) after p-value correction are represented as red dots 
(positive FC values for HMGN5 enriched over control, and negative FC the ones 
depleted compared with the background). 
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Figure 40. Significant enriched proteins in HMGN5 Co-IP. 
Graphical representation of quantitative HMGN5 Co-IP mass spec data illustrated as a 
volcano plot, according to statistical significance -log10 p-value (y-axis) and log2 fold 
change HMGN5 over GFP. Significant enriched proteins in the three biological replicates 
with a log2FC≥2 (x-axis) are shown as red dots. 
 
 
 
The mass spectrometry analysis led to the identification of 21 proteins that interact 
with HMGN5 (Table 7). As prove of the method, the identification of HMGN5 itself is 
shown in the table (LogFC=9.1). Strikingly, we demonstrated that HMGN5 directly 
interacts with CTCF. This finding is in agreement with our ChIP-seq results, which 
show a CTCF distribution close to the HMGN5 peaks (Figure 34E) and with the motif 
enrichment showing that HMGN5 has the same DNA recognition motif as CTCF 
(Figure 38). Together, those results suggest a new chromatin regulatory mechanism 
mediated by HMGN5-CTCF complexes. This hypothesis, however, needs to be 
validated with mechanistic approaches to better understand the potential function of 
such a complex. 
Remarkably, from the list of HMGN5 associated proteins, we found seven proteins 
that play a direct role in ribosomal biogenesis. Among them, we found RPL10 
(Ribosomal protein L10), which is one of the ribosomal proteins from the 60S large 
ribosomal particle (Lo et al., 2010). Interestingly, the other six proteins, LAS1L 
(Ribosomal biogenesis protein LAS1-Like), PELP1 (Proline-, glutamic acid- and 
leucine-rich protein 1), TEX10 (Testis-expressed sequence 10 protein), WDR18 (WD 
repeat-containing protein 18) and SENP3 (Sentrin-specific protease 3) NOL9 
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(Nucleolar protein 9), are all components of a protein complex involved in the pre-
rRNA processing and synthesis of the 60S ribosomal subunit (Castle, Cassimere, & 
Denicourt, 2012; Finkbeiner, Haindl, & Müller, 2011). This complex has been also 
been linked to (de)sumoylation process in transcriptional regulation (Fanis et al., 
2012). The interaction of HMGN5 with this complex suggests a direct role of HMGN5 
in the regulation of ribosomal biogenesis. 
Furthermore, we also found enriched the BANF1 protein (Barrier to autointegration 
factor), with a log2 FC ratio of 6.5, the highest ratio from all the identified partners. 
BANF1 (alternatively named as BAF) is a key component of the nuclear lamina. It 
has been described that BANF1 interacts with DNA and different groups of proteins, 
including the LEM domain containing proteins of the nuclear envelope -like LAP2β 
and LAP2α- histones and lamina proteins (reviewed in Jamin & Wiebe, 2015). 
BANF1 is essential for nuclear assembly and chromatin organization, and it is 
involved in transcription regulation, DNA damage response and immunity against 
foreign DNA (Jamin & Wiebe, 2015). This results support the hypothesis of a 
potential role of HMGN5 in linking the nuclear lamina to chromatin organization, as it 
was previously proposed (Naetar, Ferraioli, & Foisner, 2017; Zhang et al., 2013). 
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Table 7. List of identified HMGN5-binding partners 
 
Proteins identified by LC-MS/MS are shown and ranked according to the log fold change of 
HMGN5 over GFP after IBAQ normalization (logFC IBAQ HMGN5-GFP). Threshold LogFC 
≥2. Statistical significance after limma test is shown (p(HMGN5-GFP)limma and 
NegLogPval limma).  
 
Symbol Gene name log FC IBAQ (HMGN5-GFP)
p.(HMGN5-
GFP) limma
NegLogPval 
limma
HMGN5 High mobility group nucleosome-binding domain-containing protein 5 9,107876181 3,87313E-07 6,4119382743
BANF1 Barrier-to-autointegration factor 6,5017024453 7,03747E-06 5,1525833126
SFXN3 Sideroflexin-3 5,5084969494 0,000296229 3,5283727645
SSR3 Translocon-associated protein subunit gamma 5,4832879267 3.81926E-07 6,4180206783
RPL10 60S ribosomal protein L10 4,6149484045 0.001840618 2,7350364286
HIST1H2BL Histone H2B type 1-L 4,4458019511 0.002993114 2,5238766954
RAI1 Retinoic acid-induced protein 1 4,2418793154 6.28072E-05 4,201990359
MDC1 Mediator of DNA damage checkpoint protein 1 4,0649654271 0.000219704 3,6581621747
LAS1L Ribosomal biogenesis protein LAS1L 3,7235194994 2.26486E-05 4,6449587916
TEX10 Testis-expressed sequence 10 protein 3,6921512227 9.4361E-06 5,0252076059
PELP1 Proline-, glutamic acid- and leucine-rich protein 1 3,6289528062 2.26823E-05 4,6443133664
MRPS34 28S ribosomal protein S34, mitochondrial 3,4994632048 8.11635E-05 4,0906393883
WDR18 WD repeat-containing protein 18 3,3864191207 1.29558E-05 4,8875341001
SENP3 Sentrin-specific protease 3 3,3209894845 9.40407E-06 5,0266840162
NOL9 Polynucleotide 5‘-hydroxyl-kinase NOL9 2,7380299096 4.13849E-05 4,3831585583
RFC2 Replication factor C subunit 2 2,5615257116 0.003402562 2,468194003
BIRC5 Baculoviral IAP repeat-containing protein 5 2,4494346305 0.001573481 2,8031385063
SLC25A13 Calcium-binding mitochondrial carrier protein Aralar2 2,4282198421 0.000541728 3,2662189037
PBRM1 Protein polybromo-1 2,3899131448 0.0001424 3,8464906259
CTCF Transcriptional repressor CTCF 2,3859255012 0.000624106 3,2047416097
SUZ12 Polycomb protein SUZ12 2,2442595021 0.000823379 3,084400468
NDUFA10 NADH dehydrogenase [ubiquinone] 1 alpha sub-complex subunit 10, mitochondria 2,1477477616 0.002059266 2,6862876094
Discussion 
103 
5 Discussion  
 
In the past years, many efforts have been made to understand regulation and the 
dynamics of chromatin structure. This is of particular interest because chromatin 
structure plays an essential role in transcriptional regulation. However, its structural 
organization remains unclear even though a hierarchical, highly organized structure 
is shown in text books (Fussner et al., 2011; Maeshima et al., 2010). Indeed, the 3D 
chromatin ultrastructure in intact cells was recently analyzed, and it was shown that 
the chromatin is organized as flexible and disordered granular chain with diameters 
between 5- to 24 nm (Ou et al., 2017), not representing the classical view of the 
chromatin folding classically described.  
It has been shown that HMGN5 has a direct influence on the global chromatin 
structure with a high impact on transcriptional regulation. The ability of HMGN5 to 
induce chromatin decondensation -as seen by others (Rochman et al., 2009) and our 
own work (Figure 9)- makes the protein a good candidate to study the mechanism of 
decondensation of higher order structure of chromatin. 
In this work we use the human HMGN5 as a model protein to study the opening of 
higher order structure of chromatin, using genome-wide integrative analysis and in 
vitro techniques, with the aim of helping elucidating the mechanism by which the 
dynamics of chromatin opening is regulated. 
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5.1 HMGN5 has a novel RNA binding activity 
 
In the past years it was demonstrated in our laboratory that a fraction of snoRNA that 
is associated with chromatin plays a critical role in the reversible opening of higher 
order structures of chromatin in Drosophila (Schubert et al., 2012). Furthermore, it 
was demonstrated that the Drosophila decondensation factor 31 (Df31) -first 
characterized by its ability of decondensing sperm DNA (Gilles Crevel, 2000)- binds 
chromatin in an RNA-dependent manner (Schubert et al., 2012). 
In humans, HMGN5 shares common functional and structural features with Df31, 
such as the ability of chromatin decompaction and its intrinsically disordered 
structure and negatively charged aminoacids (Malicet et al., 2011).  
Here we explored the potential role of HMGN5 in RNA binding by using in vitro 
techniques like EMSA and MST, and by in vivo RNA immunoprecipitation using 
CLIP-seq analysis. 
The recombinant human HMGN5 was used for an interaction screening using 
different fluorescently labeled single-stranded nucleic acids. As shown in Figure 12, 
HMGN5 exhibits a novel and specific RNA binding activity, not described so far in the 
literature. The protein has a strong preference for binding ssRNA over ssDNA 
containing the same sequence, implying a potential function in vivo. It is important to 
mention that -from the in vitro data- HMGN5 does not have an apparent preference 
for molecules with secondary structures over non-structured ones, as very similar 
affinities were determined for the en3_RNA_rev, en3_TFO_RNA, without predicted 
secondary structure, in comparison with the snoRNA2T1 and snoRNA2T2 which 
form a high number of dsRNA bonds. Interestingly, when analyzing the EMSA 
interaction of HMGN5 with the snoRNA2T2 (Figure 12A, bottom right EMSA) two 
distinct protein-RNA complexes are formed, as revealed by the EMSA bands. With 
increasing molar ratio of HMGN5 to RNA increases (up to 2µM protein concentration) 
only one major complex remains, corresponding to the higher molecular weight 
complex. This effect could be mediated by cooperative binding, as it has been 
demonstrated for other nucleic acid binding proteins (Alfano et al., 2004; 
Schumacher et al., 2002). Moreover, this result corresponds to the binding mode also 
described for the HMGN proteins with nucleosomes particles in vitro, in which it has 
been reported the formation of complexes with nucleosome particle in vitro, in which 
it has been reported the formation of complexes as homodimers under physiological 
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conditions (Postnikov, Trieschmann, Rickers, & Bustin, 1995; Shirakawa et al., 
2000). 
 
 
5.1.1 Intrinsic disorder of HMGN5 in RNA binding 
 
Two initial studies revealed the global protein-mRNA interactome in human cell lines, 
by using large-scale proteomic analysis (Baltz et al., 2012; Castello et al., 2012), 
showing more than expected RNA binding proteins. Further studies identified RNA-
interacting proteins in vivo on a global scale (reviewed in Ryder, 2016), showing that 
the mRNA interactome is enriched on proteins containing repetitive motifs of low-
complexity sequences (LCS) which are intrinsically disordered in their native state. 
Moreover, recent evidence suggests that the intrinsically disordered regions may 
contribute to RNA binding (Järvelin, Noerenberg, Davis, & Castello, 2016).  
When analyzing HMGN5, we can observe that HMGN5 is generally disordered 
(Figure 41). An effect attributed mainly to its negative net charge (isoelectric point of 
4.2.) 
 
 
 
 
Figure 41. Intrinsic disorder 
prediction of HMGN5. 
The folding prediction of the protein was 
estimated using the online software 
FoldIndex. The residue positions in the 
protein (x-axis) are plotted against the 
folding tendency (y-axis) in a scale between 
-1 and +1. Negative values correspond to 
unfolded residues (red) and positive values 
represent folded residues (green). 
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A prediction of protein domains involved in RNA binding using the available 
prediction methods is not feasible.  Here we aimed to analyze the contribution of the 
different regions of the protein to its RNA binding ability, based on the current 
characterized nucleosomal binding function of HMGN5. As already mentioned in the 
introduction (section 2.6), the HMGN family is characterized by a conserved N-
terminal nucleosomal binding domain, responsible for its binding to chromatin in vivo 
(Bustin, 2001). 
The mutational analysis (Figure 13) shows that the nucleosomal binding domain is 
required for the RNA binding, but is not sufficient by itself for this activity. Indeed, we 
demonstrated that the N-terminal and C-terminal domains of the protein synergize in 
trans to bind RNA (Figure 14), in which the negatively charged C-terminal tail of the 
protein stabilizes the RNA binding that is mediated by the N-terminal domain 
containing the NBD.  
As the NBD has the major contribution to the RNA binding activity of HMGN5, and as 
this region is highly conserved in the HMGN family, we hypothesized that the RNA 
binding is conserved in the HMGN proteins.  
Interestingly, we demonstrated here that HMGN2, a 90 amino acids long human 
HMGN protein (one third of human HMGN5), is also able to specifically interact with 
RNA (Figure 16B and C). Nevertheless, despite the fact that HMGN2 specifically 
binds RNA molecules in vitro, HMGN5 shows higher affinity for the RNA binding 
compared with HMGN2.  
 As the N-terminal domain between both proteins is conserved, we hypothesize that 
the higher binding affinity of HMGN5 is due to the long negatively charged C-terminal 
domain. We base this assumption on the observed in vitro cooperative binding 
between the N-terminal and C-terminal part of the protein. 
Remarkably, the protein HMGB1, for which an RNA binding activity has been 
previously shown with in vitro methods (A. J. Bell et al., 2008), does not bind the 
RNA molecules at the given concentrations. This indicates the specificity of HMGN 
binding to ssRNA.  
The intrinsically disordered nature of HMGN5 should provide the flexibility to interact 
with multiple binding partners, a phenomenon known as promiscuity in binding 
(discussed in Mollica et al., 2016). Indeed, it was already shown that the C-terminal 
tail confers HMGN5 the ability to counteract the H1 binding to nucleosomes, thereby 
destabilizing the chromatin structure. Likewise, it was proposed that this region is 
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responsible for the specific chromatin location and nucleosomes interaction in vivo 
(Rochman et al., 2009). However, the negative charge and the unstructured nature of 
HMGN5 cannot explain the specific RNA binding and the chromatin decompaction 
activity, since the human protein Parathymosin (PTMS) which is also highly acidic 
(isoelectric point of 3.2) and unstructured, does not bind RNA in vitro (appendix 
Figure 47) neither decompacts chromatin in the LacI/LacO tethering system (Figure 
10). Likewise, it was already shown that the sequence, rather than the charge of the 
C-terminal tail of HMGN5 was important for the chromatin localization, judged by 
immunofluorescence experiments (Rochman et al., 2009). 
It is important to mention that PTMS was shown to interact with H1 and to globally 
decompacts chromatin (Martic, 2005). However, there was only one study showing 
this -published more than 20 years ago- and using different methods to analyze 
decompaction. The fact that we could not observe a decompaction of the LacO array 
indicates that PTMS does not have this function in the U2OS system, but may have a 
cell-type specific function, or the chromatin reorganization ability is not as dramatic 
as it is observed for HMGN5.  
Recently a large-scale identification of the RNA-interacting sites of native RNA-
binding proteins (RBPs), termed RBDmap, was published (Castello et al., 2016). In 
this study, about half of the RNA-binding sites identified mapped to intrinsically 
disordered regions (IDR) of the proteins. Among them, an RNA binding motif formed 
by Lysine (K) combined with negatively charged residues, and G, P, or Q was 
identified. This motif was repeated in low complexity regions of the AHNAK protein 
(neuroblast differentiation-associated protein). 
 Interestingly, HMGN5 possesses a similar motif repeated across the C-terminal tail. 
The motif EDGKE is repeated 11 times in the mouse HMGN5 and 4 times in the 
human protein, but the functional relevance is still unknown. We suggest that the 
repetitive motif EDGKE contributes to the stabilization of RNA-binding mediated by 
the C-terminal tail of HMGN5. However, this hypothesis has to be tested. 
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5.2 HMGN5 binds RNA in vivo 
 
As the in vitro binding analysis strongly suggested the binding of HMGN5 to RNA, we 
attempted to elucidate the binding partners of HMGN5 in cells. With the use of our 
established HMGN5_FlpIn cell lines, we performed UV-crosslinking RNA 
immunoprecipitation using an optimized protocol that includes a chromatin 
fractionation step prior to RNA immunoprecipitation. Moreover, since the 
overexpressed HMGN5 protein was fused to GFP, we used a cell line 
overexpressing GFP (GFP_FlpIn) to control for background binding of RNA, and we 
also skipped the radiolabeling and transfer step to a nitrocellulose membrane for 
RNA isolation. The success of our method can be seen, even by the difference 
observed between the libraries of HMGN5 bound RNAs compared with the GFP, as 
the biological HMGN5 replicates precipitated high levels of RNA in contrast to GFP 
(Figure 44). 
Interestingly, when analyzing the global peak distribution by genome ontology 
analysis (with feature size normalization), the protein binds predominantly protein-
coding RNAs and is enriched at 5’ untranslated region (results section 4.8). 
Nevertheless, this has to be interpreted with caution, as the different transcripts are 
not transcribed equally well, therefore the enrichment also depends on the 
transcriptional levels of the RNAs. 
Instead, the analysis of the overlap of HMGN5 with specific genomic features without 
normalization by feature size is more informative, and reveals that the major HMGN5 
peaks are found at intronic regions (46671bp overlap), compared with exons, in 
which there is less coverage (20020bp overlap). This suggests that the protein is 
binding co-transcriptionally to the nascent RNA, indicating a regulatory role of 
HMGN5 in RNA metabolism.  
The identification of specific consensus motifs in the HMGN5-bound RNA highlights 
that binding is sequence-dependent. Remarkably, one of those motifs corresponds to 
a poly-A tract, highly suggestive of a potential binding of HMGN5 to the poly-A tails of 
mRNAs –which are the most abundant HMGN5-bound RNAs discovered- thus 
participating in the regulation of mRNA metabolism by direct targeting the RNA. 
Unfortunately, as the poly-A tails correspond to repetitive sequences that do not map 
uniquely, they are filtered out from the mapping step of the analysis. Therefore, with 
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the pipeline we applied here we cannot show a direct binding of the protein to those 
sequences.  
It has been reported in the literature (and also in this study, discussed in detail in 
section 5.3) that the deregulation of HMGN5 affects a large set of genes in a cell-
specific manner in mouse and human models (Kugler et al., 2013; Malicet et al., 
2011; Rochman et al., 2009; 2011), but this is the first time that a direct interaction of 
the protein with RNA is shown.  
As the main described function of HMGN5 is the opening of chromatin structure 
through direct interaction with the nucleosome particle, we tried to explore the 
potential mechanism of RNA and nucleosome binding (results section 4.9). To our 
surprise, HMGN5 is able to interact with either nucleosome or with RNA, suggesting 
that HMGN5 may have a bimodal state or constitute a switch that enables HMGN5 
binding either to chromatin or to RNA. This hypothesis is reinforced by the fact that 
the interacting RNAs do not have a function related to the regulation of chromatin 
structure. The RNAs are not clustered in any specific pathway, supporting the dual 
regulatory function suggested by the in vitro data. Still and all, we cannot exclude the 
possibility of existence of RNA molecules (not detected in the present study) that 
may cooperate with the chromatin reorganization mediated by HMGN5. 
 
 
5.3 HMGN5 is coupling global chromatin architecture 
and gene expression 
 
It has become clear that the spatial organization of chromatin plays a central role in 
regulating gene expression. Several attempts have been made to determine the 
relationship chromatin structure-function in diverse nuclear processes, specifically 
the ones that involve transcriptional reprograming, like differentiation (Harada, 
Ohkawa, & Imbalzano, 2017), embryogenesis (Xu & Xie, 2017), or cell cycle 
regulation (Liu et al., 2017). Nevertheless, there is still a gap of knowledge on how 
the opening of higher order structure of chromatin can control gene expression. In an 
effort to try to understand the contribution of HMGN5 to this process, we made an 
integrative analysis of the genome-wide HMGN5 distribution with the transcriptional 
changes observed after deregulation of HMGN5. 
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As already mentioned, several studies have revealed that HMGN5 regulates the 
transcription fidelity of the cells. Using Affimetrix expression arrays it was 
demonstrated that an overexpression of HMGN5 altered the expression of more than 
2000 genes in mouse AtT20 cells (Rochman et al., 2009),  and more than 3000 
genes in mouse embryonic fibroblast cells (MEF) (Rochman et al., 2011). The human 
HMGN5 was shown to alter the expression of over 350 genes by approximately two 
fold in a human breast cancer cell line (Malicet et al., 2011). Moreover, the 
transcriptional regulation mediated by HMGN5 was shown to be tissue-specific 
(Kugler et al., 2013). Here we analyzed the effect of HMGN5 deregulation on the 
transcription profile using the HMGN5_FlpIn cell line. Our results are in line with the 
previous findings, as we observe a large set of genes (up to 3000 per condition) 
being affected due to overexpression or knockdown of HMGN5 (see results section 
4.6). Interestingly, a large set of genes (1287) is overlapping between HMGN5 up- 
and down regulation, showing the same type of change. In contrast to the 
expectation, most of these genes are, for example, repressed in the absence of 
HMGN5, and also when HMGN5 is overexpressed. We suggest that HMGN5 is part 
of a multifactor complex (or complexes) and the depletion or overexpression of 
HMGN5 may produce an imbalance in stoichiometry (Veitia & Potier, 2015), leading 
to the same phenotype observed in both conditions. A similar effect is described in 
(P. Wang et al., 2014b).  
Interestingly, the GO enrichment analysis indicates that the missregulation of 
HMGN5 levels by overexpression or knockdown affects genes grouped in different 
nuclear processes. As an example, both, up- and down regulation of the protein 
result in the down regulation of genes associated with cell cycle regulation. These 
results are consistent with previous findings showing that HMGN5 plays a critical role 
in cell cycle progression and that is directly involved in tumorigenesis. Indeed, it was 
consistently shown by different studies that the knockdown of HMGN5 by RNA 
interference reduces cell proliferation, and enhances the apoptotic process, making 
HMGN5 a promising candidate for therapeutic targeting in different cancer types 
(reviewed in Shi et al., 2015). 
So far only one published study analyzed the binding of HMGN5 in the genome by 
high throughput sequencing (Zhang et al., 2013). However this study was focused on 
the context of the reciprocal influence of HMGN5 and the lamina-associated protein 
LAP2α in their genomic distribution, and did not analyzed an exhaustive genome 
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occupancy profile of HMGN5. Unfortunately the raw data of their analysis is not 
available for comparison with our results (they state the analysis as preliminary ChIP-
seq results). 
When analyzing the strict overlapped distribution of HMGN5 with different genomic 
features in our data, we can observe that around 30% of the total peaks were found 
associated with promoters close to the transcription start site (TSS), and 23% were 
found associated with intronic regions (section 4.10). However, when normalizing the 
data with respect to the size distribution of each feature in the genome, the results 
reveal that HMGN5 is highly enriched at regulatory regions, including promoter-TSS, 
CpG islands and 5’UTR and is, indeed, depleted from introns.  
Moreover, the comparison with high throughput sequencing dataset in the HEK293T 
(background cell line of the stable HMGN5_FlpIn) available at the ENCODE project, 
reveals that HMGN5 highly correlates with the process of transcriptional activation, 
as revealed by the co-localization with RNA polymerase II distribution (Cho et al., 
2016)-, and the histone marks H3K4me3 and H3K27ac, respectively being 
associated with promoters of active genes and active enhancers (Shlyueva et al., 
2014). Although the sole presence of those markers does not constitute an indication 
of transcriptional activity -as the histone modification H3K4me3 has been lately 
shown to be associated with 75% of all protein-coding genes in human embryonic 
stem (ES) cells (Guenther, Levine, Boyer, Jaenisch, & Young, 2007)-, still the high 
correlation of the genome-wide HMGN5 distribution with the DNase I Hypersensitive 
Sites (DHSs), a hallmark of open chromatin regions -marking diverse classes of cis-
regulatory elements (Boyle et al., 2008; He et al., 2014)-  together with the histone 
marks, RNA polymerase II and CpG island binding, reveal that HMGN5 is associated 
with transcriptional activity.  
Interestingly, from the total peaks found at regulatory regions, including promoter-
TSS, CpG islands and 5’UTR, almost 40 percent (882 peaks) are found associated 
with genes that show transcriptional changes after deregulation of HMGN5. Of those 
peaks, 250 were found in regulatory regions of the genes that change transcription 
after both up-and down regulation of HMGN5. This result reinforces the suggested 
direct role of HMGN5 in gene regulation. 
Strikingly, more than 50 percent of those genes can be classified as genes involved 
in RNA metabolism (Figure 36A). Moreover, when analyzing only the genes with 
HMGN5 enrichment at promoter regions close to the transcription start site (TSS) 
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found overlapping with the RNA-seq profile of HMGN5 missregulation by both, 
HMGN5 overexpression and knockdown, the group is specifically categorized in RNA 
related metabolic processes, like post-transcriptional regulation of gene expression, 
rRNA metabolic process and sequence-specific mRNA binding. This demonstrates a 
direct role of HMGN5 in the regulation of RNA metabolism, explained by a direct 
influence of HMGN5 targeting at the associated regulatory regions.  
Nevertheless, it is important to mention that for several of the genes with altered 
transcription and with RNA metabolism-related functions in the RNA-seq profile, 
HMGN5 was not found binding regulatory regions, thus we believe that the 
transcriptional changes observed in those cases correspond to an indirect effect of 
HMGN5, like subsequent effects of altered gene expression or due to the binding 
with interacting factors. 
Remarkably, the fact that HMGN5 binds directly to RNAs in our CLIP-seq data, and 
its apparent preferential binding to introns, make us speculate that the transcriptional 
regulation is modulated at different levels. 1) pre-transcriptional regulation given by 
the recruitment of HMGN5 to regulatory genomic regions and thus reorganizing the 
chromatin, and 2) a co-transcriptional regulation given by the interaction of the 
protein with the nascent transcript. This apparent dual function has been recently 
seen for other chromatin binding proteins. As an example, EZH2 (Enhancer of Zeste 
homolog 2), the catalytic subunit of the Polycomb repressive complex 2 (PRC2) -
histone methyltransferase required for maintaining epigenetic silencing during 
development and cancer (Davidovich, Zheng, Goodrich, & Cech, 2013)- occupies 
active promoters while contacting the 5’ region of nascent transcripts. This effect was 
correlated with decreased levels of H3K27me3. This model of binding was suggested 
to be a mechanism by which PRC2 senses the activation states of promoters through 
contacts with nascent RNAs (Kaneko, Son, Shen, Reinberg, & Bonasio, 2013). As 
additional example, it has been shown that CTCF plays a direct role on splicing 
regulation by promoting the pausing of RNA polymerase II (Shukla et al., 2011). 
Moreover, in a recent study, using a new high-throughput technology called 
‘‘Systematic Parallel Analysis of Endogenous RNA Regulation Coupled to Barcode 
Sequencing’’ (SPAR-seq) it was revealed that hundreds of proteins, including 
transcription factors, DNA-binding and chromatin binding proteins, affect the 
Alternative Splicing (AS) (Han et al., 2017). In various cases by a dual mechanism by 
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directly binding the RNA adjacent to target exons and affecting in parallel the 
expression of splicing factors that control the AS (Han et al., 2017). 
Remarkably, we do observe that for the 126 identified HMGN5-bound RNA 
molecules, 56 exhibit transcriptional changes when HMGN5 is deregulated. From 
those, 23 specifically change when HMGN5 is overexpressed, and 16 change only 
after HMGN5 knockdown. The remaining 17 RNAs exhibit transcriptional changes 
after up- and down regulation of HMGN5. This result emphasizes the dual role of 
HMGN5 in coupling chromatin architecture with transcriptional regulation, probably 
acting as a sensor of the transcriptional state of the cells and translating the 
information by modifying the chromatin structure at the associated regulatory regions. 
This effect could be mediated by interaction with regulatory factors, as proteins (see 
section 5.4) and possibly with regulatory RNAs that were not uncovered by our 
method. 
It is important to notice that for all the identified interacting RNAs the transcriptional 
changes are mild, with log2FC less than 1. However, we are confident with the fact 
that those are biologically significant changes, since in the method the counts are 
normalized by transcript abundance (read count per gene), passing multiple-test 
adjustment to determine the statistical significance. Moreover, the qPCR validation in 
three independent biological replicates of the gene ZCCHC12 (Zinc Finger CCHC-
Type Containing 12) which has a Log2FC of 0.6 in the RNA-seq, showed a similar 
transcriptional change in the samples tested by qPCR (Figure 20), indicating the 
consistency in the expression changes. 
 
 
5.4 A Regulatory HMGN5-CTCF network 
 
Strikingly, the analysis of our ChIP-seq data reveals that there is a strict correlation of 
the genome-wide HMGN5 distribution with the CTCF occupancy (Figure 34E). Our 
de novo motif analysis shows that the most enriched motif in the HMGN5 ChIP-seq 
corresponds to the CTCF (and the paralog BORIS/CTCFL) binding site (Figure 38), a 
conserved sequence in different human cell lines (Cuddapah et al., 2008; Essien et 
al., 2009). CTCF motif was found in 17 percent of total HMGN5 peaks in the genome, 
indicating a high co-occupancy of both proteins. 
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First described as a transcription factor (TF) (Klenova et al., 1993; Lobanenkov et al., 
1990), the highly conserved zinc finger protein CTCF (CCCTC-binding factor) has 
been shown to play a key role in regulating transcription at different levels. It has 
been identified as a repressor of transcription (Burcin et al., 1997; Klenova et al., 
1993), as transcriptional activator (Vostrov & Quitschke, 1997) in heterologous 
reporter assays, playing a role in gene imprinting, and X-chromosome inactivation 
(Phillips & Corces, 2009). However, the principal function of CTCF is related to the 
organization of the 3D genome architecture by mediating long-range inter and intra 
chromosomal interactions over tens or even hundreds of kilobases creating large 
loop-domains, thus bringing gene enhancers into proximity with their target 
promoters (Ong & Corces, 2014). A widely described long-range interaction mediated 
by CTCF is the insulation activity (A. C. Bell, West, & Felsenfeld, 1999; Ciavatta, 
Rogers, & Magnuson, 2007). Here, CTCF acts as enhancer-blocking, preventing the 
inappropriate action of an enhancer on a neighboring locus (A. C. Bell et al., 1999) or 
buffering the heterochromatin spreading (barrier) (J. Wang, Lawry, Cohen, & Jia, 
2014a). CTCF has also been shown as an activator by establishing long-distance 
contacts to create an active “chromatin hub” in the β-globin locus during the 
activation of specific globin genes (Tolhuis, Palstra, Splinter, Grosveld, & de Laat, 
2002). These many variety of CTCF functions are explaned by its interplay with 
interacting complexes in a lineage-specific manner (Cuddapah et al., 2008). 
 The insulation activity, as an example, is influenced by the binding of cohesins 
(Wendt et al., 2008) and the DEAD-box RNA helicase p68 with its associated ncRNA 
(Yao et al., 2010). 
Interestingly, it has been shown that CTCF has a critical role in establishing the 
Topologically Associated Domains (TADs) as it is highly enriched at TAD boundaries 
(Dixon et al., 2012). In addition CTCF-mediated loops were strongly enriched at the 
border of Lamina-Associated Domains (LADs) (Guelen et al., 2008). 
LADs are large domains of chromatin associated with the nuclear lamina (NL) that 
are required for the spatial organization of the genome in the nuclei. LADs have well 
defined borders which are enriched for active promoters, CpG islands and CTCF in 
mammals (Guelen et al., 2008).  
The strict correlation that we observe with CTCF binding sites and the enrichment of 
HMGN5 in regulatory regions like promoters and CpG islands highly suggests that 
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HMGN5 and CTCF could have similar and/or cooperative functions in the interaction 
with the LADs.  
One of our more striking results in this regard, is that we demonstrate a direct 
interaction of HMGN5 with CTCF in vivo, as identified by quantitative mass 
spectrometry after Co-IP (see section 4.14). Since HMGN5 is tightly bound to 
chromatin, we completely hydrolyzed DNA by a combination of MNase and 
Benzonase to only isolate interacting partners that made physical contact with 
HMGN5. The result then indicates that both proteins could have a direct protein-
protein interaction or that they are part of the same protein complex. 
Interestingly, both proteins have been shown to physically interact with components 
of the nuclear lamina, which let us speculate about a role of an HMGN5-CTCF 
complex in the regulation of the lamina-chromatin interactions.  
Besides the high enrichment observed at the LADs borders, CTCF has been 
functionally linked to nuclear lamina in two recent reports. Honglei Zhao and 
colleagues showed that a complex between CTCF and PARP1 (Poly [ADP-ribose] 
polymerase 1) promotes the recruitment of circadian genes (as IGF2/H19, TARDBP 
and PARD3) to the lamina resulting in the attenuation circadian genes (Zhao et al., 
2015). Another study revealed that the CTCF-nuclear lamina complex plays an active 
role in the transcriptional control of Estrogen Receptor (ER) target genes in breast 
cancer cells (Fiorito et al., 2016). It was shown that in this complex CTCF directly 
associates the lamina components Lamin B and/or Lap2β (Lamina-associated 
polypeptide 2, isoforms beta/gamma). 
It was also shown by the group of Michael Bustin that HMGN5 directly interacts with 
the lamina-associated polypeptide 2-alpha (Lap2α) and that they reciprocally 
influence their genomic binding sites (Zhang et al., 2013).  
LAP2α is a LAP isoform not anchored to the membrane. This protein is required to 
maintain the nucleoplasmic lamin A/C in the nuclear interior and has been shown to 
be bound to hetero- and euchromatin (Gesson et al., 2016). 
Additionally, it was demonstrated that the HMGN5 dependent global chromatin 
decompaction decreases the sturdiness, elasticity and rigidity of the nucleus. Also 
mice overexpressing HMGN5 exhibit a phenotype characterized by deformed nuclei 
and disrupted lamina, which is associated with premature death because of cardiac 
malfunction (Furusawa et al., 2015). This study demonstrated a direct role of HMGN5 
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in regulating the nuclear architecture by linking the higher order organization of 
chromatin to the nuclear lamina. 
Strikingly, amongst the HMGN5-interacting proteins identified in our study, the Barrier 
to autointegration factor 1 (BANF1 and alternatively named BAF), key component of 
the lamina, was the most abundant protein. BANF1 is involved in different pathways 
associated with genome maintenance. Loss of BANF1 in Drosophila and C. elegans 
is associated with altered nuclear envelope morphology and aberrant mitotic 
phenotypes like anaphase chromosome bridges (Jamin & Wiebe, 2015) 
BANF1 also directly interacts with Lap2α, LAP2β, histones and lamina proteins 
(Jamin & Wiebe, 2015) being an essential factor for nuclear architecture and 
chromatin organization. 
Those results support the hypothesis of HMGN5 playing a role in linking the nuclear 
lamina to chromatin organization as previously proposed (Naetar et al., 2017; Zhang 
et al., 2013) and it is tantalizing to speculate that the interaction of HMGN5 with 
CTCF may play a role in this higher order chromatin-lamina interaction. Such a 
function, though, needs to be experimentally validated. 
As it was discussed in section 5.3, HMGN5 could play a dual regulatory role by 
modifying the global chromatin architecture and directly affecting the RNA 
metabolism. Due to its intrinsically disordered nature, we hypothesized that it may 
form distinct interaction complexes that, as it has been described for CTCF, would 
determine its specific function.  
Specific targeting of HMGN5 to the genome could be determine by the binding to 
regulatory RNAs, as shown for the Drosophila Df31 (Schubert et al., 2012) or CTCF 
protein (Kung et al., 2015).  
By using the MS2 tethering assay in vivo (Shevtsov & Dundr, 2011),	   we tried to 
analyze the role of candidate RNAs (from the HMGN5-RNA CLIP) in tethering and 
chromatin reorganization mediated by HMGN5. In this assay we tagged candidates 
RNAs with an MS2 stem loop and tried to tether them to the MS2 coat protein (MCP) 
that was bound to a LacO array in cells. Unfortunatelly, but we could not immobilize 
the MCP protein to the LacO (data not shown). This possibility needs to be validated 
with the use of a different method. 
Furthermore, we observed that HMGN5 interacts with seven proteins that are 
associated with pre-rRNA processing and synthesis of the 60S ribosomal subunit 
(Castle et al., 2012; Finkbeiner et al., 2011). The identified proteins include a 
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complete complex associated with the (de)sumoylation process in transcriptional 
regulation (section 4.14) -composed by the proteins LAS1L, PELP1, TEX10, WDR18, 
SENP3, and NOL9- suggests a direct role of HMGN5 in the regulation of ribosomal 
biogenesis. 
The specific interaction networks may finally determine the specific regulatory 
functions of HMGN5.  
The results presented here highlight the highly versatile and critical role of HMGN5 in 
the higher-order structure of chromatin and regulation of gene expression. 
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6 Conclusion and Perspectives 
 
 
Here we revealed that HMGN5 possesses a novel RNA binding activity. Furthermore, 
we showed that the RNA binding ability is also characteristic of other HMGN proteins, 
indicating a novel function of the HMGN family. 
The missregulation of HMGN5 in cells by overexpression and knockdown affected 
the transcription of a large set of genes (about 3000 respectively), one third of them 
being overlapped in both conditions.  
By ChIP-seq we showed that HMGN5 was preferentially associated with active 
regulatory regions like promoters and CpG islands. HMGN5 also correlates with RNA 
polymerase II target sites, and localizes at DNase I HS sites. 
The actively regulated target genes possess functions related with RNA metabolism. 
By using CLIP-seq we revealed that HMGN5 binds nascent RNA in vivo. Moreover, 
the in vitro competitive assays revealed that HMGN5 form distinct complexes with 
nucleosome and with RNA. We propose that HMGN5 plays a role in regulating RNA 
metabolism by a dual binding mechanism: 1) by opening chromatin structure at 
regulatory genomic regions and 2) and by directly contacting nascent RNA. 
We revealed that HMGN5 co-localizes and directly interacts with CTCF in vivo, 
suggesting a cooperative role of both proteins in the organization of higher order 
structure of chromatin.  
Moreover, the interaction of HMGN5 with several proteins associated with the pre-
rRNA processing -revealed by quantitative mass spectrometry- suggests a role of 
HMGN5 in the regulation of rRNA metabolism. 
Furthermore, amongst the identified interacting proteins we also found enriched the 
protein BANF1, component of the nuclear lamina.  
Since both, CTCF and HMGN5 interact with factors associated with nuclear lamina, 
we hypothesized that a CTCF-HMGN5 complex could participate in the lamina-
chromatin interplay. 
 
 
Conclusion and perspectives 
119 
 
 
To characterize the potential HMGN5-CTCF complex, different in vivo and in vitro 
studies need to be performed.  
By using pull-down assays and in vitro binding measurements (MST or EMSA), the 
protein domains involved in the interaction can be determined. 
The reciprocal influence on the binding targets can be followed by analyzing their 
mutual genome-wide distribution after overexpression or knockdown of one of both 
proteins.  
By using the LacI/LacO tethering system, the influence of CTCF on the recruitment of 
HMGN5 to the chromatin can be studied.  
It is important to characterize the role of HMGN5 in the lamina-chromatin 
interactions. In this regard, the association of HMGN5 with BANF1 and LAP2α could 
be analyzed using standard in vitro and in vivo methods, to test how they influence 
the chromatin and RNA binding ability of HMGN5. As an example, the effect of the 
lamina proteins on the decompaction mediated by HMGN5 can be tested by MNase 
accessibility assays, the LacI/LacO tethering system and by ChIP-seq analysis. 
As we showed that HMGN5 preferentially binds the canonical CTCF binding motif in 
vivo, an in vitro characterization by EMSA and MST could help to understand if the 
sequence motif influences the genomic binding preferences of HMGN5, or if the 
bnding is determined by the interacting network. 
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7 Materials and methods 
 
7.1 Materials 
 
Unless otherwise stated, all common chemicals and kits were purchased from GE 
Healthcare, Fermentas, Invitrogen, Merck, New England Biolab, Promega, Roche, 
Roth, Serva, Bio‐Rad, Stratagene/Agilent, Sigma‐Aldrich, BD Biosciences, 
Macherey-Nagel, Nugen, Pierce and Qiagen. Cell culture reagents were purchased 
from Gibco, Invitrogen, Clontech and Promega. 
 
7.1.1 Equipment and consumables 
 
7.1.1.1 Consumables 
 
Consumable Supplier 
1.5 ml and 2 ml micro centrifuge tubes Eppendorf/Sarstedt 
15 and 50mL centrifuge tubes Sarstedt 
Centrifugal spin filter column 0.5ml Merck Millipore 
Barrier food wrap Saran 
Cell culture 6 and 24 well-plate Sarstedt 
Cell scraper Sarstedt 
Cover slips, 22x22 mm Roth 
Cryovials Roth/Nunc 
Dialysis membrane Spectrum Laboratories 
Filter paper Whatman 3MM Whatman 
Filter tips Sarstedt 
Gel cassettes (disposable) Invitrogen 
Glassware Schott 
Immobilon-P Membrane Millipore 
Laboratory film Parafilm® 
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Consumable Supplier 
Latex gloves Roth 
Micro cuvettes Sarstedt 
Microscope glass slides Roth 
Monolith NT115 standard treated capillaries NanoTemper Technologies 
Pasteur glass pipettes VWR 
PCR‐reaction tubes 0.2 ml Kisker Biotech 
Petri dishes and tissue culture plates Sarstedt 
Pipette tips Sarstedt 
qPCR reaction strip tubes Kisker 
Serological pipettes Sarstedt 
Syringes Braun 
Vivaspin 500 Protein Concentrators 
(Vivaspin) Sigma 
 
 
 
7.1.1.2 Equipment 
 
Equipment Supplier 
- 20 °C freezer Siemens/Ewald 
- 80 °C freezer Sanyo 
2100 Bioanalyzer Agilent 
Agarose gel chambers University of Regensburg 
Agarose gel UV imaging system GelMax, Intas 
Autoclave Zirbus 
Bioruptor Standard Sonicator Diagenode 
Centrifuge 3-16K Sigma 
Centrifuge Avanti J-26 XP Beckman Coulter 
Centrifuge Avanti J-26-S XP Beckman Coulter 
Centrifuge Centrikon T-324 Kontron Instruments 
CO2 incubator (mammalian cells) SANYO/Binder 
Fluorescence Microscope, Axiovert 
200M Carl Zeiss 
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Equipment Supplier 
Heatblock neoBlock-Heizer Duo  neoLab 
Ice machine Ziegra 
Image Reader LAS-3000 Fuji 
Incubator Shaker Infors 
Laminar flow hood Antair BSK 
Leica TCS SP8 confocal microscope Leica Microsystems 
Magnetic plate SPRIplate® 96-Ring  Agencourt Bioscience 
Magnetic stirrer MR 3001 Heidolph 
Microbiological incubator MEMMERT 
Micropipettes Gilson 
Microwave Sharp 
Monolith NT.115 Nanotemper technologies 
Nanodrop® ND-1000 
Spectrophometer peQLab Biotechnologie GmbH 
Neubauer counting chamber Marienfeld 
Overhead rotator Scientific Industries/Labinco 
Peristaltic Pump PUMPDRIVE 5001 Heidolph 
Peristaltic Pump LKB-P1 GE Healthcare 
pH meter Knick 
Pipette controller  Integra/eppendorf 
Power Supply EPS301 Ashram Biosciences 
PURELAB Ultra ELGA LabWater 
Qubit 2.0 fluorometer Invitrogen 
Reax top vortexer Heidolph 
Real Time Thermocycler Rotor 
Gene Q Qiagen 
Safe Imager Invitrogen 
Scale Sartorius 
Sonifier 250 Branson 
Stratalinker UV crosslinker Stratagene 
Table top centrifuge Eppendorf 
Thermocycler Peqlab/Applied Biosystems 
Thermomixer compact Eppendorf 
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Equipment Supplier 
Trans-Blot® SD Semi-Dry Transfer 
Cell Bio-Rad 
Typhoon FLA 9500 GE Healthcare 
Uvikon Spectrophotometer 922 Kontron Instruments 
Vacuum Pump FB70155  Fischerbrand 
XCell SureLock™ Mini-Cell system Invitrogen 
 
 
7.1.1.3 Kits 
 
Kit Supplier 
Gateway BP Clonase II Mix Invitrogen 
Gateway LR Clonase II Mix Invitrogen 
High Sensitivity DNA Kit Agilent 
iScript™ cDNA Synthesis Kit BioRad 
NEBNext ChIP-Seq Library Prep Master Mix 
Kit New England Biolabs 
NucleoSpin RNA Kit Macherey-Nagel 
Ovation® Universal RNA-Seq System 1-16 Nugen 
PureLink® HiPure Plasmid Maxiprep Kit Invitrogen 
QIAquick PCR purification Kit Qiagen 
QIAEX® II Gel Extraction Kit Qiagen 
QIAprep Spin Miniprep Kit Qiagen 
Qiagen Plasmid Purification Midi Kit Qiagen 
Qubit® dsDNA BR Assay Kit Invitrogen 
Qubit® Protein Assay Kit Invitrogen 
Qubit® RNA BR Assay Kit Invitrogen 
RNA 6000 Pico Kit Agilent 
SuperSignal WEST Dura WB Kit Pierce 
SuperScript II Reverse Transcriptase (RT) Invitrogen 
SYBR® Green qPCR Kit Qiagen 
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7.1.2 Reagents 
 
7.1.2.1 Common reagents 
 
Product Supplier 
Agencourt AMPure XP beads Agencourt Bioscience  
Acetic acid Sigma/VVR 
Agarose, UltraPure™ Invitrogen 
Ammonium acetate Merck 
Ammonium persulfate (APS) Roth 
Ampicillin Roth 
Aprotinin Roth 
Bacto Agar BD Biosciences 
Bacto Tryptone BD Biosciences 
Bacto Yeast Extract BD Biosciences 
Bovine serum albumin (BSA) (albumin 
fraction V) Serva electrophoresis 
Bovine serum albumin (BSA), 10 mg/ml Sigma-Aldrich 
Bradford protein assay Bio-Rad 
Bromophenol Blue Roth 
Calcium chloride (CaCl2) Roth 
Chloroform Merck 
Coomassie Brilliant Blue G250 Thermo scientific 
D-Sucrose Roth 
DAPI  Sigma-Aldrich 
DMSO Merck 
DTT Sigma-Aldrich 
dNTP mix Qiagen 
EDTA Merck 
EGTA Sigma-Aldrich 
Elution buffer (EB) Qiagen 
Ethanol p. A. Merck 
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Product Supplier 
Ethidium bromide Roth 
Formaldehyde Merck/Sigma 
Formamide Roth 
GFP-Trap agarose beads Chromotek 
GFP-Trap magnetic particles Chromotek 
Glutathione Thermo scientific 
Glutathione-agarose beads  Jena Bioscience 
Glycerol Merck/Roth 
Glycine Serva electrohporesis 
Glycogen Sigma-Aldrich 
Hydrochloric acid Merck 
IGEPAL CA-630 Sigma-Aldrich 
Imidazol Roth 
IPTG Roth 
Isopropanol VVR chamicals 
Kanamycin Roth 
Leupeptin Roth 
Lithium chloride (LiCl) Roth 
Magnesium chloride (MgCl2) Merck 
Methanol Merck 
Milk powder Sucofin 
Monopotassium phosphate (KH2PO4) Merck 
Ni-NTA agarose Qiagen 
Nuclease-free water Ambion 
Orange G Sigma-Aldrich 
Paraformaldehyde (PFA) EMS  
Pepstatin Roth 
PMSF   Roth 
Potassium chloride (KCl) Merck 
Roti®-Phenol/Chloroform/Isoamyl alcohol Roth 
Rotiphorese®Gel30 (37.5:1) (acrylamide/bis-
acrylamide) Roth 
Sodium acetate Merck 
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Product Supplier 
Sodium chloride (NaCl) Sigma/VVR 
Sodium dodecyl sulfate (SDS) Roth 
Sodium hydrogen carbonate (NaHCO3) Merck 
Sodium hydroxide (NaOH) Merck 
SYBR® Green Invitrogen 
SYBR® Safe Invitrogen 
TEMED Roth 
TCEP  Thermo Scientific 
TRIS  Sigma-Aldrich 
Triton X-100 Sigma-Aldrich 
Trizol Invitrogen 
Tween-20 Roth 
Vectashield mounting medium Vector Laboratories Inc. 
β-Mercaptoethanol Sigma-Aldrich 
 
 
 
7.1.2.2 Ladders 
 
Ladder Supplier 
GeneRuler™1kb Plus DNA Ladder  Fermentas 
PageRuler Prestained Protein Ladder Plus  Fermentas 
RiboRuler Low Range RNA Ladder Thermo scientific 
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7.1.2.3 Cell culture reagents and buffers 
 
Reagent Supplier 
(DMEM), low glucose, GlutaMAX™ Gibco 
0.05% Trypsin - EDTA (1X) Gibco 
Blasticidin Gibco 
Doxycycline Clontech 
Fetal Bovine serum Gibco 
Fetal Bovine serum, Tetracycline-Free Biochrom 
FuGENE® HD Transfection Reagent Promega 
Hygromycin Invitrogen 
Lipofectamine® 3000 Invitrogen 
Lipofectamine® RNAiMAX Invitrogen 
Opti-MEM® I Reduced Serum Medium Gibco 
Trypan Blue Gibco 
Zeocin Invitrogen 
 
 
7.1.2.4 Buffers and medium 
 
Common buffers were prepared according to standard protocols (Sambrook and 
Russel 2001; LabFAQS, Roche) and additional buffers for specific methods are 
described in each individual method section. If not stated differently, all buffers are 
stored at room temperature. 
 
Buffer Composition 
ChIP High Salt Buffer 
20 mM Tris-HCl pH 8.0 
500 mM NaCl 
2 mM EDTA 
1% Triton X-100 
ChIP LiCl Buffer 
10 mM Tris-HCl pH 8.0 
250 mM LiCl 
1 mM EDTA 
1 % IGEPAL CA-630 
1 % (w/v) sodium deoxycholate 
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Buffer Composition 
ChIP Low Salt Buffer 
20 mM Tris-HCl pH 8.0 
150 mM NaCl 
2 mM EDTA 
1% Triton X-100 
 ChIP SDS Lysis Buffer 
50 mM Tris-HCl, pH 8.0 
10 mM EDTA 
1% (w/v) SDS 
1X protease inhibitor mix (PI) 
Chromatin Assembly High Salt Buffer  
10 mM Tris-HCl pH 7.6 
2M NaCl 
1 mM EDTA  
0.05% IGEPAL CA-630 
2 mM β-mercaptoethanol 
Chromatin Assembly Low Salt Buffer  
10 mM Tris-HCl pH 7.6  
50 mM NaCl 
1 mM EDTA  
0.05% IGEPAL CA-630 
2 mM β-mercaptoethanol 
Chromatin Assembly Low Salt Buffer  
10 mM Tris-HCl pH 7.6  
50 mM NaCl 
1 mM EDTA  
0.05% IGEPAL CA-630 
2 mM β-mercaptoethanol 
 
CLIP Elution Buffer 
 
10 mM Tris-HCl, pH 7.5 
(prepared in nuclease-free 
water) 
CLIP High Salt Buffer 
50 mM Tris-HCl pH 7.5 
500 mM NaCl  
 1 mM MgCl2 
0.1% SDS 
0.05% IGEPAL CA-630 
100units/mL RNAsin 
1X protease inhibitor mix (PI) 
CLIP Low Salt Buffer 
20 mM Tris-HCl pH7.5  
250 mM NaCl  
 1 mM MgCl2 
 0.025% SDS  
0.05% IGEPAL CA-630 
CLIP Lysis Buffer 
20 mM Tris-HCl pH7.6 
100 mM NaCl  
 0.1 mM EDTA 
0.5% IGEPAL CA-630 
1X protease inhibitor mix (PI) 
100U/mL Rnasin 
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Buffer Composition 
CLIP Proteinase K Buffer 
10 mM Tris-HCl pH 7.6 
10 mM NaCl 
 5 mM CaCl2 
Coomassie staining solution 
0.1% (w/v) Coomassie Brilliant 
Blue 
45% methanol 
10% acetic acid 
Co-IP Lysis Buffer 
20 mM Tris-HCl pH 7.5  
150 mM NaCl 
0.5% IGEPAL CA-630 
3 mM CaCl2 
1X protease inhibitor mix (PI) 
Co-IP Wash Buffer 1  
20 mM Tris-HCl pH 7.5 
150 mM NaCl 
0.5% IGEPAL CA-630 
0.5 mM EDTA 
1X protease inhibitor mix (PI) 
Co-IP Wash Buffer 2  50 mM Tris-HCl pH 8 
EX-X buffers 
20 mM Tris-HCl pH 7.6 
1.5 mM MgCl2 
 0.5 mM EGTA  
10% glycerol 
X mM KCl 
 Immunofluorescence Fixation solution  1X PBS  
4% (w/v) Paraformaldehyde 
GST Lysis and Wash buffer  
50 mM Tris-HCl pH 8  
300 mM NaCl  
1 mM TCEP 
0.1% Triton X-100  
1X protease inhibitor mix (PI) 
GST Elution Buffer  
20 mM Tris-HCl pH 8 
10 mM Glutathione 
pH adjusted to 8 
  His Elution Buffer  
EX100 
250 mM Imidazol 
1X protease inhibitor mix (PI) 
 His Lysis Buffer 
50 mM Tris pH7.5 
300 mM NaCl 
10 mM imidazol 
1X protease inhibitor mix (PI) 
 His Wash Buffer  
50 mM Tris pH 7.5 
500 mM NaCl 
20 mM Imidazol  
1X protease inhibitor mix (PI) 
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Buffer Composition 
 Immunofluorescence Blocking Solution  
1X PBS 
0.1% Tween 20 
4% BSA 
Immunofluorescence Permeabilization Buffer 1  1X PBS 
0.5% Triton X-100 
Immunofluorescence Permeabilization Buffer 2  1X PBS 
0.01% Triton X-100 
Immunofluorescence Wash buffer  1X PBS 
0.1% Tween 20 
Lämmli buffer (6X) (protein loading buffer) 
350 mM Tris-HCl pH 6.8 
10% (w/v) SDS 
30% (v/v) Glycerin 
5% (v/v) β-
Mercaptoethanol 
0.2% (w/v) Bromophenol 
blue 
Luria-Bertani (LB) medium 
1.0% (w/v) Bacto‐Tryptone  
1.0% (w/v) NaCl 
0.5% (w/v) Bacto‐Yeast 
extract 
MST/EMSA binding buffer 
EX100 buffer 
0.05% IGEPAL CA-630 
(for MST) 
Orange G loading dye (10X) 
50% Glycerin 
10 mM EDTA 
0.03% (w/v) Orange G 
PBS-T buffer 1X PBS 
0.1% Tween 20 
Permeabilization Buffer (genomic DNA 
extraction) 
15 mM Tris pH 7.5  
300 mM Sucrose  
60 mM KCl  
15 mM NaCl 
3 mM CaCl2 
1.5 mM MgCl2 
0.5 mM EGTA 
0.2% (v/v) IGEPAL CA-630 
PBS (Phosphate-Buffered Saline)  
137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
1.8 mM KH2PO4 
pH adjusted to 7.4 
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Buffer Composition 
1X Protease inhibitor mix (PI) 
1µg Aprotinin 
1µg/ml Leupeptin 
1µg/ml Pepstatin  
1 mM PMSF 
(All final concetrations) 
SDS-PAGE Lower Buffer (4X) 1.5 M Tris-HCl pH 8.8 0.4% SDS 
SDS-PAGE Running buffer (1X) 
25 mM Tris-HCl 
192 mM Glycine 
0.1% SDS 
TBE (1X) 
90 mM Tris-HCl pH 8.0  
90 mM boric acid 
2 mM EDTA 
Transfer buffer (Towbin) 
25 mM Tris-HCl  
192 mM Glycin 
20% Methanol 
0.05% SDS 
 Western blot Blocking solution  1x PBS-T  
5% dried milk 
Whole Cell Lysis Buffer 
20 mM Tris-HCl pH 7.5 
100 mM NaCl 
0.1 mM EDTA 
0.5% IGEPAL CA-630 
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7.1.2.5 Enzymes 
 
Enzyme Supplier 
Antarctic phosphatase  New England Biolabs 
Benzonase Sigma Aldrich 
MNase  Sigma-Aldrich 
MNase (lab made) Längst's group 
Phusion® DNA polymerase  New England Biolabs 
Proteinase K (10mg/ml) Sigma-Aldrich 
Q5 DNA Polymerase New England Biolabs 
Restriction endonucleases  New England Biolabs 
RNase A  Invitrogen 
RNase A/T1 Thermo Scientific 
RQ1 DNase Promega 
T4 DNA ligase  New England Biolabs 
T4 DNA polymerase New England Biolabs 
Taq DNA polymerase (Lab made) Längst's group 
TURBO DNA-free™ DNase  Ambion 
 
 
7.1.2.6 Antibodies 
 
Antibody Reactivity Biological source Supplier Applications 
Anti HMGN5 
(HPA000511) 
Human HMGN5 Rabbit polyclonal  (Sigma)  WB 1:2500 
IF 1:500 
Anti actin 
(A2066) 
Wide range 
including human 
Rabbit polyclonal Sigma 
 
WB 1:5000 
Anti rabbit 
HRP 
conjugated 
Ab raised in 
rabbit 
Goat  WB 1:5000 
anti-Rb-
DL488  
Ab raised in 
Rabitt 
Donkey Jackson IF 1:200 
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7.1.3 Cell lines 
 
Cell line Description Supplier Growth conditions 
HEK293T Human embryonic kidney 
ATCC, cells were 
received second 
hand from Dr. 
A.Németh 
37 °C, 5% CO2 Low 
glucose DMEM‐
GlutaMAX, 10% FBS 
U2OS /LacO 
Homo sapiens bone 
osteosarcoma 
containing a stable 
integration of an 
array of the operon 
Lac (LacO) inserted 
in a telomeric region 
Karsten Rippe’s 
laboratory 
37 °C, 5% CO2 Low 
glucose DMEM‐
GlutaMAX, 10% FBS 
T-REx™-293 
Flp-In 
Based in HEK-293T 
for inducible protein 
expression 
Life Technologies/ 
Prof. Dr. Wagner 
 
37 °C, 5% CO2, Low 
glucose DMEM‐
GlutaMAX, 10% 
Tetracycline-Free FBS,       
100 µg/ml Hygromycin, 
10 µg/ml Blasticidin 
 
GFP_FlpIn 
GFP gene stably 
integrated in T-REx 
293 cells 
Received from 
Gunter Meister's 
group 
 
37 °C, 5% CO2, Low 
glucose DMEM‐
GlutaMAX, 10% 
Tetracycline-Free FBS, 
100 µg/ml Hygromycin, 
10 µg/ml Blasticidin 
 
HMGN5_FlpIn 
HMGN5 gene stably 
integrated in T-REx 
293 cells 
Ingrid Araya 
 
37 °C, 5% CO2, Low 
glucose DMEM‐
GlutaMAX, 10% 
Tetracycline-Free FBS, 
100 µg/ml Hygromycin, 
10 µg/ml Blasticidin 
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7.1.3.1 Bacterial strains 
 
Strain Application Remarks 
DH5α 
General cloning and storage 
of common plasmids, 
blue/white screening. 
 
RecA1 and endA1 mutations 
increase insert stability and 
plasmid quality in miniprep 
DNA 
XL1blue 
General cloning and storage 
of common plasmids, 
blue/white screening. 
  
RecA1 and endA1 mutations 
increase insert stability and 
plasmid quality in miniprep 
DNA 
BL21 (DE3) pLysS 
 Protein expression 
T7 RNA Polymerase under the 
Control of the lac 
UV5 Promoter for IPTG 
inducible protein expression. 
Rosetta 2 (DE) pLysS 
 Protein expression 
Expression from T7 promoter 
with codon bias correction 
 
 
 
7.1.4 Plasmids 
 
7.1.4.1 LacI/LacO tethering plasmids 
 
Vector Remarks TAG Bacterial 
resistance 
Cloning strategy Obtained 
from 
pSV2_GFP
_LacI 
 
Mammalian 
expression vector. 
Transient 
transfection for 
LacI/LacO system 
GFP-LacI Kanamycin Not available 
Dr. 
Karsten 
Rippe’s 
Laboratory 
gBlock_pSV
2_GFP_Lac
I 
 
Mammalian 
expression vector. 
Transient 
transfection for 
LacI/LacO system 
GFP-LacI Kanamycin 
 
Modification of 
psV2_GFP_LacI 
to add EcoRI and 
XhoI restriction 
sites downstream 
of LacI sequence 
Ingrid 
Araya 
pSV2_GFP
_LacI_ 
HMGN5 
Mammalian 
expression vector. 
Transient 
transfection of 
HMGN5 for 
LacI/LacO system 
 
GFP-LacI Kanamycin 
 
HMGN5 CDS 
inserted in 
gblock_pSV2_ 
GFP_LacI with 
EcoRI and XhoI 
restriction sites  
Ingrid 
Araya 
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Vector Remarks TAG Bacterial 
resistance 
Cloning strategy Obtained 
from 
pSV2_GFP
_LacI_ 
PTMS 
 
Mammalian 
expression vector. 
Transient 
transfection of 
PTMS for LacI/LacO 
system 
 
GFP-LacI Kanamycin 
 
PTMS CDS was 
inserted in 
gblock_pSV2_GF
P_LacI with 
EcoRI and XhoI 
restriction sites  
 
Ingrid 
Araya 
 
 
 
 
7.1.4.2 Plasmids for stable cell line Flp-In  
 
Vector Remarks TAG Bacterial 
resistance 
Cloning 
strategy 
Obtained 
from 
pCDNA5
/FRT/TO
_GFP 
 
Mammalian Inducible 
expression vector 
designed for use with the 
Flp-In™ T-REx™ 
System 
  
GFP Amp Not available Dr. Helen Hoffmeister 
pCDNA5
/FRT/TO
_HMGN
5-GFP 
 
Mammalian Inducible 
expression vector 
designed for use with the 
Flp-In™ T-REx™ 
System 
 
GFP Amp 
HMGN5 CDS 
inserted in 
pCDNA5/FRT/
TO_GFP with 
HindIII and 
Xma restriction 
sites 
Ingrid Araya 
pOG44 
Flp recombinase 
expression plasmid, For 
efficient integration into 
Flp-In™ T-REx™ Cell 
Line 
 
 Amp Not available 
Life 
Technologies/ 
Prof. Dr. 
Wagner 
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7.1.4.3 Cloning plasmids 
 
 
 
 
Vector Remarks TAG Bacterial 
resistance 
Cloning 
strategy 
Obtained 
from 
pGEX-4T3 
 
Bacterial 
expression 
vector 
 
N-GST 
/thrombin 
 
Amp  Vendor 
pGEX-TEV 
 
Bacterial 
expression 
vector 
 
N-GST/ 
PreScission
/TEV 
Amp 
Created from 
pGEX4T3 
replacing the 
Thrombin site 
for the 
PreScission and 
TEV recognition 
site 
 
Ingrid Araya 
pGEX-
TEV_HMGN5
_WT 
 
Bacterial 
expression 
vector 
expressing 
HMGN5 WT 
 
N-GST/ 
PreScission
/TEV  
Amp 
HMGN5 cloned 
in pGEX-
4T3_TEV with 
KpnI and XhoI 
 
Ingrid Araya 
pGEX-
TEV_HMGN5
_dn19 
 
Bacterial 
expression 
vector 
expressing 
HMGN5 
∆N19 
 
N-GST/ 
PreScission
/TEV  
Amp 
HMGN5 ∆N19 
cloned in 
pGEX-TEV with 
KpnI and XhoI 
 
Ingrid Araya 
pGEX-
TEV_HMGN5
_dn20 
 
Bacterial 
expression 
vector 
expressing 
HMGN5 
∆N20 
 
N-GST/ 
PreScission
/TEV  
Amp 
HMGN5 ∆N20 
cloned in 
pGEX-TEV with 
KpnI and XhoI 
 
Ingrid Araya 
pGEX-
TEV_HMGN5
_dn24 
 
Bacterial 
expression 
vector 
expressing 
HMGN5 
∆N24 
 
N-GST/ 
PreScission
/TEV  
Amp 
HMGN5 ∆N24 
cloned in 
pGEX-TEV with 
KpnI and XhoI 
 
Ingrid Araya 
pGEX4T3_ 
HMGN5_ 
dC27 
 
Bacterial 
expression 
vector 
expressing 
HMGN5 
∆C27 
 
N-GST/ 
PreScission
/TEV  
Amp 
HMGN5 ∆C27 
cloned in 
pGEX-4T3 with 
BamHI and SalI 
 
Ingrid Araya 
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Vector Remarks TAG Bacterial resistance 
Cloning 
strategy 
Obtained 
from 
pGEX-
TEV_NBD 
Bacterial 
expression 
vector 
expressing 
HMGN5 NBD 
 
N-GST/ 
PreScission
/TEV 
Amp 
HMGN5 NBD 
cloned in 
pGEX-4T3 with 
BamHI and SalI 
 
Ingrid Araya 
pGEX-
TEV_HMGN5
_S20,24E 
 
Bacterial 
expression 
vector 
expressing 
HMGN5 
S20,24E 
 
N-GST/ 
PreScission
/TEV  
Amp 
Created with 
Site directed 
mutagenesis 
from pGEX-
TEV_HMGN5_
WT 
 
Ingrid Araya 
pGEX-
TEV_HMGN5
_S20E 
 
Bacterial 
expression 
vector 
expressing 
HMGN5 S20E 
 
N-GST/ 
PreScission
/TEV  
Amp 
Created with 
Site directed 
mutagenesis 
from pGEX-
TEV_HMGN5_
WT 
 
Ingrid Araya 
pGEX-
TEV_HMGN5
_S24E 
 
Bacterial 
expression 
vector 
expressing 
HMGN5 S24E 
 
N-GST/ 
PreScission
/TEV  
Amp 
Created with 
Site directed 
mutagenesis 
from pGEX-
TEV_HMGN5_
WT 
 
Ingrid Araya 
pGEX-TEV_ 
HMGN2 
Bacterial 
expression 
vector 
expressing 
human 
HMGN2 
 
N-GST/ 
PreScission
/TEV 
Amp 
HMGN2 CDS 
cloned into 
pGEG-TEV with 
EcoRI and XhoI 
from a 
synthesized 
DNA fragment  
Ingrid Araya 
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7.1.5 Oligonucleotides 
 
Cloning primers were purchased from Sigma-Aldrich and MWG. Fluorescent primers 
were obtained from Sigma-Aldrich. 
 
7.1.5.1 Cloning primers 
Name 
Gene/ binding 
site 
Orien-
tation Sequence Remarks Description 
IAP'#001 
gBlock for 
pSV2_ GFP_ 
LacI FW 
CGCAATGCGCGCC
ATTACCGAG   
 For modification 
of 
pSV2_GFP_LacI 
IAP'#002 
gBlock for 
pSV2_GFP_ 
LacI RV 
TAGATCCGGTGGA
TCCCGGGTCAG   
 For modification 
of 
pSV2_GFP_LacI 
IAP'#003 Parathymosin FW 
CGGAATTCATGTC
GGAGAAAAGCGTG 
EcoRI 
site 
For cloning in 
pSV2_GFP_ 
LacI 
IAP'#004 Parathymosin RV 
CTCTCGAGTCACG
CCGATGCCCCA XhoI site 
For cloning in 
pSV2_GFP_LacI 
IAP'#005 
pSV2_GFP_ 
LacI FW 
GAGGGCATCGTTC
CCACTGCG   
Sequencing 
primer 
IAP'#006 
pSV2_GFP_ 
LacI RV 
TTCAGGGGGAGGT
GTGGGAGG   
Sequencing 
primer 
IAP'#007 HMGN5 FW 
GCTGCAAGCTTAC
CATGCCCAAAAGA
AAGGCTG 
HindIII 
site 
For cloning in 
pCDNA5/FRT/TO 
IAP'#008 HMGN5 RV 
CTGGTCCCGGGTA
ACAATACTCTGTGG
CTCCTC XmaI site 
For cloning in 
pCDNA5/FRT/TO 
IAP'#013 HMGN5 FW 
AGCAGTTGCTGAA
ACCAAGC   
qPCR primer and 
sequencing 
IAP'#014 HMGN5 RV 
AGAAGCAGTGGCA
GCAGAAG   
qPCR primer and 
sequencing 
IAP'#015 HMGN5 FW 
CGGAATTCATGCC
CAAAAGAAAGGCT
GC 
EcoRI 
site 
For cloning in 
pSV2GFPLacI 
IAP'#016 HMGN5 RV 
CTCTCGAGCTAAAC
AATACTCTGTGGC XhoI site 
For cloning in 
pSV2GFPLacI 
IAP'#033 HMGN5 FW 
CATCGGATCCATG
CCCAAAAGAAAGG
CTGCAGG 
BamHI 
site 
For cloning in 
pGEX-4T3 
IAP'#034 HMGN5 RV 
ATCCGTCGACCATA
GCAGACAACCTGG
CAGATCTTC SalI site 
For cloning in 
pGEX-4T3 
IAP'#035 HMGN5 RV 
ATCTGCTCGAGCTA
AACAATACTCTGTG
GC XhoI site 
For cloning into 
pGEX-TEV 
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Name 
Gene/ binding 
site 
Orien-
tation Sequence Remarks Description 
IAP'#036 HMGN5 FW 
CATCGGTACCGCC
AGGTTGTCTGCTAT
GC KpnI site 
For cloning into 
pGEX-TEV 
IAP'#037 HMGN5 FW 
CATCGGTACCGCT
ATGCTTGTGCCAGT
TAC KpnI site 
For cloning into 
pGEX-TEV 
IAP'#039 
IAG_TEV_ 
PreScission FW 
TTCGAAGATCGTTT
ATGTC   
For introducing 
TEV_PreScission 
in pGEX-4T3 
IAP'#040 
IAG_TEV_ 
PreScission RV 
CGAGGCAGATCGT
CAGTCAG   
for introducing 
TEV_PreScission 
in pGEX-4T3 
IAP'#041 HMGN5 FW 
GTGAGGTACCATG 
AGGCAGGAGCCA 
AAG AG KpnI site 
For cloning into 
pGEX-TEV 
IAP'#042 HMGN5 RV 
ACGTCTCGAGCTA
AGGCTTCACCTCT
GGTGTAAC XhoI site 
For cloning into 
pGEX-TEV 
IAP'#043 HMGN5 FW 
ATCTGGTACCTCTG
CCAGGTTGTCTGC
TATG KpnI site 
For cloning into 
pGEX-TEV 
IAP'#044 HMGN5 RV 
ATCCGGTACCATG
CCCAAAAGAAAGG
CTGCAG KpnI site 
For cloning into 
pGEX-TEV 
IAP'#080 
HMGN5 (in 
pGEX-TEV) FW 
AGAGAAGAGAGGC
CAGGTTGGAGGCT
ATGCTTGTGCCAGT
TACACCAGAGGTG
AAGC   
Site directed 
mutagenesis 
HMGN5 S20,24E 
IAP'#081 
HMGN5 (in 
pGEX-TEV) RV 
GCATAGCCTCCAA
CCTGGCCTCTCTTC
TCTTTGGCTCCTGC
CTCATATCACCTTG   
Site-directed 
mutagenesis 
HMGN5 S20,24E 
IAP'#082 
HMGN5 (in 
pGEX-TEV) FW 
AGAGAAGAGAGGC
CAGGTTGTCTGCTA
TGCTTGTG   
Site-directed 
mutagenesis 
HMGN5 S20E 
IAP'#083 
HMGN5 (in 
pGEX-TEV) RV 
CAACCTGGCCTCT
CTTCTCTTTGGCTC
CTGCCTC   
Site-directed 
mutagenesis 
HMGN5 S20E 
IAP'#084 
HMGN5 (in 
pGEX-TEV) FW 
CCAGGTTGGAGGC
TATGCTTGTGCCAG
TTACAC   
Site-directed 
mutagenesis 
HMGN5 S24E 
IAP'#085 
HMGN5 (in 
pGEX-TEV) RV 
AGCATAGCCTCCA
ACCTGGCAGATCTT
CTCTTTG   
Site-directed 
mutagenesis 
HMGN5 S24E 
IAP'#118 
HMGN2 in 
gBlock FW 
TATGAATTCCCCAA
GAGAAAGGCTGAA
GG EcoRI 
For HMGN2 
cloning into 
pGEX_TEV  
IAP'#119 
HMGN2 in 
gBlock RV 
ACTCTCGAGTCACT
TGGCATCTCCAGC
AC XhoI 
For HMGN2 
cloning into 
pGEX_TEV  
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Name 
Gene/ binding 
site 
Orien-
tation Sequence Remarks Description 
LP09 
T7 promotor/lac 
operator FW 
 
AATACGACTCACTA
TAGGGGAATTGT   
Sequencing 
primer 
LP017 CMV promoter FW 
GCAAATGGGCGGT
AGGC   
Sequencing 
primer 
LP019 M13 (-49) RV 
GAGCGGATAACAA
TTTCACACAGG   
Sequencing 
primer 
LP103 
GST gene 
pGEX vector FW 
ATAGCATGGCCTTT
GCAG   
 For pGEX 
sequencing and 
PCR 
LP104 
pGEX rev 
standard RV 
GAGCTGCATGTGT
CAGAGG   
 For pGEX 
sequencing and 
PCR 
LP090 EGFP RV 
CGTCGCCGTCCAG
CTCGACCAG   
Sequencing 
primer 
LP091 EGFP RV 
TCCAGCAGGACCA
TGTGATC   
Sequencing 
primer 
 
 
7.1.5.2 qPCR primers 
Name 
Gene/ 
binding 
site 
Orientation Alternative name Sequence 
IAP'#049 VGF  FW VGF.fw TGATCAGCAGAAGGCAGAAG 
IAP'#050 VGF  RV VGF.rv GACCCTCCTCTCCACCTCTC 
IAP'#061 RPL30 FW RPL30.fw ATTCTCGCTAACAACTGCCCA 
IAP'#062 RPL30 RV RPL30.rv ATTTTCCGCATGCTGTGCC 
IAP'#073 ZCCHC12 FW ZCCHC12.fw GCAGAGGCTGGAAGTGAAAT 
IAP'#074 ZCCHC12 RV ZCCHC12.rv AGCTTAATCTGCAGGTGGGA 
IAP'#075 EGR1 FW EGR1.fw CACCTGACCGCAGAGTCTTTT 
IAP'#076 EGR1 RV EGR1.rv CAGGGAAAAGCGGCCAGTAT 
 
 
7.1.5.3 Primers for in vitro mononucleosomes assembly 
Name Binding site Orientation Sequence Modification 
RMP#012 AvaI digested 
pUC18 12X601 
FW CCCTGGAGAATCC
CGG 
 
RMP#014 AvaI digested 
pUC18 12X601 
RV CACAGGATGTATA
TATCTGACAC 
5’ Cy3 
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7.1.5.4 Fluorescent single-stranded nucleic acids 
Nucleic acid Sequence Modification 
snoRNA2T2 GAGUUUAUUACUAAUCUUUCG 
GGUAUGAAAUUC 
Cy5 
snoRNA2T1 GCUAGCGUGAUAAUGAUUUCA 
ACUUCACUGCUGACCAG 
FAM 
En3_TFO_RNA CCUCCUUUUUUCUUUUUUUUU 
UUUUUUCU 
FAM 
En3_TFO_DNA CCTCCTTTTTTCTTTTTTTTTTTT 
TTTCT 
Cy5 
En3_DNA_rev GGAGGAAAAAAGAAAAAAAAAA 
AAAAAGA 
Cy3 
En3_RNA_rev GGAGGAAAAAAGAAAAAAAAAA 
AAAAAGA 
FAM 
 
 
 
7.1.6 Software and databases 
 
Name Description Supplier Reference 
Adobe Illustrator Vector graphics editor Adobe Systems  
Axiovision Microscope imaging software  Zeiss  
BEDtools 
(v2.24.0) 
Fast and flexible suit of 
utilities for genomic 
analysis tasks 
http://bedtools.rea
dthedocs.io/en/lat
est/ 
(Pham et al., 2010) 
BioVenn Area-proportional Venn diagrams generation 
http://www.bioven
n.nl/ 
(Hulsen, de Vlieg, & 
Alkema, 2008) 
BLAST 
The Basic Local Alignment 
Search Tool (BLAST) finds 
regions of local similarity 
between sequences 
http://blast.ncbi.nl
m.nih.gov/Blast.cg
i 
(ALTSCHUL, GISH, 
MILLER, MYERS, & 
LIPMAN, 1990) 
Bowtie (v2.1.1) 
Tool for aligning 
sequencing reads to long 
reference sequences 
http://bowtie-
bio.sourceforge.ne
t/index.shtml 
(Langmead, Trapnell, Pop, 
& Salzberg, 2009) 
Bowtie2 (v2.2.4) 
Tool for aligning 
sequencing reads to long 
reference sequences 
http://bowtie-
bio.sourceforge.ne
t/bowtie2/index.sht
ml 
(Langmead & Salzberg, 
2012) 
ClueGo 
Analyze interrelations of 
terms and functional 
groups in biological 
networks  
http://apps.cytosca
pe.org/apps/clueg
o 
(Bindea et al., 2009)  
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Name Description Supplier Reference 
Cytoscape 
(v3.5.1) 
Network Data Integration, 
Analysis, and Visualization 
http://www.cytosca
pe.org/ (Shannon et al., 2003)  
FastQC Quality control tool for high throughput sequence data 
http://www.bioinfor
matics.babraham.
ac.uk/projects/fast
qc/ 
 
FoldIndex© Analysis of protein folding  (Prilusky et al., 2005)  
Geneious 9.0.2 Organization and analysis of sequence data 
Biomatters Ltd. 
http://www.geneio
us.com/ 
(Kearse et al., 2012) 
HOMER (v4.9) 
Motif discovery and next 
generation sequencing 
analysis 
http://homer.ucsd.
edu/homer/ (Heinz et al., 2010) 
ImageJ  Image processing and analysis 
https://imagej.nih.
gov/ij/ 
(C. A. Schneider, Rasband, 
& Eliceiri, 2012)  
Integrative 
genomics viewer 
(IGV) 
Visualization tool for 
interactive exploration of 
large, integrated genomic 
datasets 
http://software.bro
adinstitute.org/soft
ware/igv/ 
(J. T. Robinson et al., 
2011)  
Jaspar 
Open-access database of 
curated, non-redundant 
transcription factor (TF) 
binding profiles 
http://jaspar.gener
eg.net/ (Khan et al., 2017)  
Leica LAS AF 
Lite 
Visualization and analysis 
of Leica confocal images 
https://www.leica-
microsystems.com
/  
OligoAnalyzer 
3.1 
Evaluation of physical 
properties of primers IDT  
Pubmed Database of biomedical literature 
https://www.ncbi.nl
m.nih.gov/pubmed
/ 
PubMed [Internet]. 
Bethesda (MD): National 
Library of Medicine (US). 
[1946] - [cited 2017 12 25]. 
Available from: 
https://www.ncbi.nlm.nih.go
v/pubmed/ 
Quartzy Online laboratory management platform 
https://www.quartz
y.com/  
R (v3.1.2) 
Software environment for 
statistical computing and 
graphics 
https://www.r-
project.org/ 
R Core Team (2013). R: A 
language and environment 
for statistical computing. R 
Foundation for Statistical 
Computing, Vienna, 
Austria, URL http://www.R-
project.org/ 
 
 
Materials and methods 
143 
 
Name Description Supplier Reference 
RNAfold RNA secondary prediction tool 
http://rna.tbi.univie
.ac.at/cgi-
bin/RNAfold.cgi  
Rotorgene 6000 
Software  
Qiagen (Corbett 
Research)  
SAMtools 
(v1.3.1) 
Post-processing 
alignments in the SAM 
format, such as indexing, 
variant caller and alignment 
viewer, 
http://samtools.so
urceforge.net/ (H. Li et al., 2009)  
Sigmaplot V12.5 Graphing and statistical analysis software 
Systat  
https://systatsoftw
are.com/  
STAR Ultrafast universal RNA-seq aligner 
https://code.googl
e.com/archive/p/rn
a-star/ 
(Dobin et al., 2012) 
UCSC Genome 
Browser viewer 
 Visualization and analysis 
of genomic data 
https://genome.uc
sc.edu/ (Kent et al., 2002) 
Uniprot 
Protein sequence and 
functional information 
database 
 
http://www.uniprot.
org/  
 
7.1.7 High throughput datasets 
 
Dataset Cell type ENCODE Accession 
Producer 
Laboratory Reference 
H3K27ac 
ChIP-seq HEK293 ENCFF631VZK 
Peggy Farnham, 
USC 
 
(C. A. Davis et 
al., 2018) 
H3K4me3 
ChIP-seq HEK293 ENCFF001FJO 
John 
Stamatoyannopoulos, 
UW 
 
(C. A. Davis et 
al., 2018) 
DNase-seq HEK293 ENCFF000SPI 
Gregory Crawford, 
Duke 
 
(C. A. Davis et 
al., 2018) 
POLR2A 
ChIP-seq HEK293 ENCFF000WYF 
Sherman Weissman, 
Yale 
 
(C. A. Davis et 
al., 2018) 
CTCF ChIP-
seq HEK293 ENCFF924LOC 
John 
Stamatoyannopoulos, 
UW 
(C. A. Davis et 
al., 2018) 
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7.2 Methods 
 
7.2.1 Microbiological methods  
 
7.2.1.1 Bacterial transformation 
 
For transformation of chemically competent Escherichia coli (E. coli), 50µl of the 
bacterial strain were thawed on ice for 10 min. When transforming plasmids, 50ng 
were added to the bacteria, and for ligation products the complete ligation reaction 
was used. The samples were mixed by shortly flicking the tube. A heat-shock was 
performed at 42 °C for 45 sec in a thermomixer followed by an additional incubation 
on ice for 2 min. The transformed bacteria were resuspended in 1ml sterile pre-
warmed medium (LB or SOC) and incubated for 30 min at 37 °C with shaking at 300 
rpm in a thermomixer (for Ampicilin resistant plasmids the incubation was done in 10 
min to avoid the degradation of Ampicillin by Beta-lactamases). 150µl of the mixture 
were plated on agar plates containing the appropriate antibiotics. Plates were 
incubated at 37 °C overnight (ON) and plates were inspected after 12 – 16 h. 
 
7.2.1.2 Glycerol stock 
 
To create bacterial glycerol stocks for long-term storage, 1ml of an ON culture was 
mixed with 420µl sterile 50% glycerol, snap frozen in liquid nitrogen and then frozen 
at -80 °C. 
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7.2.2 Nucleic acids methods 
 
7.2.2.1 DNA quantification and quality measurement  
 
The concentration and purity of DNA was generally measured by spectrophotometry 
using the NanoDrop ND1000 spectrophotometer (Peqlab). The concentration is given 
by the absorbance at 260 nm and the relative purity of the sample analyzed by the 
ratio of the absorbance at 260/280, being a ratio of ~1.8 accepted as “pure” for DNA. 
For more accurate measurements prior to high throughput sequencing of ChIP 
samples and for qPCR measurements, the DNA was quantified with the Qubit® 
dsDNA BR Assay Kit (Invitrogen) and the quality measured using the High Sensitivity 
DNA Kit (Agilent) in the 2100 Bioanalyzer device. 
 
7.2.2.2 Agarose gel electrophoresis 
 
Agarose gel electrophoresis was used to separate DNA or total RNA according to 
size and as quality control of DNA isolations or PCR reactions.  The method was 
performed using gels with agarose concentration between 0.8 -1.5% depending on 
the predicted size of the nucleic acid fragments to separate, in 1X TBE buffer 
supplemented with 0.01% SYBR Safe (Invitrogen). Before loading, the samples were 
mixed with 10x Orange G loading dye. In the case of DNA, the approximate size of 
the samples was followed by comparison with the 1Kb DNA standard (Fermentas). 
The electrophoresis was done in 1X TBE buffer at constant voltage of 100-120V.  
The gels were documented using the Safe Imager blue light transilluminator system 
(Invitrogen) and analyzed with the ImageJ software. 
 
 
7.2.2.3 Polymerase chain reaction 
 
Depending on the downstream experiments, PCR reactions were performed using 
different polymerases, and programs. 
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The PCR performed for cloning (either restriction cloning, Gibson assembly or site-
directed mutagenesis) were done using the Q5 high fidelity DNA polymerase (NEB) 
or the Phusion DNA polymerase (NEB). The annealing temperature, time and 
elongation time were adjusted for each reaction. A Positive and a water negative 
control were always included. A standard reaction is done in 50µl final volume, 
containing 0.2µM of each primer, 0.2mM dNTP mix, 1X PCR reaction buffer 
containing 2 mM MgCl2 at final (1X) reaction concentrations, (provided commercially 
together with the specific DNA polymerases), from 0.4 to 1 U of DNA polymerase, 
and from 0.5 to 5ng DNA, according to the nature of the template. 
 
 
 
7.2.2.4 Colony PCR 
 
To test for the presence of insert in the plasmid constructs, colony PCR was 
performed. Individual colonies were selected and resuspended in 25µl of sterile H2O 
in a 0.2 ml PCR reaction tube. Then 25µl PCR mastermix was added to each 
sample, and the PCR run was started. As no fidelity is required for the screening, a 
selfmade Taq polymerase was used. The primers were designed to match one in the 
insert and one in the vector. Afterwards, the PCR reactions were analyzed on an 
agarose gel for presence of the amplicon. 
 
 
Basic thermocycler program for colony PCR 
Cycle step Temperature (°C) Time Number of cycles 
Initial denaturation 95 5 min 1 
Denaturation 95 30 sec 
 
35 
Annealing 
55-60 (depending 
on the template) 
30 sec 
Extension 72 1 min per Kb 
Final extension 72 5 min 1 
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7.2.2.5 Quantitative Real-Time PCR (qPCR) 
 
Real-Time quantitative PCR was used to accurately validate candidates from the 
RNA-seq dataset obtained in this study using a relative quantification.  The primers 
for mRNA amplification were designed to flank exon-intron boundaries by using the 
software Primer-BLAST from the NCBI website. The list of primers used for qPCR for 
the candidate mRNAs ZCCHC12, VGF, RPL30 and EGR1 can be found in 7.1.5.2. 
An efficiency test for each set of primers was performed. GAPDH was used as 
reference gene for quantification. Quantification was carried out using the algorithm 
proposed by (Pfaffl, 2001). To define statistical differences between mRNA levels 
from knockdown, overexpression and control groups Two-way ANOVA and Dunett´s 
post-test were used (Dunnett, 1955). 
The pipetting was done under a hood using dedicated pipettes for qPCR to avoid 
contamination. A master mix (MM) that contains the buffer, MgCl2 and dNTP 
(purchased from Qiagen) was prepared, aliquoted and kept at -20 °C. The reaction is 
described in the following table:  
 
 
Master Mix [MM] µl/rxn 
10X PCR-Buffer Qiagen 2 
25 mM MgCl2 Qiagen 0.8 
25 mM dNTPs 0.16 
H2O 6.71 
  Total volume 9.67 
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The individual qPCR reactions were performed in technical triplicates in 0.1 mL PCR 
tubes, in a final volume of 20µl. A typical reaction is shown in the table below: 
 
Component Volume (µl) 
MM 9.67 
HotStar Taq Qiagen 5u/µl 0.08 
[1:400000] SyberGreen Stock 
solution 0.25 
Primer Fw [10µM] 0.40 
Primer Rv [10µM] 0.40 
H2O 5.2 
DNA 4 
Total volume 20 
 
 
qPCR was performed using the Rotor-Gene Q system from Qiagen and analyzed 
using the Rotorgene 6000 Software. After statistical analysis the qPCR validation 
were plotted using the Sigmaplot software (v12.5). 
 
7.2.2.6 DNA precipitation 
 
To precipitate DNA obtained from large-scale PCR or DNA purified from cells, the 
samples were mixed with 2 volumes ice-cold 100% ethanol (Merck) and 0.5 volumes 
7.5 M ammonium acetate and they were incubated for 10-30 min at -20 °C. The 
samples were centrifuged at >13000g at 4 °C and the supernatant was carefully 
removed. The samples were washed twice with 700µl of 70% ethanol, followed by 
centrifugation steps of 10 min at >13000g. After the final wash, the ethanol was 
removed carefully and the pellet was air-dried for approximately 10 min. Finally, DNA 
was dissolved in the appropriate amount of Elution Buffer (Qiagen) and stored at -20 
°C. 
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7.2.2.7 Gel extraction and PCR purification 
 
When purifying PCR products for cloning, or when purifying large-scale PCR, the 
QIAquick PCR Purification Kit was used. From the large-scale PCR, DNA was first 
precipitated according to 7.2.2.6 and then the concentrated DNA was purified with 
the QIAquick PCR Purification Kit following the instructions of the manufacturer. To 
purify DNA fragments after enzymatic restriction digested for downstream 
applications (PCR and or cloning), the digestion was loaded on a 1-1.5% agarose 
gel, separated by electrophoresis (7.2.2.2) and the band extracted from the gel by 
cutting it with a clean scalpel using the blue-light screen and an orange filter. The 
DNA purification from the extracted band was carried out with the Qiaex II® Gel 
Extraction Kit according to the manufacturer’s instructions. 
 
 
7.2.2.8 Isolation of plasmid DNA  
 
Depending on the amount of plasmid DNA required, a small-scale (minipep) or large-
scale plasmid DNA purification (maxiprep) was performed. For that, a culture of 
bacteria, taken from a glycerol stock or fresh colony from plate, was performed ON in 
LB medium with the appropriate antibiotics. The minipreps were prepared from 5ml 
ON cultures using the QIAprep Spin Miniprep Kit from Qiagen, and the maxipreps 
were generated from 200ml ON culture using the PureLink® HiPure Plasmid 
Maxiprep Kit (Invitrogen) according to the instructions of the manufacturer. The 
isolated DNA was quantified as described in 7.2.2.1. 
 
7.2.2.9 Isolation of genomic DNA from human cells 
 
Starting from a 10 cm plate grown to 60-90% confluence, the medium was soaked 
from the plate, and the cells rinsed once with 1X PBS at RT. The cells were collected 
with a cell scraper in 1ml 1X PBS and transferred to a 1.5ml microcentrifuge tube. 
After a short spin down the PBS was removed and the cells lysed in 500µl 
Permeabilization Buffer. Then the cellular RNA was hydrolyzed by the addition of 
100µg of RNase A. After 2 h of digestion at 37 °C, 250µg proteinase K were added 
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and the samples incubated at 55 °C ON. The next day the samples were precipitated 
with the addition of 2 volumes ice-cold 100% ethanol and 0.5 volumes 7.5 M 
ammonium acetate. The samples were incubated 10 min at -20 °C and then 
centrifuged for 30 min at 4 °C at 13000g. The ethanol was removed and the samples 
washed twice with 700µl ice-cold 70% ethanol, with centrifugation steps of 10 min at 
4 °C. After carefull removal of all traces of ethanol by pipetting, the genomic DNA 
was air dried for 10 min, and then resuspended in 200µl Elution Buffer (Qiagen). 
Since the genomic DNA is viscous and difficult to get dissolved, the samples were 
incubated ON at 50 °C in a thermoblock to ensure that the DNA is completely 
dissolved in the buffer. The DNA concentration was determined and about 1µg DNA 
loaded on a 1.3% agarose gel for visualization. The DNA was stored at 4 °C. 
 
 
7.2.2.10 Cloning 
 
7.2.2.10.1 Restriction cloning 
 
This method was used to insert the cDNA of a gene of interest (GOI) amplified by 
PCR into a vector, by using restriction enzyme digestion and ligation to the linearized 
vector with compatible ends. The in silico design of the cloning strategy was done 
with Geneious® 9.0.2 (www.geneious.com). The specific restriction endonucleases 
were obtained from New England Biolabs (NEB) and used according to the 
recommendation of the manufacturer. When possible, High Fidelity (HF) enzymes or 
enzymes with compatible buffer were used, to simplify the digestion protocol. For 
analytical digest e.g. identification of positive clones, 500ng DNA were incubated with 
5 units of the respective restriction endonuclease in a total volume of 20µl, for 1 h at 
37 °C (when both enzymes were HF enzymes, the incubation time was reduced to 20 
min). The large-scale digestion for subsequent ligation reaction was done with 5µg of 
plasmid DNA and 2.5µg of insert. In both cases 20 units of each restriction 
endonuclease in a total volume of 30-40µl were used. To verify the completion of the 
reaction, DNA was electrophoretically separated using 0.8-1.5% TBE agarose gels 
supplemented with SYBR Safe (Invitrogen). 
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7.2.2.10.1.1 Ligation 
 
Ligation of DNA fragments obtained from restriction digest with cohesive ends was 
performed with T4 DNA ligase (NEB). The molar ratio insert:vector was 3:1 using the 
following formula 
 𝑛𝑔  𝑣𝑒𝑐𝑡𝑜𝑟  ×  𝑑𝑒𝑠𝑖𝑟𝑒d  𝑚𝑜𝑙𝑎𝑟  𝑟𝑎𝑡𝑖𝑜  × 𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡  𝑙𝑒𝑛𝑔ℎ𝑡   𝑏𝑝𝑣𝑒𝑐𝑡𝑜𝑟  𝑙𝑒𝑛𝑔ℎ𝑡  (𝑏𝑝) =   𝑛𝑔  𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡 
 
The ligation was normally done in 20-30µl volume, using 1µl (400 U) of T4 DNA 
ligase, in 1X T4 DNA Ligase Reaction Buffer, with incubation at RT for 30 min. The 
reaction mixture was immediately used for bacterial transformation as described in 
7.2.1.1. 
 
7.2.2.10.2 Gibson assembly 
 
When cloning large insert fragments, or in case no compatible restriction sites are 
present in the fragment or the vector, the Gibson assembly method was used(Gibson 
et al., 2009)  
Primers with 30-40 bp overlap were designed (Geneious® 9.0.2), and the vector and 
DNA fragment (cDNA or genomic DNA) were amplified with Q5 High Fidelity DNA 
polymerase. The PCR products were analyzed on a 0.8% agarose gel, and if the 
desired amplification products were pure, the raw PCR mix was used for the 
assembly reaction, otherwise the fragments were gel purified and then assembled. 
The fragments were assembled using the Gibson Assembly kit (NEB) following the 
instructions of the manufacturer. Briefly, a molar ratio of 3:1 insert/vector was used, 
with 50ng of vector, mixed with the Gibson Assembly Master Mix in a final volume of 
20µl and incubated at 50 °C for 1 h. NEB 5-alpha competent E. coli cells were 
transformed with 2µl of the master mix/fragment mixture using the transformation 
protocol described in 7.2.1.1, using SOC medium. The next day, a few colonies were 
selected and grown ON in 5ml LB medium supplemented with antibiotics, and the 
plasmid was purified for sequencing according to the protocol described in 7.2.2.8. 
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7.2.2.10.3 Site-directed mutagenesis 
 
To create the phosphomimetic mutants of HMGN5 (S20E, S24E and S20,24E), the 
site-directed mutagenesis strategy (SMD) was used. The starting DNA clone mutated 
was pGEX_TEV_HMGN5, containing a N-terminal GST tag. For the mutation of 2 
amino acids at the same time (HMGN5 S20,24E) the primers were designed 
following the protocol described in (Zheng, 2004), using partially overlapping primers 
of about 50nt, containing the mutated sequences (designed with Geneious® 9.0.2). 
50ng of the HMGN5 plasmid was fully amplified with the Q5 HF DNA polymerase 
(NEB), using 16 cycles of amplification and 1 min of extension/Kilobase at 72 °C, in a 
final volume of 50µl. 4µl of the PCR product were loaded on a 0.8% agarose gel to 
check the amplified plasmid. The product was purified with the QIAquick PCR 
Purification Kit and then subjected to DpnI treatment to hydrolyze the methylated 
parental plasmid. For this treatment 10 U of DpnI were used to treat 100-150ng of 
DNA, at 37 °C for 1 h. After incubation, the samples were heat-inactivated at 80 °C 
for 20 min. Then 1µl of the product was used to transform DH5α cells using the 
protocol described in 7.2.1.1. The selected clones were then sequenced and used to 
transform BL21 cells for protein expression and purification. 
 
 
7.2.2.11 RNA purification 
 
Total RNA was purified with Trizol to prepare cDNAs, or to isolate RNA from CLIP 
assays. The Trizol method is an improved adaptation of the  “Acid guanidinium 
thiocyanate-phenol-chloroform extraction” (Chomczynski & Sacchi, 1987). In all 
cases, the RNA extraction was performed in a fume hood, always wearing a lab coat, 
gloves and safety glasses. A dedicated set of pipettes, and “Safe-lock” 
microcentrifuge tubes were used. In general, RNA purification was performed using 1 
confluent 10 cm culture dish as starting material. RNA purification for high throughput 
sequencing was performed with the NucleoSpin RNA Kit (MACHEREY-NAGEL). The 
purified RNA was dissolved in nuclease-free H2O and remaining genomic DNA was 
eliminated with TURBO DNA-free™ DNase (Ambion) according with the 
manufacturer’s instructions. 
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7.2.2.12 Measurement of quality and quantity of total RNA 
 
The RNA quantity was assessed using the Qubit RNA HS Assay Kit (Invitrogen), 
which is an accurate method for measuring low RNA concentrations. A working 
solution master mix was prepared by diluting the Qubit® RNA HS Reagent 1:200 in 
Qubit® RNA HS Buffer. 1µl of RNA (total RNA or RNA coming from CLIP samples) 
was added to 199µl of working solution. After vortexing and incubation at RT for 2 
min, the RNA concentration was determined based on a standard calibration curve.  
The quality of the total RNA, used for routine cDNA synthesis, was determined by 
loading 200-500ng of the quantified sample on a native 1% agarose gel 
electrophoresis. The gels were stained with Ethidium bromide (EtBr) and visualized 
with the Agarose gel UV imaging system (Intas). The quality of total RNA purified for 
high throughput sequencing, or the RNA purified from CLIP experiments was 
measured using the Agilent RNA 6000 Pico Kit on a Bioanalyzer device. 
 
7.2.2.13 cDNA synthesis 
 
500 ng of total RNA (section 7.2.2.11) were used to prepare cDNA using the 
SuperScript II reverse transcriptase (Invitrogen) and random hexamers (Invitrogen) to 
prime the reactions. The protocol was performed following the recommendations of 
the manufacturer. cDNA was then used for qPCR validation (7.2.2.5) or quality 
control of RNA-seq. When corresponding, cDNAwas used as template for cloning.  
 
 
 
7.2.2.14 MgCl2-dependent RNA fragmentation 
 
To get fragmented RNA for competition EMSA assays (methods 7.2.4.2.2), total RNA 
from one 10 cm plate of HeLa cells was extracted with Trizol according to section 
7.2.2.11 and dissolved in buffer Ex0 (containing 1.5 mM MgCl2) at a concentration of 
500ng/µl in a volume of 50µl. The RNA was incubated at 95 °C for increasing time 
points (up to 10 min) in a thermocycler (standardization in Figure 46 in Appendix). 
After incubation, the fragmented RNA was loaded on a 1% agarose gel 
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electrophoresis as described in 7.2.2.2 and stained with EtBr. Gels were documented 
using the Agarose gel UV imaging system (Intas). 
 
 
 
7.2.3 Proteins 
 
Unless otherwise indicated, proteins were always manipulated on ice and for long-
term storage they were aliquoted, snap frozen with liquid nitrogen and kept at -80 °C. 
Depending on the experiment setup the buffers were pre-chilled at 4 °C and 
supplemented with protease inhibitors mix (PI) when necessary. 
 
 
7.2.3.1 Protein quantification 
 
7.2.3.1.1 Qubit quantification 
 
The purified recombinant proteins were quantified using the Qubit® Protein Assay Kit 
(Invitrogen). For this purpose, a working solution was prepared by diluting the Qubit® 
Protein Reagent 1:200 in Qubit® Protein Buffer. 1-5µl of the stock proteins were 
mixed with the working solution in a final volume of 200µl, vortexed for a few seconds 
(avoiding the formation of bubbles) and incubated for 15 min at RT.  The protein 
concentration was determined based on a standard calibration curve of protein 
standards provided with the kit. 
 
7.2.3.1.2 Bradford assay 
 
Whole cell extracts (WCE) or nuclear extracts (NE), prepared for western blot 
analysis were quantified by using a modified protocol of the Bradford Coomassie 
brilliant blue assay (Bradford, 1976). 6 standards of BSA dilutions were prepared in 
water (0, 0.1, 0.25, 0.5, 1.5, and 5 µg/µl). 10µl of each standard, 1-10µl protein 
sample and a background control (water or buffer) were added to 1ml of a 1:5 dilution 
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of the Bradford reagent, respectively, in a disposable micro cuvette. The samples 
were mixed and the absorbance at 590 and 450 nm was measured. To get the 
linearization of the concentration curve over the protein concentration range, the 
absorbance was corrected using the ratio of absorbance at 590 nm over 450 nm by a 
mathematical equation described in (Ernst & Zor, 2010). 
 
7.2.3.2 Denaturing Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
To visualize and determine the quality/purity of proteins, and when performing 
western blots, the proteins were analyzed using denaturing Polyacrylamide Gel 
Electrophoresis (SDS-PAGE). The stacking and resolving gels were prepared 
according to standard protocols, using a ready to use 30% Acrylamide/Bisacrylamide 
solution (Rotiphorese® NF-Acrylamide/Bis-solution 30%). Depending on the size of 
proteins to be analyzed, the separation gels were prepared with concentrations of 
polyacrylamide ranging between 10 and 17%, 1X SDS-PAGE Lower Buffer, 0.1% 
APS, and 0.1% TEMED. The gels were prepared in the cassettes of the 
XCell SureLock™ Mini-Cell system, filling the separation gel up to 2 cm under the rim 
of the cassette. The gels were then covered with a layer of isopropanol until the 
polymerization was completed. A 5% stacking gel was prepared with the Rotiphorese 
solution, 1X SDS-PAGE Upper Buffer, 0.1% APS and 0.1% TEMED. After complete 
removal of the isopropanol, the freshly prepared solution was poured covering the 
resolving gels, and a 12-15 wells comb was inserted. The samples to be analyzed 
were mixed with 1X Lämmli Buffer (Protein Loading Buffer), boiled for 5 min at 95 °C 
and loaded on the gels. The proteins were separated at 40mA in SDS-PAGE running 
buffer for 50-55 min. The electrophoretic mobility of the proteins and the size was 
followed by comparison with the Prestained protein ladder PageRuler™ Plus. For 
visualization, the gels were stained with Coomassie Brilliant Blue solution for 5-10 
min and then destained by boiling in water using a microwave, until the bands were 
visible. The gels were documented using a common office scanner.  
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7.2.3.3 Native Polyacrylamide gel electrophoresis (PAGE) 
 
Native polyacrylamide gel electrophoresis was mainly used for EMSA experiments to 
analyze protein-RNA, protein-DNA or protein-nucleosome interactions, or to reveal 
the assembly of nucleosomes in vitro. The gels were prepared with a ready to use 
30% Acrylamide/Bisacrylamide solution (Rotiphorese® NF-Acrylamide/Bis-solution 
30%) to a final concentration between 6 to 8 %, 0.4X TBE, 80µl APS per 10ml 
solution and 8µl TEMED per 10ml solution. The XCell SureLock™ cassettes were 
fully filled with the freshly prepared PAA solution and 10 well combs were inserted. 
Before loading the samples, the gels were rinsed with a syringe and pre run at 80V 
for 30 min at room temperature to remove unpolymerized acrylamide. The 
electrophoretic mobility was done at room temperature at 100V between 30 and 60 
min depending on the application. The gels were visualized and documented using 
the Typhoon FLA 9500 (GE Healthcare). 
 
  
7.2.3.4 Whole cell extract preparation 
 
Tissue culture from 6-well plates or 10 cm culture dishes were washed twice with ice-
cold PBS, and then harvested with a cell scraper in 1ml ice-cold PBS.  The cells were 
transferred to a 1.5ml microcentrifuge tube and sedimented by centrifugation at 500-
1000g for 2 min at 4 °C. The supernatant was aspirated and the cells resuspended in 
100-500µl Whole Cell Lysis Buffer supplemented with protease inhibitor mix (PI). 
After incubation for 15 min on ice with vigorously vortexing every 5 minutes, the 
extracts were sonicated with a Bioruptor device at low intensity, during 1 min (15 sec 
ON/ 15 sec OFF) to help disrupting the membranes. The cell lysate was centrifuged 
at 13000g for 15 min at 4 °C. Subsequently, the supernatant was saved and 
quantified (7.2.3.1.2) or stored at -80 °C for later downstream applications. 
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7.2.3.5 Nuclei preparation 
 
The nuclei were isolated using the “rapid, efficient, and practical method” (REAP) 
(Nabbi & Riabowol, 2015). Tissue cultures were grown to 70-90% confluence in 10 
cm culture dishes. The culture dishes were placed on ice, the medium was aspirated 
and the cells were washed twice in ice-cold PBS before scraping them of the culture 
dish with 1ml ice-cold PBS. The cells were transferred to a 1.5ml microcentrifuge 
tube and centrifuged at 500g for 2 min at 4 °C. The supernatant was removed and 
the cell pellet resuspended in 500µl ice-cold PBS containing 0.1% IGEPAL CA-630. 
The cell suspension was resuspended five times on ice with a P1000 micropipette 
and then centrifuged for 5–10 sec at 10.000 rpm. Resuspension step and 
centrifugation were repeated 2 more times in 500µl ice-cold PBS/0.1% IGEPAL CA-
630. Finally the supernatant was aspirated, and the nuclei (white pellet) were 
resuspended in 100-200µl ice-cold PBS/0.1% IGEPAL CA-630 supplemented with 
protease inhibitor mix (PI) and sonicated for 1 min using a Bioruptor device at high 
intensity (15 sec ON/15 sec OFF). The samples were stored at  -80 °C or 
immediately used in the downstream experiments.  
 
 
7.2.3.6 Semi dry Western blot  
 
Proteins to be analyzed by western blot were first subjected to a SDS-PAGE 
(7.2.3.2). Depending on the quality of the antibodies and the relative abundance of 
the proteins to be detected, 20-100µg of total protein extract was used. To mount the 
transfer to a PVDF membrane, four Whatman filter papers were cut to the size of the 
gel (6X8 cm), the membrane was activated in 100% methanol for 1-2 min and then 
soaked in Transfer Buffer (Towbin) together with the Whatman papers and the gel for 
5-10 min.  The “sandwich” was build up in the Bio-Rad ‘Trans-Blot SD Apparatus’ 
from anode to cathode, starting with two soaked Whatman papers, followed by the 
activated membrane, then the gel and finally two soaked Whatman papers, making 
sure that no air bubbles were trapped in the blot. Depending on the gel percentage, 
the transfer took place for 40 min to 1 h at 1.5-2.5mA/cm2.  
After transfer, the membranes were incubated for 30 min in blocking solution (1X 
PBS-T, containing 5% dried milk) at room temperature while gently shaking. The 
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membranes were then incubated with an appropriate dilution of primary antibody 
prepared in blocking solution, for 1 h at room temperature or ON at 4 °C with gentle 
shaking. The membranes were washed four times for 2-5 min with PBS-T, and then 
incubated for 45 min with the secondary antibody (generally HRP conjugated). The 
membranes were then washed 4 times for 2-5 min with PBS-T. The antigen-antibody 
complexes were detected using Supersignal West Dura (Pierce) by preparing a 1:1 
dilution of the reagents given in the kit (300-500µl each depending on the size of the 
membrane), and mixed on a piece of parafilm (bigger than the membrane). The 
mixture was spread over the parafilm in form of drops, and the membrane was 
placed on top. The membranes were incubated for 2-3 min protected from light. For 
signal detection the membranes were placed between two layers of a transparent 
disposal bag, and the protein ladder was marked with a fluorescent marker. Western 
blot signals were detected with a LAS-3000 Imager. 
 
 
 
7.2.3.7 Expression and purification of proteins 
 
7.2.3.7.1 Small-scale bacterial protein production 
 
Prior to large-scale protein expression, His-tagged or GST-tagged proteins were 
expressed in a small-scale to check for the proper expression of the proteins. In 
general, BL21 cells, or modified BL21 strains were used. 2 or 3 colonies were 
selected after transformation and grown ON in 2-3ml of LB medium supplemented 
with the specific antibiotics. The next day 1ml culture was taken to prepare a glycerol 
stock (7.2.1.2); the remaining culture was used to inoculate 15-20ml of LB containing 
antibiotics and grown until the OD600 reached 0.3-0.6 and 1ml of the culture was 
taken as “non-induced” sample. Protein expression was induced with 1 mM IPTG, 
and 1ml of samples were taken after 1, 2, and 4 hours, or until the OD600 reached 
1.5. All the samples were pelleted for 30 sec at >2000g, the supernatant was 
discarded, and the samples were resuspended in 1X Lämmli buffer. Lämmli buffer 
was added according to the formula: 1 OD=150µl Lämmli buffer. 15-20µl bacterial 
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whole cell preparation were loaded on a 10-15% SDS-PAGE (see 7.2.3.2), 
depending on the size of the protein.  
 
7.2.3.7.2 GST-tagged protein purification 
 
7.2.3.7.2.1 Large-scale protein expression 
 
For every 50ml expression volume, a 5ml pre‐culture was inoculated and incubated 
at 37 °C with shaking (180 rpm) overnight. The pre-culture was diluted to an OD600 
of about 0.05-0.1 with fresh LB medium supplemented with antibiotics. The samples 
were incubated at 37 °C on a shaker until the OD600 reached 0.3-0.6 and then 
protein expression was induced by the addition of 1 mM IPTG and incubated for 3-4 
h. Afterwards, the samples were centrifuged for 10 min at >4000g at 4 °C, the 
supernatant was removed and the pellet were frozen in liquid nitrogen and stored at  
-80 °C until purification. 
 
 
 
7.2.3.7.2.2 Lysis and protein purification 
 
For the purification of GST-tagged proteins, pellets corresponding to 50ml bacterial 
culture were resuspended with 10ml ice-cold GST Lysis Buffer supplemented with 
protease inhibitor mix (PI) on ice, in a 15ml falcon tube. The cell lysates were 
prepared by sonication using a Branson sonifier 250D (50% amplitude, 50% Duty 
cycle, 4X 20 sec ON/20 sec OFF) keeping the samples on ice. The lysates were 
centrifuged at >4000g, 4 °C for 30 min. The supernatant was transferred to a new 
tube for purification and the pellets were discarded. 
For every sample to be purified, 150µl of GST‐agarose beads were washed two 
times in 1ml 1X PBS by resuspending and spinning down in a tabletop centrifuge at 
500g for 1 min. The bacterial lysates were then mixed with the washed beads and 
incubated in an overhead rotator for 0.5-1 h at room temperature (RT). The 
supernatant was discarded and the beads were washed four times with 10ml GST‐
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wash buffer at RT for 5 min with gentle agitation. The proteins were eluted with 150µl 
GST Elution Buffer (pH adjusted to 8.0 with NaOH directly prior to use, adding 2-3µl 
of 2 M NaOH per ml of buffer and monitored with a pH indicator) for 20 min in an 
overhead rotator. The beads were spun down and the supernatant was transferred 
into a concentrator column (3kDa or 10kDa, depending on the protein size) for 
concentration and buffer exchange. The samples were quantified, aliquoted and 
stored at -80 °C. 
 
 
 
7.2.3.7.3 His-tagged protein purification 
 
7.2.3.7.3.1 Large-scale expression 
 
For the large-scale protein purification of His-tagged proteins an overnight culture of 
20-30ml was added to 500ml of LB supplemented with antibiotics and incubated on a 
shaker at 37 °C until the OD600 reached 0.3-0.6. Protein expression was induced 
with 1mM IPTG and incubated on a shaker at 37°C until the OD was 1.5 (about 4 h). 
The cultures were centrifuged at 10000g for 10 min and the pellets were frozen at      
-80 °C, or immediately used for protein purification. 
 
 
7.2.3.7.3.2 Preparation of the bacterial cell extract 
 
The cell pellets obtained in 7.2.3.7.3.1 were resuspended in 45ml ice-cold His Lysis 
buffer + PI on ice, and the cell suspension was sonicated 6X 20s on ice, with a 
Branson sonifier (50% duty cycle, intensity level 5, 20 sec ON/ 20 sec OFF). 
 The insoluble cell fragments were spun down at >4000g for 30 min at 4 °C in a 50ml 
centrifuge tube and the supernatant was transferred into a fresh 50ml tube for further 
purification. 
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7.2.3.7.3.3 Purification of the His-tagged Proteins 
 
 The supernatant (7.2.3.7.3.2) was mixed with 1-1.5ml of 50% Ni-NTA beads slurry 
(pre-washed with 10ml of His Lysis Buffer). The reaction was incubated at 4 °C for 1 
h with gentle agitation. The beads were spun down at 2000g for 5 min at 4 °C and 
the supernatant was discarded. The beads were transferred into a 15ml falcon tube 
and washed 4 times with 10ml His Wash Buffer for 5 min at 4 °C on a rotating wheel 
with centrifugation steps of 5 min at 2000g.  
The proteins were eluted with 3ml His Elution Buffer for 60 min at 4 °C on a rotating 
wheel. The beads were then centrifuged at 2000g for 5min and the supernatant 
transferred to a concentrator column (Vivaspin 500) for concentration and buffer 
exchange. Samples were quantified using the Qubit system (described in 7.2.3.1.1), 
aliquoted, snap frozen and stored at -80 °C for the downstream experiments. 
 
 
 
7.2.4 In vitro interactions 
 
7.2.4.1 In vitro reconstitution of nucleosomes 
 
Mononucleosomes were assembled using the salt gradient dialysis method (Rhodes 
& Laskey, 1989) using histones purified from chicken blood. For that purpose the 
plasmid pUC18 12x601 that contains an array of the strong nucleosome positioning 
sequence 601 was hydrolyzed with the enzyme AvaI to obtain a 200 bp fragment 
containing the 601 sequence. DNA fragments were purified from an agarose gel 
(7.2.2.7) and used as templates for a large-scale PCR reaction to generate a 149 bp 
long Cy3 labeled DNA (Primers RMP#012 and RMP#014). The assembly reactions 
were performed in dialysis chamber prepared on a lid of siliconized 1.5ml tubes. A 
hole was melted in the middle of the lid (so called O-ring), the cap was smoothened 
with a scalpel and the bottom of the tube was cut off. A piece of dialysis membrane 
with a MWCO of 6–8 kDa (Spectrapor) was pre-incubated for 5 min in Chromatin 
Assembly High Salt Buffer and then placed between the tube and the lid to create the 
dialysis chamber. The chambers were placed in a Styrofoam floater and transferred 
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to a 3 liter beaker filled with 300ml Chromatin Assembly High Salt Buffer, containing 
a magnetic stirrer. The air bubbles below each membrane were removed by using a 
bent Pasteur pipet, and the chambers were checked for leakage. In general, a small-
scale assembly was performed to determine the appropriate ratio of histones to DNA. 
The small-scale reactions were prepared in a final volume of 50µl of High Salt Buffer, 
and BSA in a final concentration of 200ng/µl, containing 1µg of the purified 
fluorescently labeled DNA, and histones to DNA concentration ratios between 0.4:1 
to 1.5:1. The large-scale assembly was performed in a final volume of 250µl High 
Salt Buffer, containing 5µg of DNA, 200ng/µl BSA and the previously determined 
histones concentration (supplementary Figure 45). 
The assembly reactions were loaded into the dialysis chambers and dialysis was 
started by pumping 3 liter of Chromatin Assembly Low Salt Buffer into the beaker at a 
flow rate of about 150–300 ml/h at RT. The beaker containing the reactions was 
covered with aluminum foil to protect the samples from light. After the dialysis was 
complete, the volume of the samples was determined to estimate the concentration 
of the nucleosomes. 
The quality of the assembly reaction was analyzed on a 6% native PAA gel in 0.4X 
TBE (section 7.2.3.3) and run for 1 h at RT. The assembled nucleosomes were 
stored at 4 °C protected from light. 
 
 
7.2.4.2 Protein-nucleic acids interactions 
 
7.2.4.2.1 EMSA 
 
To analyze the interaction of proteins with RNA, DNA or nucleosomes, 
electrophoretic mobility shift assay (EMSA) were performed. Protein concentration 
was titrated over the potential interaction partner. Therefore, proteins were used in a 
dilution ratio of 2:1 keeping constant the fluorescently labeled partner, being 50nM for 
DNA and RNA, and 50ng of nucleosome, respectively. The reactions had a final 
volume of 10µl in EX100 buffer and were incubated for 10 min at RT. 4µl of each 
reaction (a total of 9 serial dilutions and one negative control without protein) were 
loaded on a 6% native PAA gel. The EMSAs were run for 30 min at 100V at RT when 
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analyzing protein-DNA or protein-RNA interactions, or 1 h at 100V for protein-
nucleosome interactions. The gels were documented using a Typhoon 9500 device 
and analyzed using the ImageJ software.  
 
7.2.4.2.2 Competitive binding assay 
 
To perform the competitive binding assays between RNA and nucleosome, the 
protein-nucleosome complexes were kept at constant concentration (2µM protein and 
50ng of nucleosome) adding increasing amounts of non-labeled fragmented HeLa 
RNA (RNA fragmentation decribed in 7.2.2.14) (up to 2µg) for competition. The 
reactions were loaded on 6% native PAA gel and run 1 h at 100V. The gels were 
documented using a Typhoon 9500 device and analyzed using the ImageJ software.  
 
7.2.4.2.3 Microscale thermophoresis (MST) 
 
Microscale thermophoresis was used to determine the binding affinity of HMGN5 to 
different nucleic acids. The technique is a powerful method to determine molecular 
interactions in solution. MST is based on the motion of molecules along a 
temperature gradient, which depends on changes in the hydration shell, charge or 
size (Jerabek-Willemsen, Wienken, Braun, Baaske, & Duhr, 2011).   
For the interactions, titration series of the proteins were prepared by diluting the 
proteins in a 2:1 ratio with EX100 Buffer (as indicated in the plots). The binding 
reactions were performed in a final volume of 10µl containing 50nM of the 
fluorescently labeled nucleic acids (Table 1), varying protein concentrations and 
0.005% IGEPAL CA-630. 15 serial dilutions and one control without protein were 
incubated for 10 min at RT and used to fill up MonolithNT™ standard capillaries. The 
binding was measured using a Monolith NT.015T/NT.115 device (NanoTemper) at 
RT with laser ON for 40 sec, LED 20 and Laser power 40. The thermophoresis 
signals were plotted using the Sigmaplot software (v12.5) and fitted according to the 
Hill equation 𝑓 = 𝑏 +    !!!!!(!!!"/[!])!  were f is the measured raw fluorescence, m and b 
correspond to the maximum and minimum fluorescence values of the titration curve, 
C corresponds to the concentration of the unlabeled protein, and n is the Hill 
coefficient. For data evaluation, the thermophoresis signals were normalized to 
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fraction bound (X) 𝑋 = !!!!!! to correct for the maximum (m) and minimum (b) values 
of the binding curve. 
 
 
 
 
7.2.5 Mammalian Cell culture  
 
7.2.5.1 Basic cell culture techniques 
 
7.2.5.1.1 Techniques for mammalian cell manipulation 
 
The manipulation of the mammalian cell cultures was done in accordance with the 
“Guidance for a Good Cell Culture Practice” (GCCP), in compliance with regulations 
and ethical principles, using safety-working procedures. Materials were handled with 
standard precautions under a sterile hood in laminar flow. All the materials and the 
surface of the working place were wiped with 70% ethanol, and the medium and 
trypsin were always warmed up to 37 °C directly before use. Medium and trypsin 
were kept at 4 °C when not in use and PBS was always stored at room temperature. 
Antibiotics were stored at 4 °C or at -20 °C depending on the recommendations of 
the manufacturer. 
Cell lines used in this thesis were cultured in low glucose DMEM GlutaMAX™ 
medium supplemented with 10% FBS and grown in humidified incubators at 37 °C 
(atmosphere 95% air/ 5% CO2). 
 
7.2.5.1.2 Thawing of mammalian frozen cells 
 
New batches of cells were thawed quickly in a water bath at 37 °C and transferred to 
a 75cm2 culture flask containing 25ml of pre-warmed medium. After 20-24 h of 
incubation at 37 °C the cells were checked for viability under a microscope. The 
medium was aspirated using a sterile Pasteur pipette, the cells were rinsed once with 
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10ml PBS to remove non-attached cells and remaining DMSO, and fresh medium 
was added. 
 
 
 
7.2.5.1.3 Culturing adherent cells  
 
For maintenance, the cells were grown in 75cm2 flasks. Splitting was performed 
every 2-3 days when 80-90% confluence was reached. For splitting, the medium was 
aspirated with a Pasteur pipette and the cells were washed once with 10ml sterile 
PBS, afterwards 5ml of 0.05% Trypsin - EDTA (1X) solution (Gibco) were added and 
incubated at 37 °C for 3-5 min. Cells were detached using 5ml trypsin. The 
detachment was monitored under a light microscope. Trypsin was inactivated with 4-
5 volumes of fresh medium and the cells were resuspended several times using a 
10ml serological pipette until all cell clumps were dissolved. The cells were then 
transferred into a 75cm2 culture flask, diluting the cells by a factor of 1:6-1:10 in 25ml 
fresh medium. When performing large-scale experiments, the cells were seeded in 
15 cm culture plates using 20-25ml of fresh medium. Every splitting step increased 
the passage number by 1 and was documented. After 15 passages cells were 
discarded. 
 
 
7.2.5.1.4 Cryopreservation of cells 
 
The cryopreservation of cells was always conducted as early as possible, best at low 
passage numbers (not more than 5). Before cryopreservation, cells were checked for 
contamination under a microscope. Cells with 70-80% confluence were detached 
from the flasks with 0.05% Trypsin - EDTA (1X) for 3-5 min, then resuspended with 5 
volumes of fresh medium, centrifuged at 500g for 5 min at RT and the medium was 
removed. The pellets were resuspended in 10ml fresh medium. 500µl of cells 
suspension was mixed with Trypan Blue (Gibco) to analyze cellular integrity and to 
count the cells in a Neubauer chamber. The remaining cells were centrifuged at 500g 
for 2-3min, the medium was aspirated and the cells were resuspended quickly in 
Materials and methods 
166 
complete medium containing 10% DMSO reaching a cell number of of 1x107 cells/ml. 
1ml aliquots were transferred into labeled cryovials and quickly placed in a insulator 
box and stored overnight at -80 °C. The insulator box ensures a freezing rate of 1 
°C/min. After 24 h the cryovials were permanently stored at -80 °C. 
 
 
7.2.5.2 Generation of stable Flp-In cell line 
 
To establish an inducible cell line expressing HMGN5, the T-REx™-293 Flp-In cell 
line (Life Technologies) was used. The system uses Flp recombinase-mediated 
integration derived from Saccharomyces cerevisiae, that allows Tetracycline-
inducible expression of a gene of interest from a specific genomic 
location(O'Gorman, Fox, & Wahl, 1991). The cell line contains a Flp recombination 
target site (FRT site) integrated in the genome. The coding sequence of HMGN5 
(NM_030763.2) was cloned in frame with a C-terminal GFP in the expression vector 
pcDNA5/FRT/TO, which contains the recombination site FRT and a Hygromycin 
resistance cassette for selection. The expression of the protein is controlled by a 
hybrid human cytomegalovirus (CMV)/TetO2 promoter for high-level, Tetracycline-
regulated expression. The plasmid is co-transfected with the pOG44 vector that 
transiently expresses the Flp recombinase, mediating recombination between the 
FRT sites on the plasmid and the genome, resulting in a stable single integration of 
the gene of interest in the genome. 
For maintenance, T-REx cells were grown in low glucose DMEM medium as 
described in section 7.2.5.1.3) plus Tetracycline-Free FBS (Biochrom) supplemented 
with 100 µg/ml Zeocin and 10 µg/ml Blasticidin freshly before use. For transfection, 
the cells were seeded in T25 culture flasks at 50-60% confluence in medium without 
antibiotics. After 24 h of incubation at 37 °C the cells were transfected with the 
pOG44 and pcDNA5/FRT/TO© constructs in a 9:1ratio. For this, the plasmids were 
diluted to 10ng/µl in 150µl Opti-MEM® I Reduced Serum Medium. Subsequently the 
FuGENE® HD Transfection Reagent was added to the mixture in a ratio of 3µl per µg 
of DNA and incubated for 15 min at RT. The mixture was then transferred to the T25 
flask containing the cells in 3ml medium without antibiotics. 
After 24 h of incubation at 37 °C, the cells were washed with 5ml PBS and fresh 
medium was added. 48 h post transfection the medium was aspirated and the cells 
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were trypsinized with 1ml 0.05% Trypsin - EDTA (1X) for 3-5 min. The cells were 
resuspended in 5ml fresh medium and 3 aliquots of 0.5, 1 and 3.5ml were taken and 
transferred to P10 dishes in a final volume of 8ml with medium plus antibiotics for 
selection (100 µg/ml Hygromycin and 10 µg/ml Blasticidin). The medium with the 
selective antibiotics was changed every 3 days until foci could be identified by eye 
(about 10-12 days). 
The Hygromycin-resistant foci were picked by scraping them with a pipet tip and 
resuspended in 500µl medium plus antibiotics for further expansion in 24-well plates. 
When 60-70% confluence was reached, cells were split in a 1:5 ratio. One part was 
used for testing protein expression with 1 µg/ml Doxycycline in 3ml of complete 
medium (without antibiotics). The Doxycycline induction was tested in 6-well plates 
containing coverslips for immunofluorescence analysis. One part of the splitted cells 
was taken and cultivated without Doxycycline induction as control. The remaining 
cells were grown in 6-well plates and incubated with medium plus antibiotics. Once 
cells reached 70-90% confluence, they were split and expanded in 75cm2 flasks to 
prepare cryocultures as described in 7.2.5.1.4. Only clones showing stable protein 
expression (analyzed by the GFP expression level) after induction and not (or 
undetectable) in the non-induced control cells were picked for further expansion.  
 
 
7.2.5.3 Recruitment HMGN5 to a cellular LacO array 
 
The tethering of HMGN5 to a specific genomic locus was performed using the 
LacO/lacI system in U2OS cells. The method allows the targeting of a protein to an 
array of tandem repeat (256 copies) of the bacterial Lac operator (LacO) which is 
inserted in a highly compacted telomeric region in U2OS cells (Jegou et al., 2009), 
allowing for the analysis of chromatin decompaction.  
The coding sequence of the human HMGN5 (NM_030763.2) was cloned 
downstream of the fusion gene GFP-LacI in the vector pSV2_GFP-LacI, to generate 
the construct pSV2_GFP-LacI-HMGN5. 
U2OS cells (kindly provided by Dr. Karsten Rippe) were maintained in low glucose 
DMEM medium supplemented with 10% FBS. For transfection, cells were seeded on 
coverslips in 6-well plates at 70% confluence (150000 cells approx.) in 3ml complete 
DMEM and incubated for 24 h at 37 °C. Cells were then transfected with the vector 
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pSV2_GFP-LacI-HMGN5, and control cells were transfected with the vector 
pSV2_GFP-LacI (to express GFP-LacI). The plasmids were diluted to 20ng/µl of in 
153µl OptiMEM. 12µl of Lipofectamine 3000 (Invitrogen) reagent (ratio reagent:DNA 
4:1) were added to the mixture and carefully mixed by pipetting to form the complex. 
After 15 min incubation at RT, 150µl of complex were added to each well and gently 
mixed.  Cells were incubated for 24 hour at 37 °C and analyzed by 
immunofluorescence microscopy according to 7.2.5.4.  
 
 
7.2.5.4 Immunofluorescence microscopy  
 
7.2.5.4.1 Fixation and Permeabilization of cells 
 
Adherent cells grown on coverslips were washed twice with 1X PBS at RT for 2-3 
min with gentle agitation. Cells were then fixed in 4% paraformaldehyde (PFA)/PBS 
for 10 min at RT on an overhead rotator. A few drops of Immunofluorescence 
Permeabilization buffer 1 (0.5% Triton X-100/PBS) were added after 9 minutes. 
Samples were washed 3 times with Immunofluorescence Permeabilization buffer 2 
(0.01% Triton /PBS) for 3 min at RT. An additional wash step using 0.5% Triton X-
100/PBS for 5 min at RT was performed. Then the cells were washed twice with 1X 
PBS and an immunofluorescence step was performed (see next section). 
 
 
7.2.5.4.2 Immunofluorescence 
 
All steps were performed at RT; the wash steps were done in an overhead rotator. 
The blocking solution was prepared using Albumin Bovine Fraction V (Serva). Cells 
were incubated with the primary antibody diluted in 4% BSA/PBS-Tween for 45 min. 
After three wash steps with 0.1% PBS-T for 5 min, the samples were incubated with 
the secondary antibody diluted in 4% BSA/PBS-T for 30 min and washed twice in 
0.1% PBS-T for 5 min. DNA counterstaining was performed with 50 ng/ml DAPI in 
PBS-T for 5 min, then rinsed once with 0.1% PBS-T followed by rinsing with 1X PBS. 
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The coverslips with the cells were mounted on microscopy slides using Vectashield 
mounting medium (Sigma). The edges of the coverslips were sealed with nail polish 
and the samples were stored at 4 °C. The next day they were analyzed by 
microscopy. 
 
 
7.2.6 Chromatin specific methods 
 
 
7.2.6.1 Chromatin Immunoprecipitation with GFP-Trap 
 
 The HMGN5-FlpIn stable cell line was used to perform the chromatin 
immunoprecipitation (ChIP) of HMGN5. As control, the GFP-FlpIn cell line was used. 
Experiments were performed in triplicates, seeding cells in one 15 cm plate for each 
experiment, using low glucose DMEM/Tet free FBS without antibiotics. When the 
cells were 70% confluent, protein expression was induced with 1 µg/ml Doxycycline 
for 24 h at 37 °C. The cells were washed twice with 1X PBS for 5 min at RT with 
gentle agitation. Formaldehyde was added to a final concentration of 0.8 % in 15ml 
PBS and incubated 10 min with gentle agitation at RT. The reaction was stopped with 
125 mM glycine and incubated for 5 min with gentle shaking at RT. Cells were 
washed twice with 10ml ice-cold PBS and then harvested in 4ml ice-cold PBS by 
pipetting (cells can be easily detached from the plates). Cells were then transferred 
into 15ml falcon tubes and centrifuged at 2000g for 5 min at 4 °C. The pelleted cells 
were washed with 2ml ice-cold PBS and pelleted for 5 min at 2000g. The pellets 
were resuspended in 900µl ChIP SDS Lysis Buffer and incubated for 10 min on ice. 
For sonication the samples were split into three aliquots of 300µl in 1.5ml tubes 
(maximum volume that can be processed in the Bioruptor device). The Bioruptor was 
precooled by the addition of crashed ice to the water bath and 3 cycles of 10 min with 
30s ON/ 30s OFF at high intensity were applied (fresh ice was added to the water 
bath between cycles). The cell debris was pelleted at 13000g for 10 min at 4 °C. The 
supernatant containing the chromatin was transferred to a new microcentrifuge tube. 
Cross-linked material was either immediately used for immunoprecipitation or stored 
at -80 °C. 
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For the immunoprecipitation only siliconized 1.5ml Eppendorf tubes were used. Per 
sample 10µl GFP-Trap agarose beads were equilibrated with 300µl ChIP Low Salt 
Buffer. The beads were centrifuged for 2 min at 500g, and the supernatant was 
discarded. The chromatin was added to the equilibrated beads and diluted to 500µl 
with ChIP Low Salt Buffer. The binding reaction was incubated for 2 h at 4 °C on a 
rotating wheel. The beads were spun down for 1 min at 500g at RT and the 
supernatant was removed. 
Bead washing was performed for 2-3 min at RT on a rotating wheel, followed by 
centrifugation steps of 1 min at 500g and RT. The beads were washed twice with 
700µl ChIP Low Salt Buffer, then one time with 700µl ChIP High Salt Buffer followed 
by a wash with ChIP LiCl Buffer. A final washing step was done with 500µl EB buffer 
(Qiagen) and the beads were finally resuspended in 500µl EB buffer. 
Since the GBP (GFP Binding Protein) of the GFP-Trap beads is covalently linked to 
the beads, and the interaction with GFP is very strong, the protein-DNA complexes 
were not eluted but directly decrosslinked on the beads and isolated. 8µl RNase A 
(20mg/ml) were added to each sample and incubated for 2 h at 37 °C with occasional 
vortexing. 5µl of 10mg/ml Proteinase K were added to each sample followed by an 
incubation of 1 h at 55 °C in a thermomixer. To revert the crosslinking, a final ON 
incubation at 65 °C was performed. 
  
 
7.2.6.1.1 DNA purification 
 
The samples were transferred to “Safe-lock” tubes, and a phenol/chloroform 
extraction was performed. Briefly, 1 volume of phenol/chloroform/isoamyl alcohol 
(Roth) was added to each sample and mixed vigorously by vortexing. A 
centrifugation step for 5 min at 13000g RT was performed to separate the organic 
and the aqueous phase. The upper aqueous phase containing the DNA was carefully 
transferred to a fresh tube. The phenolic extraction was repeated. To remove traces 
of phenol the samples were mixed with 1 volume of chloroform p.a., mixed by 
vortexing and centrifuged for 5 min at RT. The aqueous phase was transferred to a 
fresh tube and the DNA was precipitated with 2 volumes ice-cold 100% EtOH and 0.1 
volume 3 M sodium acetate pH 5.2. DNA was precipitated for 20 min at -20 °C. The 
samples were centrifuged for 15 min at 13000g and 4 °C, the supernatant was 
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aspirated carefully and the DNA washed with 500µl of 70% ice-cold ethanol. The 
ethanol was removed with a pipette and the pellet was air-dried for approx. 15min. 
The pellets were dissolved in 60µl of sterile H2O and stored at -20 °C until analyzed.  
 
7.2.6.2 RNA Immunoprecipitation with GFP-Trap 
 
For RNA immunoprecipitation the HMGN5-FlpIn and the control cell line GFP-FlpIn 
were used. The cells were seeded in 15 cm culture dishes in low glucose DMEM/ 
10% Tet-free FBS without antibiotics and grown at 37 °C until 70-80% confluence 
was reached. Protein expression was induced with 1µg/ml Doxycycline for 6 h at 37 
°C. After induction the cells were washed twice with PBS. All PBS traces were 
removed and the plates were placed without lid on ice into the stratalinker UV 
crosslinker (Stratagene). UV crosslinking was performed by applying 150mJ/cm2 UV 
light at 254 nm. While on ice, cells were harvested in 1.5 ml ice-cold PBS with a 
scraper and transferred into a 2 ml tube. Cells were centrifuged at 2000g for 3 min at 
4 °C and washed with 2ml ice-cold PBS. For sonication, the samples were 
resuspended in 400µl CLIP Lysis Buffer and vortexed for a few seconds. The 
samples were split into 4 aliquots of 100µl in 0.6 ml tubes and sonicated for 15 min 
with high intensity in a precooled Bioruptor (30 sec ON/ 30 sec OFF). The cell debris 
was pelleted for 5 min at 8000g and 4 °C and the supernatant was transferred to a 
fresh tube. For the immunoprecipitation steps only siliconized microcentrifuge tubes 
were used. Per sample, 10µl of GFP-Trap_M (magnetic) beads were equilibrated 
with 300µl CLIP Low Salt Buffer and placed in a 96-well magnetic plate (SPRIplate® 
96-Ring). The magnetic beads on suspension were concentrated to a ring for 5 min, 
until the solution became clear, and the supernatant was removed. The equilibrated 
beads were mixed with 200µl of the sonicated samples and diluted to 500µl with 
CLIP Medium Salt Buffer + PI + 100 U/ml RNasin. The samples were incubated for 2 
hours at 4 °C on a rotating wheel. 
After incubation the samples were placed in the magnetic plate for 5 min to remove 
the supernatant. All the washing steps were performed at RT incubating with buffer 
for 5 min on a rotating wheel, and the beads were placed in a magnetic plate for 5 
min followed by complete removal of the supernatant with a 200µl pipette. Beads 
were washed 3X with 700µl CLIP Low Salt Buffer, then 2X with 700µl CLIP High Salt 
Buffer and finally once with 500µl CLIP Elution buffer (EB). RNA was partially 
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digested on-bead using 500µl EB plus 1µl RNase A/T1 cocktail pre-diluted 1:100 (the 
dilution was previously standardized (See results 4.7). RNA hydrolysis was 
performed for 10 min at 37 °C on a rotating wheel. The samples were then placed in 
a magnetic plate, incubated for 1-2 min and the supernatant was removed. The 
beads were washed once with 500µl CLIP Elution Buffer and immediately 
resuspended in 30µl 1X DNase Q1 buffer containing 100U/ml RNasin and 1µl DNase 
Q1 to remove contaminant DNA. The DNA was hydrolyzed for 1 h at 37 °C in a 
thermomixer. The samples were diluted to 200µl with Proteinase K Buffer, and 
proteinase K was added to a concentration of 300µg/ml. The reaction was incubated 
for 2 h at 37 °C. 
Finally, the RNA was purified using the Trizol reagent (using Safe-lock tubes), 
following the instructions of the manufacturer and being careful in not carrying over 
magnetic beads. The RNA was eluted in 20µl nuclease-free water, quantified and 
analyzed in a Bioanalyzer using the Agilent RNA 6000 Pico Kit (Section 7.2.2.12).  
The RNA was stored at -80 °C and used to prepare libraries (section 7.2.7.3). 
 
 
7.2.6.3 Knockdown of HMGN5 
 
HMGN5-FlpIn cells seeded in 6-well plates were grown to 70% in 2.5ml low glucose 
DMEM medium without antibiotics. Tho perform the transfection, 100pmol of a 
SmartPool siRNA against HMGN5 or a non-targeting siRNA pool (synthesized at 
Gunter Maister’s laboratory) were diluted in 250µl Opti-MEM. 5µl of Lipofectamine 
RNAimax reagent (Invitrogen) were diluted in 250µl Opti-MEM and were combined 
with the diluted siRNA. To form the complexes RNAi-Lipofectamine, the mixture was 
incubated 20 min at RT, and then added by drops to the cells. 24 h post transfection 
the cells were harvested with a cell scraper and used for the downstream 
experiments. To check the efficient knockdown of HMGN5, whole cell protein extract 
were prepared (7.2.3.4) and HMGN5 was detected by western blot (methods 7.2.3.6) 
using the antibody anti-HMGN5 HPA000511 (Sigma). 
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7.2.6.4 RNA preparation and quality control for RNA-seq 
 
To perform RNA-seq, total RNA was prurified from HMGN5-FlpIn cells after HMGN5 
overexpression, knockdown and from non-treated control cells. For HMGN5 
overexpression, cells were grown in 10 cm culture plates in low glucose DMEM 
medium without antibiotics until 70% confluence was reached. Protein expression 
was induced with 1µg/ml Doxycycline for 24 h at 37°C. HMGN5 knockdownd was 
performed as described in 7.2.6.3. RNA isolation was prepared from 3 biological 
replicates per condition using the NucleoSpin RNA Kit (Macherey-Nagel) as 
described in 7.2.2.11. Isolated RNA was quantified with the Qubit RNA kit (methods 
7.2.2.12). Before library preparation, the samples were subjected to quality control. 
For this purpose 300ng of isolated RNA were loaded on a 1% TAE-agarose gel 
electrophoresis and stained with Ethidium bromide (EtBr). RNA quality was estimated 
by the integrity of 28S and 18S ribosomal RNAs (supplementary Figure 43A). As an 
additional quality control, cDNA was prepared (7.2.2.13) and 0.5µl cDNA were used 
for PCR amplification of a 611bp fragment of human beta actin (Supplementary 
Figure 43B). In general, purified RNA was stored at -80 °C and the cDNA at -20 °C. 
After quality control, total RNA was processed for high throughput sequencing as 
indicated in 7.2.7.1. 
 
 
7.2.6.5 HMGN5 Co-Immunoprecipitation (Co-IP) 
 
Cells were grown to 70% confluence in 15 cm plates in low glucose DMEM without 
antibiotics. Protein expression was induced with 1µg/ml Doxycycline for 8 h (3 plates 
for HMGN5 and 3 for GFP control). Cells were washed once with 1X PBS and 
harvested in 2ml ice-cold PBS using a cell scraper. Subsequently, the cells were 
lysed using 1ml Co-IP Lysis Buffer containing *MNase/benzonase on ice (to 
hydrolyze genomic DNA) and incubated for 10 min at 37 °C. The reaction was 
stopped with EDTA in a final concentration of 20mM. Co-IP was performed with 
500µl of lysate per each biological replicate. The samples were mixed with 500µl Co-
IP Wash Buffer 1 and transferred to a 1.5ml microcentrifuge tube. To each sample 
15µl of GFP_Trap magnetic beads (pre-washed with 300µl Co-IP Lysis Buffer) were 
added and incubated for 1 h at 4 °C with gentle rotation. Samples were placed on a 
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magnetic rack for 5 min and the supernatant was removed. Beads were washed 3X 
with 700µl ice-cold Co-IP Wash buffer 1, and 3X with 100µl ice-cold Co-IP Wash 
Buffer 2. To remove wash solution, the beads were placed on a magnetic rack, 
incubated for 2-3 min and the supernatant was carefully removed by pipetting. Beads 
were stored dried at -20 °C until used for mass spectrometry (7.2.6.5.1). 
 
*MNaseBenzonase treatment: 2µl Benzonase were previously added to 6ml Co-IP 
Lysis Buffer and 1ml buffer per sample was used for lysis. Then 1µl of MNase 
(Sigma) was added per lysed sample.  
 
 
7.2.6.5.1 Mass spectrometry of HMGN5 Co-IP 
 
After HMGN5 and GFP control co-IP (methods 7.2.6.5), the independent biological 
replicates were digested on-bead and subjected to mass spectrometry. A label-free 
quantitative proteomics was performed by liquid chromatography tandem mass 
spectrometry (LC-MS/MS) at the Protein Analysis Unit of the Biomedical Center from 
the Ludwig Maximilian University, in collaboration with the laboratory of Dr. Axel 
Imhof. The data obtained was processed with the Perseus software to calculate 
Intensity-based absolute quantification (iBAQ) as a measure of abundance of the 
identified proteins. The UniProt database was used for protein identification. Protein 
enrichment in the HMGN5 samples compared to the GFP control was calculated by 
Log2 fold change (Log2 FC) normalization over the GFP control (log2 FC IBAQ 
HMGN5-GFP). The significance was evaluated using t-test and limma test, both 
adjusted for multiple comparisons. Proteins were considered enriched in the HMGN5 
samples over GFP only when Log2 fold change was ≥2 and with statistical 
significance (p-value <0.05) in both, t-test and limma test. 
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7.2.7 High throughput sequencing  
 
The processing steps of high throughput sequencing datasets from RNA-seq, ChIP-
seq and CLIP-seq were performed by Julia Wimmer from the University clinic of the 
University of Regensburg (UKR). Comparison of HMGN5 ChIP-seq with ENCODE 
datasets was performed by Uwe Schwartz. 
 
7.2.7.1 RNA-seq 
 
At least 3µg of RNA and 2 biological replicates per condition -HMGN5 knockdown, 
overexpression and control cells (RNA isolation described in 7.2.2.11)- were sent to 
the GeneCore Facility (EMBL Heidelberg) for library preparation and high throughput 
sequencing. The sequencing was performed on an Illumina Hiseq2000 platform with 
a read length of 50bp paired-end. Raw data was delivered as compressed FASTQ 
files. 
Prior to mapping to the reference genome, the quality control of the reads was 
performed using the software FastQC. All pre-processing steps were performed with 
the software packages SAMtools or BEDtools. The sequencing reads were mapped 
to the hg19 human reference genome using the STAR aligner with standard settings. 
The DEseq2 package from R (v3.1.2) was used to perform a differential gene 
expression analysis of HMGN5 overexpression and knockdown over the non-treated 
control using standard settings.  
The RNA-seq was further validated by qPCR using four genes that were differentially 
expressed, using the method described in 7.2.2.5.  
Gene Ontology Enrichment Analysis was performed using the ClueGo plug-in 
(v2.3.3) from the Cytoscape software (v.3.5.1). The significance of the enrichments 
was obtained with a hypergeometric test and the p-value correction with the 
Bonferroni step-down method (p-value <0.005). The selected leading terms 
correspond to the most significant term in each group. 
When corresponding, plots were performed using the Sigmaplot software (v12.5). 
Visualization of grouped datasets was performed with the BioVenn tool (available 
online at http://www.biovenn.nl/index.php). 
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7.2.7.2 ChIP-seq 
 
To perform high throughput sequencing of the HMGN5 and GFP ChIP samples 
(7.2.6.1), the NEBNext® ChIP-Seq Library kit was used to prepare the libraries. 
Quality of the libraries was analyzed with the High Sensitivity DNA kit (Agilent) on a 
Bioanalyzer. Deep sequencing was performed at the KFB Regensburg, on an 
Illumina HiSeq 1000 platform, using 50bp single-end sequencing. Quality control was 
performed with the FastQC software (v0.10.1). As the library adapters were 
overrepresented (~10%), a filtering step to remove reads with adapter sequences 
was done with Homer tools (v4.7). The sequences were aligned to the hg19 
reference genome using Bowtie2 (v2.2.4) with standard settings, keeping only 
uniquely mapped reads. Peak calling was done using the ‘findPeaks’ tool of the 
Homer software, and bed files were created for UCSC genome browser analysis 
using the 'makeUCSCfile' command. 
As the ChIP enrichments covered broad regions, peak finding was performed appling 
the “histone style” parameter, including 7 different peak sizes (200, 250, 300, 350, 
400, 450 and 500bp). The commandlines are described in "merge2" strategy 
(Appendix 9.3.1). 
Peak finding was performed twice using either Hneg1 or Hneg2 (non-induced 
controls) as background for each individual Hpos sample (HMGN5 induced: Hpos1, 
Hpos2). The resulting peaks were combined in one peak file using the 'mergePeaks' 
command.   
Subsequently, the peaks of Hpos1 and Hpos2 were compared and only the peaks 
present in both samples were kept (common peaks with literal overlap).  
Finally gene (GO) and genome ontology analyses were performed. Peaks were 
annotated using the 'annotatePeaks.pl' command of Homer, using the hg19 
reference genome and default settings. The output file strategy2_merge2.ann.txt was 
generated. 
The motif enrichment analysis was done on the strategy2_merge2.ann.txt peak file 
with the 'findMotifsGenome.pl' command on hg19 genome assuming a peak size 
distribution of 1000bp (see above on peak finding description). Motif search was 
repeated using a 200bp peak size distribution (smallest peak finding size) as control. 
This parameter is the standard option in the Homer software (transcription factor 
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peak distribution) based on the assumption that most of the motifs are found +/- 50-
75 bp from the peak center (see description of “findMotifsGenome.pl” command from 
the Homer software). 
Gene ontology enrichment analysis was performed using the ClueGo plug-in (v2.3.3) 
from the Cytoscape software (v.3.5.1). The significance of the enrichments was 
performed with a hypergeometric test and the p-value correction with the Bonferroni 
step-down method (p-value <0.005). The selected leading terms correspond to the 
most significant term in the group (Bindea et al., 2009). 
When corresponding, plots were performed using the Sigmaplot software (v12.5). 
Visualization of grouped datasets was performed with the BioVenn tool.  
 
 
7.2.7.3 CLIP-seq 
 
After isolation of immunoprecipitated RNA by CLIP (section 7.2.6.2), stranded 
libraries were prepared using the Ovation Universal RNA-seq kit (Nugen) according 
to the manufacturer’s instructions. Library size distribution was analyzed using a High 
Sensitivity DNA kit (Agilent) and run in the Bioanalyzer device (See supplementary 
Figure 44). Each library was prepared with a specific barcode for multiplex 
sequencing (Table 8) and they were sent to the KFB Regensburg for high throughput 
sequencing. The samples were quantified by kappa PCR and then combined in one 
lane, and 50bp single-end sequencing was performed on an Illumina HiSeq 1000 
platform. 
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Table 8. Barcodes for CLIP-seq 
Sample Ligation adaptor mix Barcode 
sequence 
HMGN5 1 L2V12DR-BC1 AACCAG 
HMGN5 2 L2V12DR-BC2 TGGTGA 
HMGN5 3 L2V12DR-BC3 AGTGAG 
GFP 1 L2V12DR-BC4 GCACTA 
GFP 2 L2V12DR-BC5 ACCTCA 
GFP 3 L2V12DR-BC6 GTGCTT 
For each biological replicate of HMGN5 and GFP samples, the specific name of Adaptor 
Ligation mix from the Ovation universal RNA-seq kit (Ligation adaptor mix) and the 
associated barcode sequence are indicated. 
 
 
 
The command lines to process the CLIP-seq data are detailed in the Appendix 
section 9.3.2. 
FASTQ files containing the raw data were subjected to quality control analysis using 
the FastQC software. As there was less than 10% adapter contamination, the 
trimming step was ommited. The reads were mapped to the hg38 human reference 
genome using the Bowtie software (v2.1.1).  
The pre-build bowtie indexes for hg38 genome (w/o alternate haplotypes) were 
obtained from ftp://ftp.ccb.jhu.edu/pub/data/bowtie_indexes/GRCh38_no_alt.zip. 
The alignments were exported as BAM files for visualization and indexes were 
created using the BEDtools utilities (v2.24.0). 
To identify the enriched regions a peak finding was performed using the 'findPeaks' 
command of Homer (v4.9), for each of the three HMGN5 samples and additionally a 
combined alignment of all three HMGN5 samples. As background we used combined 
alignments of the GFP2 and GFP3 experiments. For the analysis only uniquely 
mapping reads were selected. 
To obtain the enriched RNA bound to HMGN5, a differential gene expression 
analysis (DGE) was done using the edgeR software package from R (v3.1.2). The 
transcription database for DGE analysis was obtained from the annotation package 
“TxDb.Hsapiens.UCSC.hg38.knownGene” from Bioconductor (v3.0). Read count was 
generated according to the settings described in 
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http://htseq.readthedocs.io/en/master/count.html. The RNA reads were normalized to 
counts per million (CPM) to control the differences in library sizes. Three settings for 
filtering were tested, using 5, 10 and 20 CPM as threshold. The final analysis was 
done using a threshold of 5 CPM (A gene is considered to be expressed in a library -
thus informative- when it has a count of at least 5-10 CPM). Read counting was 
performed in two different ways, by counting exons/introns obtained from genes, or 
obtained from transcripts and the resulting data was combined. 
Finally we searched for overrepresented motifs in the HMGN5-bound RNAs using the 
'findMotifsGenome.pl' command of Homer (v4.9). Motif finding was done with the 
merged common HMGN5 peaks over GFP2+3 using the hg38 genome. 
'mergePeaks' and 'findMotifsGenome.pl' were used to obtain common peaks with 
literal overlap. As control, the peak search was repeated determining peaks with a 
distance of 50bp and 100pb away from the peak center. Peaks were annotated using 
the 'annotatePeaks.pl' command for the hg38, using default setting. Additionally, 
gene ontology and genome ontology analysis were performed with Homer.  
Gene ontology enrichment analysis was analyzed using the ClueGo plug-in (v2.3.3) 
of the Cytoscape software (v.3.5.1). The significance of the enrichments was 
performed with a hypergeometric test and the p-value correction with the Bonferroni 
step-down method (p-value <0.005). The selected leading terms correspond to the 
most significant term in the group. When corresponding, the plots were performed 
using the Sigmaplot software (v12.5). 
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9 Appendix 
 
9.1 Supplementary Figures 
 
 
 
 
Figure 42. Standardization of HMGN5 knockdown. 
HEK293T cells were transfected with 40nM (final concentration) of a smartpool siRNA 
against hHMGN5 or 40nM of a non-targeting control smartpool siRNA (NTC). A no-
treatment control was prepared in parallel. A) Knockdown analyzed by western blot. After 24 
h of incubation the cells were lysed and 20µg of total protein extract were loaded on 12% 
SDS-PAGE and transferred to a PDVF membrane for western blot detection. HMGN5 was 
detected with the anti-HGMN5 antibody HPA000511 (Sigma) at a dilution of 1:2500. β-actin 
was used as a loading control, detected with the anti-actin antibody A2066 (Sigma) at a 
1:5000 dilution. B) Immunofluorescence detection of HMGN5 in HEK293T cells. After 24 h 
of knockdown the cells were fixed in 4% PFA and subjected to immunostaining using the 
anti HMGN5 antibody HPA000511 at a dilution of 1:500. DNA was counterstained with 
DAPI. In the merged images the DNA is shown in red and the HMGN5 signal in green. The 
immunofluorescences were visualized with the Fluorescent Microscope Axiovert 200M. C) 
The same cells shown in (B) were visualized by confocal mocriscopy using a Leica SP8 
device. 
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Figure 43. Total RNA quality control. 
A) Total RNA extracted from each biological sample after overexpression, knockdown and 
no-treatment control of HMGN5-FlpIn cell lines. 300ng of extracted RNA was loaded on a 
1% Native TAE-agarose gel and separated by electrophoresis. The RNA was stained with 
BrEt and visualized with UV. The 28S and 18S ribosomal RNA are indicated. B) cDNA 
quality control. 500ng of each RNA samples were used for cDNA synthesis, and 0.5µl cDNA 
were used for PCR amplification of a 611bp fragment of human beta actin in every biological 
sample of the specific treatments. An –RT (only RNA) control was used to estimate genomic 
DNA contamination. 1Kb DNA ruler was used as molecular marker reference. 
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Figure 44. Electopherogram of the libraries for CLIP-seq run with the High 
sensitivity DNA chip.  
Isolated RNAs from each CLIP replicate (3 HMGN5 and 3 GFP samples) were used to 
prepare stranded-libraries with the Ovation Universal RNA-seq kit from Nugen. 1 µl of each 
library was loaded on a High sensitivity DNA chip and analyzed on a Bioanalyzer instrument. 
The peaks at 35 and 10380bp correspond to the lower and upper DNA markers respectively. 
Each individual library presents a peak size distribution around 250bp. 
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Figure 45. In vitro mononucleosomes 
assembly.  
Mononucleosomes were reconstituted using an AvaI 
digested Cy3 labeled PCR fragment containing the 
601 sequence, and histones purified from chicken 
blood. The assembly was performed using a 
histones:DNA ratio of 1.4:1 and 2:1. Assembled 
nucleosomes were loaded on a 6% Native PAGE and 
visualized with the Thyphoon 9500 device. 
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Figure 46. MgCl2-dependent RNA fragmentation.  
Total RNA extracted from HeLa cells was dissolved at 500ng/µl in EX0 buffer (containing 
1.5 mM MgCl2) and was subjected to a time course fragmentation. Samples were incubated 
at 95°C. from 0 to 10 min After incubation, per lane 1µg of RNA was loaded on a 1% 
agarose gel and separated by electrophoresis. The gel was stained with Ethidum bromide 
and visualized in an UV transiluminator. 1kb GeneRuler™1kb Plus DNA Ladder was used 
as molecular weight reference (M). The 1000bp and 500bp bands of the marker are 
indicated. 
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Figure 47. Interaction of PTMS with RNA.  
A recombinant his-tagged human parathymosin (PTMS) was used for RNA interactions using 
EMSA experiments. The fluorescently labeled snoRNA2T2 was kept at a constant 
concentration of 50nM and a 2:1 serial dilution of the protein was used starting with 2000nM 
as highest concentration. A negative control without protein was performed (lane 1). The 
interactions were loaded on a 6% native PAGE and documented with a Typhoon FLA 9500 
(GE Healthcare). 
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9.2 Supplementary tables 
 
 
 
Table 9.  Identified HMGN5-associated exons 
Tx_id Gene logFC logCPM p-value FDR 
91266 HMGN5 -4.5199134 8.966831944 6.73E-19 1.92E-14 
62341 CEBPE 3.93205741 5.935729426 5.45E-16 7.79E-12 
31974 AARS2 -6.666727435 4.003751002 3.65E-10 3.48E-06 
59363 RRP36 -10.3608153 3.473334418 1.24E-07 0.000707709 
59364 RRP36 -10.3608153 3.473334418 1.24E-07 0.000707709 
32747 EPB41L2 -10.28473286 3.398826771 2.00E-07 0.000953513 
48327 SEC31B -10.2232589 3.338682149 4.50E-07 0.001657266 
50387 IGHMBP2 -10.22493055 3.340293141 4.64E-07 0.001657266 
73789 KIAA0753 -10.20720177 3.323085719 6.19E-07 0.001967874 
73788 KIAA0753 -10.16746698 3.284294108 1.08E-06 0.003096795 
20448 ADD1 -10.25766138 3.37206897 1.27E-06 0.00322348 
43459 TLN1 -10.15798845 3.274855612 1.37E-06 0.00322348 
59365 ARHGEF7 -10.16218473 3.278974165 1.53E-06 0.00322348 
73790 KIAA0753 -10.13290018 3.250561664 1.58E-06 0.00322348 
84788 ATP9A -10.09323531 3.211655277 1.99E-06 0.003557829 
84787 ATP9A -10.09323534 3.211655277 1.99E-06 0.003557829 
78607 PDCD5 -4.031511994 4.269416698 2.15E-06 0.003616876 
78174 CC2D1A -7.901146497 3.430437839 3.09E-06 0.004904088 
14893 CUL3 -10.02978445 3.149642084 5.16E-06 0.00704886 
14892 CUL3 -10.02978458 3.149642084 5.18E-06 0.00704886 
7700 DCAF8 -9.998470469 3.119095594 7.14E-06 0.008167912 
3449 METTL13 -9.971481171 3.0929969 7.33E-06 0.008167912 
3452 METTL13 -9.971481176 3.0929969 7.34E-06 0.008167912 
54925 ASIC1 -9.970167116 3.091660389 7.98E-06 0.008167912 
54926 ASIC1 -9.970167118 3.091660389 7.98E-06 0.008167912 
54924 ASIC1 -9.970167174 3.091660389 8.00E-06 0.008167912 
29482 ABCC10 -9.954154388 3.076345219 1.02E-05 0.008846739 
38347 CDCA2 -9.941953488 3.064324407 1.02E-05 0.008846739 
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38346 CDCA2 -9.941953465 3.064324407 1.02E-05 0.008846739 
38345 CDCA2 -9.941953443 3.064324407 1.02E-05 0.008846739 
54927 ASIC1 -9.926145208 3.048819717 1.21E-05 0.00972174 
86359 CDC45 -9.919433798 3.042275815 1.22E-05 0.00972174 
64841 PML -7.692991943 3.222443584 1.59E-05 0.011640079 
64840 PML -7.69299472 3.222443584 1.59E-05 0.011640079 
64839 PML -7.692997395 3.222443584 1.59E-05 0.011640079 
3451 METTL13 -9.889495357 3.013287054 1.63E-05 0.011680737 
3450 METTL13 -9.86103196 2.985603946 2.13E-05 0.014861697 
75115 DCAKD -9.844252237 2.96906729 2.47E-05 0.01628555 
86358 CDC45 -9.83198955 2.957323856 2.60E-05 0.01628555 
86357 CDC45 -9.831989554 2.957323856 2.60E-05 0.01628555 
78296 TPM4 -9.860248869 2.984476632 2.63E-05 0.01628555 
59366 ARHGEF7 -9.825891433 2.951382351 2.84E-05 0.016739451 
50388 IGHMBP2 -9.857010535 2.981249972 2.94E-05 0.016797307 
7294 SLC39A1 -5.640989368 3.482744067 3.21E-05 0.017971912 
7292 SLC39A1 -5.62828656 3.471041421 3.61E-05 0.019328159 
7699 DCAF8 -9.804317271 2.930250661 3.65E-05 0.019328159 
78428 CRTC1 -9.808523772 2.934275856 4.31E-05 0.020317771 
37084 TRIM4 -9.787641912 2.91409594 4.32E-05 0.020317771 
66863 SCAPER -9.808257867 2.934789942 4.33E-05 0.020317771 
66864 SCAPER -9.808257864 2.934789942 4.33E-05 0.020317771 
66862 SCAPER -9.808257711 2.934789942 4.33E-05 0.020317771 
75116 DCAKD -9.78103501 2.907608006 4.48E-05 0.020503133 
75973 MCRIP1 -6.178905944 3.257883937 4.58E-05 0.020503133 
75972 MCRIP1 -6.178891633 3.257883937 4.59E-05 0.020503133 
85406 BACE2 -7.495704088 3.027084977 5.15E-05 0.022608053 
71698 SPECC1 -2.716336112 4.323516314 5.30E-05 0.022608053 
71697 SPECC1 -2.716335494 4.323516314 5.30E-05 0.022608053 
70897 MBTPS1 -9.742503243 2.870393567 5.50E-05 0.022608053 
5630 TRAPPC3 -9.737891512 2.866083448 5.57E-05 0.022608053 
71694 SPECC1 -2.686800027 4.337597447 5.61E-05 0.022608053 
71695 SPECC1 -2.686799425 4.337597447 5.61E-05 0.022608053 
18044 SGO1 -9.727819078 2.856381195 6.52E-05 0.025868325 
75790 FBF1 -9.732859964 2.860880471 6.60E-05 0.025868325 
86360 CDC45 -9.719659768 2.84844862 6.79E-05 0.026227123 
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66866 SCAPER -9.749753071 2.878140554 6.90E-05 0.026313421 
52879 SYVN1 -9.711015275 2.83998755 7.33E-05 0.026565937 
52880 SYVN1 -9.711015277 2.83998755 7.33E-05 0.026565937 
63062 RPS6KL1 -9.720383526 2.848773645 7.39E-05 0.026565937 
78609 PDCD5 -3.787592467 3.986420955 7.76E-05 0.026565937 
7298 SLC39A1 -5.532997894 3.382789591 7.81E-05 0.026565937 
7297 SLC39A1 -5.532997067 3.382789591 7.81E-05 0.026565937 
7295 SLC39A1 -5.53297912 3.382789591 7.83E-05 0.026565937 
66390 ALDH1A2 -9.718240545 2.847474065 7.98E-05 0.026565937 
66392 ALDH1A2 -9.718240468 2.847474065 7.99E-05 0.026565937 
66391 ALDH1A2 -9.718240438 2.847474065 7.99E-05 0.026565937 
85407 BACE2 -7.442804267 2.973952239 8.09E-05 0.026597203 
84965 GMEB2 -9.706515658 2.835477464 8.41E-05 0.027337047 
66867 SCAPER -9.721925995 2.851228435 8.79E-05 0.028236376 
54928 ASIC1 -9.688534523 2.818194895 8.92E-05 0.028351876 
31853 MOCS1 -9.727425018 2.855496723 0.000102811 0.032265093 
7296 SLC39A1 -5.496364407 3.348997119 0.000105086 0.032265093 
49838 FAM111B -9.702449886 2.832328217 0.000105787 0.032265093 
49837 FAM111B -9.702449621 2.832328217 0.000106061 0.032265093 
85408 BACE2 -7.398819961 2.929892825 0.00011397 0.032522213 
58455 SBNO1 -7.399294461 2.93040712 0.000114974 0.032522213 
58457 SBNO1 -7.399297916 2.93040712 0.000115039 0.032522213 
58456 SBNO1 -7.39930012 2.93040712 0.000115081 0.032522213 
8721 ITPKB -9.686794227 2.816269053 0.000115715 0.032522213 
54027 PRDM10 -9.657084008 2.788060667 0.000116724 0.032522213 
54028 PRDM10 -9.657083993 2.788060667 0.000116765 0.032522213 
75118 DCAKD -9.673585531 2.803312674 0.000116928 0.032522213 
75117 DCAKD -9.673585683 2.803312674 0.000117142 0.032522213 
69493 METTL26 -9.6532322 2.783871434 0.000119957 0.032688532 
27300 FBN2 -2.021098282 5.018327303 0.000120027 0.032688532 
75114 DCAKD -9.668736263 2.798617086 0.000121191 0.032694061 
84964 GMEB2 -9.636869587 2.768338499 0.000128964 0.03440545 
1363 MAST2 -9.646714006 2.777893021 0.000129941 0.03440545 
87834 LARGE1 -9.68244887 2.811655497 0.00013647 0.035802696 
17245 GFM1 -9.698583161 2.827999453 0.000139747 0.036276104 
48319 SEC31B -2.281418361 4.586867657 0.000140812 0.036276104 
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31852 MOCS1 -9.653563792 2.78403644 0.000145279 0.036430819 
31851 MOCS1 -9.653563827 2.78403644 0.000145357 0.036430819 
48318 SEC31B -2.267283815 4.574554244 0.000146742 0.036430819 
58454 SBNO1 -9.618315851 2.750345106 0.000147411 0.036430819 
51938 PLEKHA7 -7.374309822 2.90516 0.000147782 0.036430819 
77879 CLEC4GP1 -3.967050588 3.839826948 0.0001566 0.037362005 
77878 CLEC4GP1 -3.967049405 3.839826948 0.000156665 0.037362005 
77877 CLEC4GP1 -3.967049286 3.839826948 0.000156672 0.037362005 
77876 CLEC4GP1 -3.967047246 3.839826948 0.000156786 0.037362005 
81444 HNRNPL -9.623904151 2.755221998 0.00016411 0.038784133 
18560 IFRD2 -6.500859328 3.12196974 0.000165506 0.038793541 
6463 TMED5 -7.343712711 2.874557967 0.000183447 0.041987491 
6462 TMED5 -7.343714306 2.874557967 0.000183492 0.041987491 
6461 TMED5 -7.343715901 2.874557967 0.000183537 0.041987491 
43369 KIF24 -9.623930227 2.755961617 0.000185408 0.042078798 
18559 IFRD2 -6.485583918 3.108310158 0.000187891 0.042306498 
67487 WDR90 -9.658550229 2.78855843 0.000197222 0.043601746 
11717 RETREG2 -9.729158643 2.856432138 0.000197773 0.043601746 
11716 RETREG2 -9.729159046 2.856432138 0.000198217 0.043601746 
79138 ZNF221 -9.566886813 2.700756563 0.000208392 0.044543376 
79137 ZNF221 -9.566886783 2.700756563 0.000208729 0.044543376 
52881 SYVN1 -9.573300526 2.706716256 0.000212459 0.04500361 
48016 GRID1 -9.587169575 2.720416632 0.000221991 0.046566128 
83425 PIGT -9.608036752 2.740926827 0.000223494 0.046566128 
15426 CAPN7 -9.588152196 2.720510229 0.000224721 0.046566128 
20746 TBC1D1 -7.330114125 2.859920377 0.00022653 0.046603351 
49927 TMEM132A -7.345403318 3.047752684 0.00023267 0.046660021 
49928 TMEM132A -7.345402447 3.047752684 0.00023269 0.046660021 
79507 AP2A1 -6.418692675 2.915843246 0.000233052 0.046660021 
79506 AP2A1 -6.418689901 2.915843246 0.000233333 0.046660021 
57438 SARNP -9.541039705 2.675616291 0.000245386 0.048729595 
9015 ACP1 -9.552529483 2.686284877 0.000254666 0.049967445 
71026 SPATA2L -5.98890898 2.975698486 0.000257333 0.049967445 
54026 PRDM10 -9.539806772 2.674902931 0.000261272 0.049967445 
54025 PRDM10 -9.539806701 2.674902931 0.000261566 0.049967445 
54024 PRDM10 -9.539806613 2.674902931 0.000261927 0.049967445 
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54023 PRDM10 -9.53980657 2.674902931 0.000262104 0.049967445 
20637  Unidentified -3.561796171 4.681635546 3.74E-06 0.005632355 
30742  Unidentified -6.860895713 3.338915124 5.56E-06 0.007227569 
28961  Unidentified -9.961374362 3.083402336 9.69E-06 0.008846739 
28960  Unidentified -9.929488654 3.052354046 1.22E-05 0.00972174 
28838  Unidentified -9.86862523 2.993366863 2.67E-05 0.01628555 
28839  Unidentified -9.868624941 2.993366863 2.68E-05 0.01628555 
31459  Unidentified -9.84642236 2.971374302 2.87E-05 0.016739451 
72136  Unidentified -7.518678577 3.202010083 3.31E-05 0.018204906 
30739  Unidentified -6.640802006 3.127765811 4.14E-05 0.020317771 
30740  Unidentified -6.640801998 3.127765811 4.14E-05 0.020317771 
30741  Unidentified -7.417265061 3.108249451 7.34E-05 0.026565937 
28959  Unidentified -9.666892724 2.798393146 0.000204649 0.044391396 
28958  Unidentified -9.666892507 2.798393146 0.000204912 0.044391396 
List of RNAs generated by counting exons obtained from transcripts. The Transcript Id 
(Tx_id), name of associated gene, log fold change (LogFC), Log normalized counts per 
million (LogCPM), p-value and adjusted false discovery rate (FDR) are shown in the list. FDR 
cutoff: 0.05. The negative LogFC values correspond to enrichment of HMGN5 over GFP. 
Genes for DGE analysis were extracted from TxDb.Hsapiens.UCSC.hg38.knownGene 
database of hg38 human reference genome. 
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Table 10. Identified HMGN5-associated introns 
Tx_id Gene name logFC logCPM p-value FDR 
28963 CSNK2B -10.57284844 2.602688125 2.00E-10 1.67E-06 
28962 CSNK2B -10.32288718 2.359067287 4.61E-09 2.89E-05 
70418 TOX3 -7.618927237 2.39595837 4.01E-08 0.00014371 
51553 MOB2 -10.12201589 2.163675689 5.84E-08 0.000162901 
28960 LY6G5B -10.06003812 2.104242312 8.85E-08 0.000209141 
25675 G3BP1 -5.1776663 2.731225356 1.08E-07 0.000209141 
25674 G3BP1 -5.177663497 2.731225356 1.08E-07 0.000209141 
25673 G3BP1 -5.177660694 2.731225356 1.08E-07 0.000209141 
67488 WDR90 -10.06870594 2.111911219 1.38E-07 0.000246887 
28961 LY6G5B -9.932080302 1.980545806 1.56E-07 0.000246887 
4914 ENO1 -4.060905817 2.989744799 1.57E-07 0.000246887 
42278 AKAP2 -3.618873362 3.102655176 2.34E-07 0.000317207 
42277 AKAP2 -3.61887332 3.102655176 2.34E-07 0.000317207 
43457 TLN1 -9.589848183 1.651615196 5.97E-07 0.00065174 
1578 NFIA -7.238785294 1.916972301 5.74E-07 0.00065174 
1577 NFIA -7.238771966 1.916972301 5.72E-07 0.00065174 
20638 TAPT1-AS1 -3.222021858 3.680936008 6.59E-07 0.000662033 
20639 TAPT1-AS1 -3.222020606 3.680936008 6.59E-07 0.000662033 
16428 ST3GAL6 -4.203696894 2.717764913 7.83E-07 0.000755889 
4915 ENO1 -3.991224239 2.866444377 8.73E-07 0.000782529 
16426 ST3GAL6 -4.173234815 2.688983048 1.25E-06 0.000976947 
16427 ST3GAL6 -4.173234784 2.688983048 1.24E-06 0.000976947 
16429 ST3GAL6 -4.173234753 2.688983048 1.24E-06 0.000976947 
68438 FUS -7.229492411 2.031812665 1.70E-06 0.001211976 
85477 PDE9A -7.06423973 1.747890562 1.74E-06 0.001211976 
16431 ST3GAL6 -4.110383791 2.629681577 2.28E-06 0.001506548 
71982 RASL10B -9.409586198 1.48000323 2.55E-06 0.001640172 
73388 BAHCC1 -6.333293588 1.969561588 3.47E-06 0.002122117 
16430 ST3GAL6 -4.09189762 2.612267693 3.46E-06 0.002122117 
2383 ATP1A1 -9.207676185 1.288596489 5.05E-06 0.002869415 
42874 GPSM1 -9.19334333 1.274637329 5.21E-06 0.002869415 
73434 RAC3 -6.990524563 1.80474533 5.08E-06 0.002869415 
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72063  Unidentified -1.999661976 4.024715531 5.42E-06 0.002869415 
21458 GSTCD -4.019514004 2.574695205 7.13E-06 0.003649981 
28178 MAPK9 -3.677815912 2.808176011 7.99E-06 0.003884737 
28179 MAPK9 -3.677815014 2.808176011 7.99E-06 0.003884737 
28177 MAPK9 -3.6778013 2.808176011 8.05E-06 0.003884737 
72572 NFE2L1 -6.227636108 1.759044953 1.00E-05 0.004414283 
80063 ZNF587 -6.027533835 1.678877426 9.76E-06 0.004414283 
80062 ZNF587 -6.027530192 1.678877426 9.78E-06 0.004414283 
51552 MOB2 -9.66244054 1.720311 1.03E-05 0.004419196 
32918  Unidentified -2.307741185 4.076507551 1.22E-05 0.004574152 
12169 SH3YL1 -6.013069032 1.556948572 1.37E-05 0.004839221 
12165 SH3YL1 -6.008227086 1.55238919 1.39E-05 0.004839221 
46812 EDRF1 -5.928230959 2.255867817 1.38E-05 0.004839221 
18334 CCDC12 -3.827549312 2.573040691 1.52E-05 0.004960297 
51899 RRAS2 -3.133201226 3.079162806 1.51E-05 0.004960297 
51900 RRAS2 -3.133198654 3.079162806 1.51E-05 0.004960297 
51902 RRAS2 -3.133195835 3.079162806 1.51E-05 0.004960297 
65638  Unidentified -4.269157755 2.513311881 1.71E-05 0.005430562 
51609 NAP1L4 -5.966074876 1.621452482 1.96E-05 0.006144728 
36079 RAPGEF5 -5.837762476 1.499646664 2.00E-05 0.006203235 
33882 DBNL -5.881068939 1.54115342 2.08E-05 0.006350793 
17058 SPSB4 -1.860596418 4.098032492 2.39E-05 0.00715133 
1139 SMAP2 -5.292999922 1.895757613 2.55E-05 0.007155936 
45045 RBM17 -4.972575825 2.079436449 2.79E-05 0.007155936 
1138 SMAP2 -5.105723364 2.055875768 3.15E-05 0.007977015 
51033 TTC12 -5.845517077 1.507746274 3.22E-05 0.007999808 
18335 CCDC12 -3.7651382 2.514353313 3.20E-05 0.007999808 
51032 TTC12 -5.815217117 1.479198321 3.38E-05 0.008256094 
51031 TTC12 -5.815212986 1.479198321 3.39E-05 0.008256094 
13171 LRRTM4 -1.377708427 5.852014679 3.46E-05 0.008293965 
13172 LRRTM4 -1.377708383 5.852014679 3.47E-05 0.008293965 
80485 CD320 -5.433449976 1.947411152 3.51E-05 0.008308383 
46813 EDRF1 -5.767291619 2.109662116 4.44E-05 0.009960837 
46811 EDRF1 -5.767276585 2.109662116 4.45E-05 0.009960837 
45044 RBM17 -4.463915503 2.229249849 4.38E-05 0.009960837 
80486 CD320 -5.330577109 1.849679784 4.81E-05 0.010587271 
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4037 SYT14 -1.635851737 4.304743494 4.99E-05 0.010611306 
4036 SYT14 -1.635851725 4.304743494 4.99E-05 0.010611306 
4033 SYT14 -1.635851716 4.304743494 4.99E-05 0.010611306 
4034 SYT14 -1.635851714 4.304743494 4.99E-05 0.010611306 
72310 TUBG2 -6.758361706 1.596828218 5.05E-05 0.010641458 
4035 SYT14 -1.630021533 4.299967331 5.35E-05 0.011190942 
393 VPS13D -2.434268944 3.325006473 5.83E-05 0.012084784 
80484 CD320 -5.244417064 1.768045288 6.33E-05 0.013028851 
4038 SYT14 -1.612974292 4.286033027 6.39E-05 0.01303249 
29530 SLC29A1 -4.870576526 1.763017338 6.81E-05 0.013142134 
29528 SLC29A1 -4.870576082 1.763017338 6.82E-05 0.013142134 
29529 SLC29A1 -4.870575882 1.763017338 6.82E-05 0.013142134 
26672 PDE4D -1.819552239 4.546007944 6.52E-05 0.013142134 
28180 MAPK9 -3.604547129 2.560134371 7.44E-05 0.013622223 
46850 GLRX3 -4.730550724 1.783908083 8.01E-05 0.01457424 
31808 MTCH1 -5.27636376 1.451268676 9.82E-05 0.016933501 
31810 MTCH1 -5.276362244 1.451268676 9.80E-05 0.016933501 
46784  Unidentified -5.210693438 1.819722321 9.85E-05 0.016933501 
58189 ATXN2 -1.349895097 5.293590955 0.000107317 0.017719305 
58188 ATXN2 -1.349894868 5.293590955 0.000107213 0.017719305 
38905 PKIA -5.95146042 1.484124771 0.000129135 0.020527733 
38906 PKIA -5.951457889 1.484124771 0.000129097 0.020527733 
81345 ZNF461 -3.650259427 2.411623679 0.000142552 0.022084051 
81344 ZNF461 -3.650256847 2.411623679 0.000142445 0.022084051 
81343 ZNF461 -3.650255074 2.411623679 0.000142371 0.022084051 
58187 ATXN2 -1.30784954 5.314083908 0.00015518 0.023747319 
58186 ATXN2 -1.307849435 5.314083908 0.000155066 0.023747319 
89300 EDA -1.644938825 5.643596671 0.000159824 0.024168013 
89299 EDA -1.644938688 5.643596671 0.000159855 0.024168013 
71240 ALOX12P2 -2.557815117 3.318003849 0.000168563 0.024891552 
71241 ALOX12P2 -2.557814662 3.318003849 0.000168608 0.024891552 
77413 PIGN -2.222032016 3.333440086 0.000168507 0.024891552 
77412 PIGN -2.222031837 3.333440086 0.000168479 0.024891552 
9823 ZNF638 -5.143363823 1.931245397 0.000174723 0.025201351 
51034 TTC12 -5.577986361 1.259082348 0.000179625 0.025607137 
25534 KIAA0141 -4.52964464 1.728096885 0.000189826 0.025607137 
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57018 GXYLT1 -4.558711725 1.821714497 0.000198957 0.02641921 
83102 CBFA2T2 -2.818637183 2.721158381 0.000216543 0.028305068 
83101 CBFA2T2 -2.818636767 2.721158381 0.00021645 0.028305068 
31809 MTCH1 -5.195393297 1.374945988 0.00021807 0.028356963 
76088 SMCHD1 -1.90360414 4.047435412 0.00022656 0.029036245 
76087 SMCHD1 -1.903602411 4.047435412 0.000226764 0.029036245 
65435 ASB7 -5.059992576 1.942727428 0.000239388 0.029890198 
57017 GXYLT1 -4.48800068 1.755777926 0.000244026 0.030318391 
64623 TPM1 -4.312421181 1.646272933 0.000267261 0.032560488 
69730 CDIP1 -4.186341168 1.835627765 0.000271001 0.032703069 
6064 NDC1 -2.002650579 3.547331115 0.000279506 0.033403678 
44484 PSMB7 -3.25853715 2.766563948 0.000282212 0.033567236 
23911 CENPU -4.247762059 1.859132912 0.000302883 0.035520923 
23910 CENPU -4.247757708 1.859132912 0.000303335 0.035520923 
59387 ATP11A -1.937303161 3.662112336 0.000300971 0.035520923 
392 VPS13D -1.845492069 3.659357642 0.000304299 0.035520923 
69732 CDIP1 -4.178310332 1.827698887 0.000306711 0.035636684 
88133 CENPM -2.296072168 3.183440912 0.00031904 0.036898406 
6065 NDC1 -1.989589108 3.536378794 0.000331349 0.038146172 
75873 DNAH17 -1.308332025 4.982111803 0.000348112 0.039892999 
22051 WDR17 -3.623857522 2.581048664 0.000355669 0.040051991 
69728 CDIP1 -4.120428292 1.773884539 0.000377255 0.041526156 
69729 CDIP1 -4.120424641 1.773884539 0.000376915 0.041526156 
69731 CDIP1 -4.120420992 1.773884539 0.000376576 0.041526156 
61153 ARID4A -3.473198428 2.360606864 0.000383244 0.042001185 
6063 NDC1 -1.975635227 3.524689148 0.000392629 0.042291036 
21459 GSTCD -2.652168151 3.047205409 0.00039894 0.042787168 
40959 PTK2 -2.275105225 3.148395097 0.000421621 0.04502732 
26191 SDHAP3 -1.466666921 4.25373813 0.000452308 0.047695729 
91504 COL4A6 -4.423758122 1.562553024 0.000463071 0.048423708 
91505 COL4A6 -4.423756917 1.562553024 0.000462647 0.048423708 
List of RNAs generated by counting introns obtained from transcripts. The Transcript Id 
(Tx_id), name of associated gene, log fold change (LogFC), Log normalized counts per 
million (LogCPM), p-value and adjusted false discovery rate (FDR) are shown in the list. FDR 
cutoff: 0.05. The negative LogFC values correspond to enrichment of HMGN5 over GFP. 
Genes for DGE analysis were extracted from TxDb.Hsapiens.UCSC.hg38.knownGene 
database of hg38 human reference genome. 
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9.3 High throughput sequencing command lines 
 
9.3.1 ChIP-seq analysis command lines 
 
The following script was applied to identify the HMGN5-binding sites in the genome 
using the HMGN5 Flp-In cell line (background HEK293T). The storage of raw and 
processed dataset is indicated in the script. ChIP-seq analysis was performed by Dr. 
Julia Wimmer from the University clinic of the University of Regensburg. 
 
 
##Installed Software: 
 
homer-4.7  
hg19 package  
bowtie2-2.2.4  
blatSuite 
FastQC 
ghostscript-9.14 
 
 
#bash_profile augmented with new paths, bowtie2 variables set as 
described on bowtie2 website. 
#Genome: hg19 obtained from UCSC ("chromFa.tar.gz", 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/bigZips/ , 2015-02-
06) > stored in 
/users/admin/NGSanalysis_JuliaW/GenomeFasta/hg19_unmasked >unzip 
with % tar -xfvz chromFa.tar.gz 
 
 
#Genomes collection for hg19 downloaded from bowtie2 website > *.bt2 
files copied to /Users/admin/HTS-Software/bowtie2-2.2.4/index 
 
 
###ChIP command line: 
##raw data 
50bp, seq 
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##Mapping to the (unmasked) hg19 reference genome (Illuminaís 
iGenome collection contained bt2 index files> no need to build 
bowtie2 genome manually > copied to ../HTS-
software/bowtie2_2.2.4/index. Allow multi mapper, homer will later 
take only uniquely mapped reads (if advised) according to SAM flag. 
Use standard parameters for alignment, scoring, reporting, and 
effort. Works with compressed fastq.gz files! 
 
 
#Usage 
 
#bowtie2 [options]* -x <bt2-idx> {-1 <m1> -2 <m2> | -U <r>} -S 
[<hit>] 
 
#Options 
#-q Reads are fastq files 
 
(#ó-phred33 phreed33+ quality scores are used by very latest 
Illumina pipelines, should be default) 
#-p <int>  number of threads (here: 24 cores available) 
#-x <bt2-idx> normally path to genome index files, but path was 
exported to .bash_profile > ìhg19î info should be sufficient 
#-U <string> path to (unzipped?) fastq file 
#-S <string> path to SAM output (with name!) 
 
 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Hpos1_ACAGTG_L006
_R1_001.fastq.gz -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hpos1; 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Hpos2_GCCAAT_L006
_R1_001.fastq.gz -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hpos2; 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
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/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Hneg1_CGATGT_L006
_R1_001.fastq.gz -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hneg1; 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Hneg2_TGACCA_L006
_R1_001.fastq.gz -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hneg2; 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Gneg1_CAGATC_L006
_R1_001.fastq.gz -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Gneg1; 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Gneg2_CTTGTA_L006
_R1_001.fastq.gz -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Gneg2; 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Gpos1_ATCACG_L006
_R1_001.fastq.gz -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Gpos1; 
 
 
##Creating tag directories (Homer) 
 
#Usage 
 
% makeTagDirectory <Output Directory Name> [options] <alignment 
file1> [alignment file2] Ö 
 
#Options 
 
#-unique (default) keep only uniquely aligned reads 
 
#-genome <string> -checkGC This analysis will produce several output 
files in addition to the basic quality control analysis  
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makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_hg19 -genome 
hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hpos1; 
makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_hg19 -genome 
hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hpos2; 
makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_hg19 -genome 
hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hneg1; 
makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_hg19 -genome 
hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hneg2; 
makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Gpos1_hg19 -genome 
hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Gpos1; 
makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Gneg1_hg19 -genome 
hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Gneg1; 
makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Gneg2_hg19 -genome 
hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Gneg2; 
 
 
##Making Genome Browser Files (homer) 
 
#Usage 
 
% makeUCSCfile <tag directory> -o auto 
#Options 
#-o auto output file is stored in the corresponding tag directory 
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cd /Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/ 
 
makeUCSCfile HMGN5_Hpos1_hg19 -o auto; 
makeUCSCfile HMGN5_Hpos2_hg19 -o auto; 
makeUCSCfile HMGN5_Hneg1_hg19 -o auto; 
makeUCSCfile HMGN5_Hneg2_hg19 -o auto; 
makeUCSCfile HMGN5_Gpos1_hg19 -o auto; 
makeUCSCfile HMGN5_Gneg1_hg19 -o auto; 
makeUCSCfile HMGN5_Gneg2_hg19 -o auto; 
 
>>> Fastqc results failed for uper base sequence content and 
persequence GC content > each samples has Illumina adapter sequences 
overrepresented (~10%), which could cause these failures >>> #use 
homer tools to remove corresponding adapter sequences and run fastqc 
again. 
 
 
###Trimming reads with adapter sequences 
 
##Major adapter sequences 
 
Hpos1 13.5% GATCGGAAGAGCACACGTCTGAACTCCAGTCACACAGTGATCTCGTATGC
 TruSeq Index 5 
 
Hpos2 8.4% GATCGGAAGAGCACACGTCTGAACTCCAGTCACGCCAATATCTCGTATGC
 TruSeq Index 6 
Hneg1 8.7% GATCGGAAGAGCACACGTCTGAACTCCAGTCACCGATGTATCTCGTATGC
 TruSeq Index 2 
Hneg2 7.7% GATCGGAAGAGCACACGTCTGAACTCCAGTCACTGACCAATCTCGTATGC
 TruSeq Index 4 
Gpos1 8.6% GATCGGAAGAGCACACGTCTGAACTCCAGTCACATCACGATCTCGTATGC
 TruSeq Index 1 
Gneg1 11.0% GATCGGAAGAGCACACGTCTGAACTCCAGTCACCAGATCATCTCGTATGC
 TruSeq Index 7 
Gneg2 10.4% GATCGGAAGAGCACACGTCTGAACTCCAGTCACCTTGTAATCTCGTATGC
 TruSeq Index 12 
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##Usage 
 
% homerTools trim [options] <sequence file1> 
#Options 
-len <#> (trim sequences to this length) 
-min <#> (remove sequence that are shorter than this after timming) 
-3 <#> (trim this many bp off the 3' end of the sequence) 
-5 <#> (trim this many bp off the 5' end of the sequence) 
-3 <ACGT> (trim adapter sequence (i.e. "-3 GGAGGATTT") from the 3' 
end of the sequence) 
-5 <ACGT> (trim adapter sequence (i.e. "-5 GGAGGATTT") from the 5' 
end of the sequence) 
 
cd 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Hpos1/; 
 
homerTools trim -3 
GATCGGAAGAGCACACGTCTGAACTCCAGTCACACAGTGATCTCGTATGC -min 50 
Hpos1_ACAGTG_L006_R1_001.fastq; 
 
#Trimmed output: 22391698 of 25900301 reads 
 
 
cd 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Hpos2/; 
 
homerTools trim -3 
GATCGGAAGAGCACACGTCTGAACTCCAGTCACGCCAATATCTCGTATGC -min 50 
Hpos2_GCCAAT_L006_R1_001.fastq; 
 
#Trimmed output: 28692900 of 31326646 reads 
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cd 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Hneg1/; 
 
homerTools trim -3 
GATCGGAAGAGCACACGTCTGAACTCCAGTCACCGATGTATCTCGTATGC -min 50 
Hneg1_CGATGT_L006_R1_001.fastq; 
 
#Trimmed output: 28389091 of 31100985 reads 
 
cd 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Hneg2/; 
 
homerTools trim -3 
GATCGGAAGAGCACACGTCTGAACTCCAGTCACTGACCAATCTCGTATGC -min 50 
Hneg2_TGACCA_L006_R1_001.fastq; 
 
#Trimmed output: 27471492 of 29771949 reads 
 
cd 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Gpos1/; 
 
homerTools trim -3 
GATCGGAAGAGCACACGTCTGAACTCCAGTCACATCACGATCTCGTATGC -min 50 
Gpos1_ATCACG_L006_R1_001.fastq; 
 
#Trimmed output: 28224082 of 30880894 reads 
 
cd 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Gneg1/; 
 
homerTools trim -3 
GATCGGAAGAGCACACGTCTGAACTCCAGTCACCAGATCATCTCGTATGC -min 50 
Gneg1_CAGATC_L006_R1_001.fastq; 
 
#Trimmed output: 33851770 of 38068436 reads 
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cd 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Gneg2/; 
 
homerTools trim -3 
GATCGGAAGAGCACACGTCTGAACTCCAGTCACCTTGTAATCTCGTATGC -min 50 
Gneg2_CTTGTA_L006_R1_001.fastq; 
 
#Trimmed output: 25439957 of 28410531 reads 
 
 
>>> change file name *.fastq.trimmed to *.trimmedAdapt.fastq to 
enable analysis with fastqc. 
 
 
>> all parameters improved. Still, kmer content, per base sequence 
content and per sequence Gc content give warnings/failures >>> 
remaining adapter contaminations in reads (but too low to be 
reported as overrepresented sequence! 
 
>Repeat mapping with cleaned read files. 
 
##Mapping with bowtie2 
 
old alignment files were deleted! 
 
#Usage 
 
% bowtie2 [options]* -x <bt2-idx> {-1 <m1> -2 <m2> | -U <r>} -S 
[<hit>] 
 
#Options 
 
#-q Reads are fastq files 
 
(#ó-phred33 phreed33+ quality scores are used by very latest 
Illumina pipelines, should be default) 
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#-p <int>  number of threads (here: 24 cores available) 
 
#-x <bt2-idx> normally path to genome index files, but path was 
exported to .bash_profile > ìhg19î info should be sufficient 
 
#-U <string> path to (unzipped?) fastq file 
 
#-S <string> path to SAM output (with name!) 
 
 
 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Hpos1/Hpos1_ACAGTG_L006_R1_001.trimmed.fastq -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hpos1_trimme
d; 
 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Hpos2/Hpos2_GCCAAT_L006_R1_001.trimmed.fastq -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hpos2_trimme
d; 
 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Hneg1/Hneg1_CGATGT_L006_R1_001.trimmed.fastq -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hneg1_trimme
d; 
 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Hneg2/Hneg2_TGACCA_L006_R1_001.trimmed.fastq -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hneg2_trimme
d; 
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bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Gneg1/Gneg1_CAGATC_L006_R1_001.trimmed.fastq -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Gneg1_trimme
d; 
 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Gneg2/Gneg2_CTTGTA_L006_R1_001.trimmed.fastq -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Gneg2_trimme
d; 
 
bowtie2 -q -p 20 -x /Users/admin/HTS-Software/bowtie2-
2.2.4/index/hg19 -U 
/Users/admin/NGSanalysis_JuliaW/RawData/ChIP/HMGN5/Project_S124_11-
12/Sample_Gpos1/Gpos1_ATCACG_L006_R1_001.trimmed.fastq -S 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Gpos1_trimme
d; 
 
>>>as expected, the number of uniquely aligned reads (which will be 
used to create tag directories) is the same, but the alignment 
statistics have improved. In the now smaller, but still existing 
number of unmappable reads the remaining adapter contaminations are 
contained! 
 
##Creating tag directories (Homer) 
 
old tag dirs from untrimmed mappings are kept for the moment!! 
 
#Usage 
% makeTagDirectory <Output Directory Name> [options] <alignment 
file1> [alignment file2] Ö 
#Options 
#-unique (default) keep only uniquely aligned reads 
#-genome <string> -checkGC This analysis will produce several output 
files in addition to the basic quality control analysis  
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makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-genome hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hpos1_trimme
d; 
 
makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-genome hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hpos2_trimme
d; 
 
makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19 
-genome hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hneg1_trimme
d; 
 
makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19 
-genome hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Hneg2_trimme
d; 
 
makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Gpos1_trimmed_hg19 
-genome hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Gpos1_trimme
d; 
 
makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Gneg1_trimmed_hg19 
-genome hg19 -checkGC 
/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Gneg1_trimme
d; 
 
makeTagDirectory 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Gneg2_trimmed_hg19 
-genome hg19 -checkGC 
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/Users/admin/NGSanalysis_JuliaW/ChIP/bowtie2_hg19/HMGN5_Gneg2_trimme
d; 
 
 
##Making Genome Browser Files (homer) 
 
old ones from untrimmed mappings are kept for the moment!! 
#Usage 
% makeUCSCfile <tag directory> -o auto 
#Options 
#-o auto output file is stored in the corresponding tag directory 
 
 
cd /Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/ 
 
makeUCSCfile HMGN5_Hpos1_trimmed_hg19 -o auto; 
makeUCSCfile HMGN5_Hpos2_trimmed_hg19 -o auto; 
makeUCSCfile HMGN5_Hneg1_trimmed_hg19 -o auto; 
makeUCSCfile HMGN5_Hneg2_trimmed_hg19 -o auto; 
makeUCSCfile HMGN5_Gpos1_trimmed_hg19 -o auto; 
makeUCSCfile HMGN5_Gneg1_trimmed_hg19 -o auto; 
makeUCSCfile HMGN5_Gneg2_trimmed_hg19 -o auto; 
 
 
###FINDING PEAKS using HOMER's findPeaks tool 
#extended regions are covered by reads >use -region option 
#'regions' show spikes of varying size > find peaks with varying 
initial peak size (before stitching into regions) and combine 
generated peak files 
#high background and middle enrichment success > use poisson 
distribution p-value<0.001 (lowers tag threshold) instead of default 
FDR<0.1% to identify initial peaks and lower enrichment over 
background to 2-fold 
#Use 2 strategies to identify peaks: strategy1 - keep peaks from 
both Hpos samples // strategy2 - keep only reads found for 
both Hpos samples 
#Use two different 'peak size assumptions': merge - 
~200bp(auto)+350bp+500bp(histone) // merge2 - 
~200bp(auto)+250bp+300+350bp+400bp+450bp+500bp(histone) 
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*********MERGE***************************** 
 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~~~~~~~~ 
 
~~~~~~~~~~~r_sauto_d1000_F2_p10-
3~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 
 
cd /Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/ 
 
mkdir region_sauto_D1000_F2_p10-3/ 
 
cd region_sauto_D1000_F2_p10-3/ 
 
 findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-region -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_sauto_D1000_F2
_p10-3/HMGN5_Hpos1.1_r_sauto_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
202bp, 8 tags 
 
 
 
        168925 peaks passed threshold     
#threshold here: poisson distribution p-value <0.001 
 
        Differential Peaks: 42421 of 168925 (25.11% passed)
 #Enrichment over Input 
 
        Stitching together putative peaks into regions 
 #Retained peaks are merged into regions (here: when closer than 
1000bp) 
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        Checking regions against input... 
 
        Differential Peaks: 31634 of 31918 (99.11% passed)
 #Enrichment over Input in regions 
 
        Clonal filtering: 31585 of 31634 (99.85% passed) #Clonal 
Filtering 
 
        Total Peaks identified = 31585     
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-region -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_sauto_D1000_F2
_p10-3/HMGN5_Hpos1.2_r_sauto_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19 
 
202bp, 8 tags 
 
        168925 peaks passed threshold 
 
        Differential Peaks: 51669 of 168925 (30.59% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 36843 of 37179 (99.10% passed) 
 
        Clonal filtering: 36748 of 36843 (99.74% passed) 
 
        Total Peaks identified = 36748 
 
 
cd 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_sauto_D1000_F2
_p10-3 
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mergePeaks -prefix g HMGN5_Hpos1.1_r_sauto_d1000_F2_p10-3.txt 
HMGN5_Hpos1.2_r_sauto_d1000_F2_p10-3.txt; 
 
HMGN5_Hpos1.1_r_sauto_d1000_F2_p10-3.txt        
HMGN5_Hpos1.2_r_sauto_d1000_F2_p10-3.txt        Total   Name 
 
        X       21202   HMGN5_Hpos1.2_r_sauto_d1000_F2_p10-3.txt 
 
X               16028   HMGN5_Hpos1.1_r_sauto_d1000_F2_p10-3.txt 
 
X       X       15520   HMGN5_Hpos1.1_r_sauto_d1000_F2_p10-
3.txt|HMGN5_Hpos1.2_r_sauto_d1000_F2_p10-3.txt 
 
 
mv  g_HMGN5_Hpos1.1_r_sauto_d1000_F2_p10-
3.txt_HMGN5_Hpos1.2_r_sauto_d1000_F2_p10-3.txt 
g_Hpos1_r_sauto_d1000_F2_p10-3.txt; 
 
 
 findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-region -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_sauto_D1000_F2
_p10-3/HMGN5_Hpos2.1_r_sauto_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
204bp, 9tags 
 
               276310 peaks passed threshold 
 
        Differential Peaks: 59232 of 276310 (21.44% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 41890 of 42388 (98.83% passed) 
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        Clonal filtering: 41821 of 41890 (99.84% passed) 
 
        Total Peaks identified = 41821 
 
 
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-region -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_sauto_D1000_F2
_p10-3/HMGN5_Hpos2.2_r_sauto_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19
; 
 
204bp, 9tags 
 
        276310 peaks passed threshold 
 
        Differential Peaks: 73259 of 276310 (26.51% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 49454 of 50018 (98.87% passed) 
 
        Clonal filtering: 49348 of 49454 (99.79% passed) 
 
        Total Peaks identified = 49348 
 
 
cd 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_sauto_D1000_F2
_p10-3 
 
mergePeaks -prefix g HMGN5_Hpos2.1_r_sauto_d1000_F2_p10-3.txt 
HMGN5_Hpos2.2_r_sauto_d1000_F2_p10-3.txt; 
 
HMGN5_Hpos2.1_r_sauto_d1000_F2_p10-3.txt        
HMGN5_Hpos2.2_r_sauto_d1000_F2_p10-3.txt        
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 Total   Name 
 
        X       30874   HMGN5_Hpos2.2_r_sauto_d1000_F2_p10-3.txt 
 
X               23319   HMGN5_Hpos2.1_r_sauto_d1000_F2_p10-3.txt 
 
X       X       18442   HMGN5_Hpos2.1_r_sauto_d1000_F2_p10-
3.txt|HMGN5_Hpos2.2_r_sauto_d1000_F2_p10-3.txt 
 
 
mv  g_HMGN5_Hpos2.1_r_sauto_d1000_F2_p10-
3.txt_HMGN5_Hpos2.2_r_sauto_d1000_F2_p10-3.txt 
g_Hpos2_r_sauto_d1000_F2_p10-3.txt; 
 
 
mergePeaks -prefix g g_Hpos1_r_sauto_d1000_F2_p10-3.txt 
g_Hpos2_r_sauto_d1000_F2_p10-3.txt; 
 
g_Hpos1_r_sauto_d1000_F2_p10-3.txt      
g_Hpos2_r_sauto_d1000_F2_p10-3.txt      Total   Name 
 
        X       16248   g_Hpos2_r_sauto_d1000_F2_p10-3.txt 
 
X               13327   g_Hpos1_r_sauto_d1000_F2_p10-3.txt 
 
X       X       2188    g_Hpos1_r_sauto_d1000_F2_p10-
3.txt|g_Hpos2_r_sauto_d1000_F2_p10-3.txt 
 
 
mergePeaks -prefix 1000 -d 1000 g_Hpos1_r_sauto_d1000_F2_p10-3.txt 
g_Hpos2_r_sauto_d1000_F2_p10-3.txt; 
 
g_Hpos1_r_sauto_d1000_F2_p10-3.txt      
g_Hpos2_r_sauto_d1000_F2_p10-3.txt      Total   Name 
 
        X       15920   g_Hpos2_r_sauto_d1000_F2_p10-3.txt 
 
X               13002   g_Hpos1_r_sauto_d1000_F2_p10-3.txt 
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X       X       2513    g_Hpos1_r_sauto_d1000_F2_p10-
3.txt|g_Hpos2_r_sauto_d1000_F2_p10-3.txt 
 
mv  g_g_Hpos1_r_sauto_d1000_F2_p10-
3.txt_g_Hpos2_r_sauto_d1000_F2_p10-3.txt 
g_g_Hpos_r_sauto_d1000_F2_p10-3.txt; 
 
mv  1000_g_Hpos1_r_sauto_d1000_F2_p10-
3.txt_g_Hpos2_r_sauto_d1000_F2_p10-3.txt 
1000_g_Hpos_r_sauto_d1000_F2_p10-3.txt; 
 
 
cp g_g_Hpos_r_sauto_d1000_F2_p10-3.txt 
/Users/admin/Dropbox/JuliaW_Laengst/g_g_Hpos_r_sauto_d1000_F2_p10-
3.txt; 
 
cp 1000_g_Hpos_r_sauto_d1000_F2_p10-3.txt 
/Users/admin/Dropbox/JuliaW_Laengst/1000_g_Hpos_r_sauto_d1000_F2_p10
-3.txt; 
 
 
~~~~~~~~~~~~~~~~region_s250_D1000_F2_p10-3~~~~~~~~~~~~~~~~~~~ 
 
cd /Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/ 
 
mkdir region_s250_D1000_F2_p10-3/ 
 
cd region_s250_D1000_F2_p10-3/ 
 
 findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-region -size 250 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s250_D1000_F2_
p10-3/HMGN5_Hpos1.1_r_s250_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
poisson threshold: 9 tags 
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 155975 peaks passed threshold 
 
        Differential Peaks: 37779 of 155975 (24.22% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 27805 of 28040 (99.16% passed) 
 
        Clonal filtering: 27776 of 27805 (99.90% passed) 
 
        Total Peaks identified = 27776 
 
 
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-region -size 250 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s250_D1000_F2_
p10-3/HMGN5_Hpos1.2_r_s250_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19 
 
 155975 peaks passed threshold 
 
        Differential Peaks: 46843 of 155975 (30.03% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 32894 of 33133 (99.28% passed) 
 
        Clonal filtering: 32846 of 32894 (99.85% passed) 
 
        Total Peaks identified = 32846 
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cd 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s250_D1000_F2_
p10-3 
 
mergePeaks -prefix g HMGN5_Hpos1.1_r_s250_d1000_F2_p10-3.txt 
HMGN5_Hpos1.2_r_s250_d1000_F2_p10-3.txt; 
 
        X       18898   HMGN5_Hpos1.2_r_s250_d1000_F2_p10-3.txt 
 
X               13813   HMGN5_Hpos1.1_r_s250_d1000_F2_p10-3.txt 
 
X       X       13924   HMGN5_Hpos1.1_r_s250_d1000_F2_p10-
3.txt|HMGN5_Hpos1.2_r_s250_d1000_F2_p10-3.txt 
 
 
mv  g_HMGN5_Hpos1.1_r_s250_d1000_F2_p10-
3.txt_HMGN5_Hpos1.2_r_s250_d1000_F2_p10-3.txt 
g_Hpos1_r_s250_d1000_F2_p10-3.txt; 
 
 
 findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-region -size 250 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s250_D1000_F2_
p10-3/HMGN5_Hpos2.1_r_s250_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
poisson threshold: 10 tags 
 
 276664 peaks passed threshold 
 
        Differential Peaks: 53993 of 276664 (19.52% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
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        Differential Peaks: 37280 of 37592 (99.17% passed) 
 
        Clonal filtering: 37237 of 37280 (99.88% passed) 
 
        Total Peaks identified = 37237 
 
 
 
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-region -size 250 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s250_D1000_F2_
p10-3/HMGN5_Hpos2.2_r_s250_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19
; 
 
poisson threshold: 10 tags 
 
 276664 peaks passed threshold 
 
 Differential Peaks: 68232 of 276664 (24.66% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 44582 of 44996 (99.08% passed) 
 
        Clonal filtering: 44517 of 44582 (99.85% passed) 
 
        Total Peaks identified = 44517 
 
 
cd 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s250_D1000_F2_
p10-3 
 
mergePeaks -prefix g HMGN5_Hpos2.1_r_s250_d1000_F2_p10-3.txt 
HMGN5_Hpos2.2_r_s250_d1000_F2_p10-3.txt; 
Appendix 
233 
 
        X       27610   HMGN5_Hpos2.2_r_s250_d1000_F2_p10-3.txt 
 
X               20285   HMGN5_Hpos2.1_r_s250_d1000_F2_p10-3.txt 
 
X       X       16874   HMGN5_Hpos2.1_r_s250_d1000_F2_p10-
3.txt|HMGN5_Hpos2.2_r_s250_d1000_F2_p10-3.txt 
 
 
 
mv  g_HMGN5_Hpos2.1_r_s250_d1000_F2_p10-
3.txt_HMGN5_Hpos2.2_r_s250_d1000_F2_p10-3.txt 
g_Hpos2_r_s250_d1000_F2_p10-3.txt; 
 
 
 
~~~~~~~~~~~~~~~~region_s300_D1000_F2_p10-3~~~~~~~~~~~~~~~~~~~ 
 
cd /Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/ 
 
mkdir region_s300_D1000_F2_p10-3/ 
 
cd region_s300_D1000_F2_p10-3/ 
 
 findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-region -size 300 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s300_D1000_F2_
p10-3/HMGN5_Hpos1.1_r_s300_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
poisson threshold: 10 tags 
 
 144077 peaks passed threshold 
 
        Differential Peaks: 33356 of 144077 (23.15% passed) 
 
        Stitching together putative peaks into regions 
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        Checking regions against input... 
 
        Differential Peaks: 24122 of 24284 (99.33% passed) 
 
        Clonal filtering: 24109 of 24122 (99.95% passed) 
 
        Total Peaks identified = 24109 
 
 
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-region -size 300 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s300_D1000_F2_
p10-3/HMGN5_Hpos1.2_r_s300_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19 
 
 144077 peaks passed threshold 
 
        Differential Peaks: 41966 of 144077 (29.13% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 28935 of 29129 (99.33% passed) 
 
        Clonal filtering: 28909 of 28935 (99.91% passed) 
 
        Total Peaks identified = 28909 
 
 
cd 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s300_D1000_F2_
p10-3 
 
mergePeaks -prefix g HMGN5_Hpos1.1_r_s300_d1000_F2_p10-3.txt 
HMGN5_Hpos1.2_r_s300_d1000_F2_p10-3.txt; 
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        X       16716   HMGN5_Hpos1.2_r_s300_d1000_F2_p10-3.txt 
 
X               11901   HMGN5_Hpos1.1_r_s300_d1000_F2_p10-3.txt 
 
X       X       12172   HMGN5_Hpos1.1_r_s300_d1000_F2_p10-
3.txt|HMGN5_Hpos1.2_r_s300_d1000_F2_p10-3.txt 
 
 
 
 
mv  g_HMGN5_Hpos1.1_r_s300_d1000_F2_p10-
3.txt_HMGN5_Hpos1.2_r_s300_d1000_F2_p10-3.txt 
g_Hpos1_r_s300_d1000_F2_p10-3.txt; 
 
 
 findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-region -size 300 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s300_D1000_F2_
p10-3/HMGN5_Hpos2.1_r_s300_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
poisson threshold: 12 tags 
 
   171915 peaks passed threshold 
 
        Differential Peaks: 39618 of 171915 (23.05% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 26514 of 26747 (99.13% passed) 
 
        Clonal filtering: 26495 of 26514 (99.93% passed) 
 
        Total Peaks identified = 26495 
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findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-region -size 300 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s300_D1000_F2_
p10-3/HMGN5_Hpos2.2_r_s300_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19
; 
 
poisson threshold: 12 tags 
 
171915 peaks passed threshold 
 
        Differential Peaks: 49776 of 171915 (28.95% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 31630 of 31888 (99.19% passed) 
 
        Clonal filtering: 31613 of 31630 (99.95% passed) 
 
        Total Peaks identified = 31613 
 
 
 
 
 
cd 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s300_D1000_F2_
p10-3 
 
mergePeaks -prefix g HMGN5_Hpos2.1_r_s300_d1000_F2_p10-3.txt 
HMGN5_Hpos2.2_r_s300_d1000_F2_p10-3.txt; 
 
        X       18143   HMGN5_Hpos2.2_r_s300_d1000_F2_p10-3.txt 
 
X               12994   HMGN5_Hpos2.1_r_s300_d1000_F2_p10-3.txt 
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X       X       13437   HMGN5_Hpos2.1_r_s300_d1000_F2_p10-
3.txt|HMGN5_Hpos2.2_r_s300_d1000_F2_p10-3.txt 
 
 
mv  g_HMGN5_Hpos2.1_r_s300_d1000_F2_p10-
3.txt_HMGN5_Hpos2.2_r_s300_d1000_F2_p10-3.txt 
g_Hpos2_r_s300_d1000_F2_p10-3.txt; 
 
 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~~~~~ 
 
~~~~~~~~~~~~~~~~region_s350_D1000_F2_p10-3~~~~~~~~~~~~~~~~~~~ 
 
cd /Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/ 
 
mkdir region_s350_D1000_F2_p10-3/ 
 
cd region_s350_D1000_F2_p10-3/ 
 
 findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-region -size 350 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s350_D1000_F2_
p10-3/HMGN5_Hpos1.1_r_s350_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
poisson threshold: 11 tags 
 
132836 peaks passed threshold 
 
        Differential Peaks: 30345 of 132836 (22.84% passed) 
 
        Stitching together putative peaks into regions 
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        Checking regions against input... 
 
        Differential Peaks: 21516 of 21678 (99.25% passed) 
 
        Clonal filtering: 21512 of 21516 (99.98% passed) 
 
        Total Peaks identified = 21512 
 
 
 
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-region -size 350 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s350_D1000_F2_
p10-3/HMGN5_Hpos1.2_r_s350_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19 
 
poisson threshold: 11 tags 
 
 132836 peaks passed threshold 
 
        Differential Peaks: 38420 of 132836 (28.92% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 26076 of 26250 (99.34% passed) 
 
        Clonal filtering: 26067 of 26076 (99.97% passed) 
 
        Total Peaks identified = 26067 
 
 
cd 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s350_D1000_F2_
p10-3 
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mergePeaks -prefix g HMGN5_Hpos1.1_r_s350_d1000_F2_p10-3.txt 
HMGN5_Hpos1.2_r_s350_d1000_F2_p10-3.txt; 
 
HMGN5_Hpos1.1_r_s350_d1000_F2_p10-3.txt 
HMGN5_Hpos1.2_r_s350_d1000_F2_p10-3.txt Total   Name 
 
        X       14882   HMGN5_Hpos1.2_r_s350_d1000_F2_p10-3.txt 
 
X               10314   HMGN5_Hpos1.1_r_s350_d1000_F2_p10-3.txt 
 
X       X       11169   HMGN5_Hpos1.1_r_s350_d1000_F2_p10-
3.txt|HMGN5_Hpos1.2_r_s350_d1000_F2_p10-3.txt 
 
 
 
mv  g_HMGN5_Hpos1.1_r_s350_d1000_F2_p10-
3.txt_HMGN5_Hpos1.2_r_s350_d1000_F2_p10-3.txt 
g_Hpos1_r_s350_d1000_F2_p10-3.txt; 
 
 
 findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-region -size 350 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s350_D1000_F2_
p10-3/HMGN5_Hpos2.1_r_s350_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
poisson threshold: 13 tags 
 
 177111 peaks passed threshold 
 
        Differential Peaks: 39872 of 177111 (22.51% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 26387 of 26619 (99.13% passed) 
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        Clonal filtering: 26375 of 26387 (99.95% passed) 
 
        Total Peaks identified = 26375 
 
 
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-region -size 350 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s350_D1000_F2_
p10-3/HMGN5_Hpos2.2_r_s350_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19
; 
 
poisson threshold: 13 tags 
 
 177111 peaks passed threshold 
 
        Differential Peaks: 50816 of 177111 (28.69% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 31853 of 32133 (99.13% passed) 
 
        Clonal filtering: 31840 of 31853 (99.96% passed) 
 
        Total Peaks identified = 31840 
 
 
cd 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s350_D1000_F2_
p10-3 
 
mergePeaks -prefix g HMGN5_Hpos2.1_r_s350_d1000_F2_p10-3.txt 
HMGN5_Hpos2.2_r_s350_d1000_F2_p10-3.txt; 
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HMGN5_Hpos2.1_r_s350_d1000_F2_p10-3.txt 
HMGN5_Hpos2.2_r_s350_d1000_F2_p10-3.txt Total   Name 
 
        X       18268   HMGN5_Hpos2.2_r_s350_d1000_F2_p10-3.txt 
 
X               12768   HMGN5_Hpos2.1_r_s350_d1000_F2_p10-3.txt 
 
X       X       13539   HMGN5_Hpos2.1_r_s350_d1000_F2_p10-
3.txt|HMGN5_Hpos2.2_r_s350_d1000_F2_p10-3.txt 
 
 
mv  g_HMGN5_Hpos2.1_r_s350_d1000_F2_p10-
3.txt_HMGN5_Hpos2.2_r_s350_d1000_F2_p10-3.txt 
g_Hpos2_r_s350_d1000_F2_p10-3.txt; 
 
 
~~~~~~~~~~~~~~~~region_s400_D1000_F2_p10-3~~~~~~~~~~~~~~~~~~~ 
 
cd /Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/ 
 
mkdir region_s400_D1000_F2_p10-3/ 
 
cd region_s400_D1000_F2_p10-3/ 
 
 findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-region -size 400 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s400_D1000_F2_
p10-3/HMGN5_Hpos1.1_r_s400_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
poisson threshold: 12 tags 
 
 122151 peaks passed threshold 
 
        Differential Peaks: 27892 of 122151 (22.83% passed) 
 
        Stitching together putative peaks into regions 
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        Checking regions against input... 
 
        Differential Peaks: 19396 of 19511 (99.41% passed) 
 
        Clonal filtering: 19393 of 19396 (99.98% passed) 
 
        Total Peaks identified = 19393 
 
 
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-region -size 400 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s400_D1000_F2_
p10-3/HMGN5_Hpos1.2_r_s400_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19 
 
 122151 peaks passed threshold 
 
        Differential Peaks: 35611 of 122151 (29.15% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 23742 of 23903 (99.33% passed) 
 
        Clonal filtering: 23738 of 23742 (99.98% passed) 
 
        Total Peaks identified = 23738 
 
 
cd 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s400_D1000_F2_
p10-3 
 
mergePeaks -prefix g HMGN5_Hpos1.1_r_s400_d1000_F2_p10-3.txt 
HMGN5_Hpos1.2_r_s400_d1000_F2_p10-3.txt; 
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        X       13252   HMGN5_Hpos1.2_r_s400_d1000_F2_p10-3.txt 
 
X               8896    HMGN5_Hpos1.1_r_s400_d1000_F2_p10-3.txt 
 
X       X       10468   HMGN5_Hpos1.1_r_s400_d1000_F2_p10-
3.txt|HMGN5_Hpos1.2_r_s400_d1000_F2_p10-3.txt 
 
 
 
mv  g_HMGN5_Hpos1.1_r_s400_d1000_F2_p10-
3.txt_HMGN5_Hpos1.2_r_s400_d1000_F2_p10-3.txt 
g_Hpos1_r_s400_d1000_F2_p10-3.txt; 
 
 
 findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-region -size 400 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s400_D1000_F2_
p10-3/HMGN5_Hpos2.1_r_s400_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
poisson threshold: 14 tags 
 
 177677 peaks passed threshold 
 
        Differential Peaks: 39333 of 177677 (22.14% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 25829 of 26044 (99.17% passed) 
 
        Clonal filtering: 25826 of 25829 (99.99% passed) 
 
        Total Peaks identified = 25826 
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findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-region -size 400 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s400_D1000_F2_
p10-3/HMGN5_Hpos2.2_r_s400_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19
; 
 
poisson threshold: 14 tags 
 
 177677 peaks passed threshold 
 
        Differential Peaks: 50297 of 177677 (28.31% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 31359 of 31627 (99.15% passed) 
 
        Clonal filtering: 31352 of 31359 (99.98% passed) 
 
        Total Peaks identified = 31352 
 
cd 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s400_D1000_F2_
p10-3 
 
mergePeaks -prefix g HMGN5_Hpos2.1_r_s400_d1000_F2_p10-3.txt 
HMGN5_Hpos2.2_r_s400_d1000_F2_p10-3.txt; 
 
        X       17986   HMGN5_Hpos2.2_r_s400_d1000_F2_p10-3.txt 
 
X               12435   HMGN5_Hpos2.1_r_s400_d1000_F2_p10-3.txt 
 
X       X       13324   HMGN5_Hpos2.1_r_s400_d1000_F2_p10-
3.txt|HMGN5_Hpos2.2_r_s400_d1000_F2_p10-3.txt 
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mv  g_HMGN5_Hpos2.1_r_s400_d1000_F2_p10-
3.txt_HMGN5_Hpos2.2_r_s400_d1000_F2_p10-3.txt 
g_Hpos2_r_s400_d1000_F2_p10-3.txt; 
 
 
~~~~~~~~~~~~~~~~region_s450_D1000_F2_p10-3~~~~~~~~~~~~~~~~~~~ 
 
cd /Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/ 
 
mkdir region_s450_D1000_F2_p10-3/ 
 
cd region_s450_D1000_F2_p10-3/ 
 
 findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-region -size 450 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s450_D1000_F2_
p10-3/HMGN5_Hpos1.1_r_s450_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
poisson threshold: 13 tags 
 
112573 peaks passed threshold 
 
        Differential Peaks: 26462 of 112573 (23.51% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 18123 of 18266 (99.22% passed) 
 
        Clonal filtering: 18123 of 18123 (100.00% passed) 
 
        Total Peaks identified = 18123 
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findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-region -size 450 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s450_D1000_F2_
p10-3/HMGN5_Hpos1.2_r_s450_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19 
 
 112573 peaks passed threshold 
 
        Differential Peaks: 33506 of 112573 (29.76% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 21931 of 22113 (99.18% passed) 
 
        Clonal filtering: 21930 of 21931 (100.00% passed) 
 
        Total Peaks identified = 21930 
 
 
cd 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s450_D1000_F2_
p10-3 
 
mergePeaks -prefix g HMGN5_Hpos1.1_r_s450_d1000_F2_p10-3.txt 
HMGN5_Hpos1.2_r_s450_d1000_F2_p10-3.txt; 
 
HMGN5_Hpos1.1_r_s450_d1000_F2_p10-3.txt 
HMGN5_Hpos1.2_r_s450_d1000_F2_p10-3.txtTotal    Name 
 
        X       11983   HMGN5_Hpos1.2_r_s450_d1000_F2_p10-3.txt 
 
X               8160    HMGN5_Hpos1.1_r_s450_d1000_F2_p10-3.txt 
 
X       X       9918    HMGN5_Hpos1.1_r_s450_d1000_F2_p10-
3.txt|HMGN5_Hpos1.2_r_s450_d1000_F2_p10-3.txt 
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mv  g_HMGN5_Hpos1.1_r_s450_d1000_F2_p10-
3.txt_HMGN5_Hpos1.2_r_s450_d1000_F2_p10-3.txt 
g_Hpos1_r_s450_d1000_F2_p10-3.txt; 
 
 
 findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-region -size 450 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s450_D1000_F2_
p10-3/HMGN5_Hpos2.1_r_s450_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
poisson threshold: 15 tags 
 
 176694 peaks passed threshold 
 
        Differential Peaks: 38686 of 176694 (21.89% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 24927 of 25162 (99.07% passed) 
 
        Clonal filtering: 24926 of 24927 (100.00% passed) 
 
        Total Peaks identified = 24926 
 
 
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-region -size 450 -minDist 1000 -F 2 -poisson 0.001 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s450_D1000_F2_
p10-3/HMGN5_Hpos2.2_r_s450_d1000_F2_p10-3.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19
; 
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poisson threshold: 15 tags 
 
 176694 peaks passed threshold 
 
        Differential Peaks: 50013 of 176694 (28.30% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 30812 of 31089 (99.11% passed) 
 
        Clonal filtering: 30810 of 30812 (99.99% passed) 
 
        Total Peaks identified = 30810 
 
cd 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s450_D1000_F2_
p10-3 
 
mergePeaks -prefix g HMGN5_Hpos2.1_r_s450_d1000_F2_p10-3.txt 
HMGN5_Hpos2.2_r_s450_d1000_F2_p10-3.txt; 
 
        X       17626   HMGN5_Hpos2.2_r_s450_d1000_F2_p10-3.txt 
 
X               11708   HMGN5_Hpos2.1_r_s450_d1000_F2_p10-3.txt 
 
X       X       13137   HMGN5_Hpos2.1_r_s450_d1000_F2_p10-
3.txt|HMGN5_Hpos2.2_r_s450_d1000_F2_p10-3.txt 
 
 
mv  g_HMGN5_Hpos2.1_r_s450_d1000_F2_p10-
3.txt_HMGN5_Hpos2.2_r_s450_d1000_F2_p10-3.txt 
g_Hpos2_r_s450_d1000_F2_p10-3.txt; 
 
 
~~~~~~~~~~~~~histone_F2~~~~~~~~~~~~~~~~~~~~ 
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cd /Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles 
 
mkdir histone_F2; 
 
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-style histone -F 2 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/histone_F2/HMGN5_Hpos
1.1_histone.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
155015 peaks passed threshold 
 
        Differential Peaks: 31879 of 155015 (20.57% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 21954 of 22143 (99.15% passed) 
 
        Clonal filtering: 21953 of 21954 (100.00% passed) 
 
        Total Peaks identified = 21953 
 
 
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
-style histone -F 2 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/histone_F2/HMGN5_Hpos
1.2_histone.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19
; 
 
 155015 peaks passed threshold 
 
        Differential Peaks: 40805 of 155015 (26.32% passed) 
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        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 26979 of 27178 (99.27% passed) 
 
        Clonal filtering: 26978 of 26979 (100.00% passed) 
 
        Total Peaks identified = 26978 
 
 
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-style histone -F 2 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/histone_F2/HMGN5_Hpos
2.1_histone.txt -i 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19
; 
 
 173466 peaks passed threshold 
 
        Differential Peaks: 37499 of 173466 (21.62% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 23990 of 24218 (99.06% passed) 
 
        Clonal filtering: 23988 of 23990 (99.99% passed) 
 
        Total Peaks identified = 23988 
 
 
findPeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-style histone -F 2 -o 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/histone_F2/HMGN5_Hpos
2.2_histone.txt -i 
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/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19
; 
 
 173466 peaks passed threshold 
 
        Differential Peaks: 48611 of 173466 (28.02% passed) 
 
        Stitching together putative peaks into regions 
 
        Checking regions against input... 
 
        Differential Peaks: 29697 of 30008 (98.96% passed) 
 
        Clonal filtering: 29695 of 29697 (99.99% passed) 
 
        Total Peaks identified = 29695 
 
 
## finding common peaks (default: -d given (from v4.4)) 
 
 
cd /Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/histone_F2 
 
mergePeaks -prefix 0309 HMGN5_Hpos1.1_histone.txt 
HMGN5_Hpos1.2_histone.txt; 
 
HMGN5_Hpos1.1_histone.txt       HMGN5_Hpos1.2_histone.txt       
Total   Name 
 
X       15523   HMGN5_Hpos1.2_histone.txt 
 
X               10483   HMGN5_Hpos1.1_histone.txt 
 
X       X       11431   
HMGN5_Hpos1.1_histone.txt|HMGN5_Hpos1.2_histone.txt 
 
mv 0309_HMGN5_Hpos1.1_histone.txt_HMGN5_Hpos1.2_histone.txt 
0309_Hpos1_histone.txt; 
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mergePeaks -prefix 0309 HMGN5_Hpos2.1_histone.txt 
HMGN5_Hpos2.2_histone.txt 
 
HMGN5_Hpos2.1_histone.txt       HMGN5_Hpos2.2_histone.txt       
Total   Name 
 
X       16982   HMGN5_Hpos2.2_histone.txt 
 
X               11248   HMGN5_Hpos2.1_histone.txt 
 
X       X       12658   
HMGN5_Hpos2.1_histone.txt|HMGN5_Hpos2.2_histone.txt 
 
 
mv 0309_HMGN5_Hpos2.1_histone.txt_HMGN5_Hpos2.2_histone.txt 
0309_Hpos2_histone.txt; 
 
mergePeaks -prefix given 0309_Hpos1_histone.txt 
0309_Hpos2_histone.txt 
 
0309_Hpos1_histone.txt  0309_Hpos2_histone.txt  Total   Name 
 
        X       9892    0309_Hpos2_histone.txt 
 
X               8651    0309_Hpos1_histone.txt 
 
X       X       2754    
0309_Hpos1_histone.txt|0309_Hpos2_histone.txt 
 
 
 
mergePeaks -prefix 1000 -d 1000 0309_Hpos1_histone.txt 
0309_Hpos2_histone.txt > Hpos_histone_1000.txt; 
 
0309_Hpos1_histone.txt  0309_Hpos2_histone.txt  Total   Name 
 
        X       9872    0309_Hpos2_histone.txt 
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X               8640    0309_Hpos1_histone.txt 
 
X       X       2781    
0309_Hpos1_histone.txt|0309_Hpos2_histone.txt 
 
 
 
--------------merging------------ 
 
 
cd /Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/ 
 
mkdir merge2 
 
cd merge2 
 
#Hpos1 
 
mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/histone_F2/0309_Hpos1
_histone.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s450_D1000_F2_
p10-3/g_Hpos1_r_s450_d1000_F2_p10-3.txt > 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450.txt 
 
        X       2107    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s450_D1000_F2_
p10-3/g_Hpos1_r_s450_d1000_F2_p10-3.txt 
 
X               3630    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/histone_F2/0309_Hpos1
_histone.txt 
 
X       X       7792    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/histone_F2/0309_Hpos1
_histone.txt|/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s
450_D1000_F2_p10-3/g_Hpos1_r_s450_d1000_F2_p10-3.txt 
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mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s400_D1000_F2_
p10-3/g_Hpos1_r_s400_d1000_F2_p10-3.txt > 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450_s400.txt; 
 
        X       2062    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s400_D1000_F2_
p10-3/g_Hpos1_r_s400_d1000_F2_p10-3.txt 
 
X               5153    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450.txt 
 
X       X       8370    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450.txt|/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s400_
D1000_F2_p10-3/g_Hpos1_r_s400_d1000_F2_p10-3.txt 
 
rm 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450.txt; 
 
 
mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450_s400.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s350_D1000_F2_
p10-3/g_Hpos1_r_s350_d1000_F2_p10-3.txt 
>/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone
_s450_s400_s350.txt 
 
        X       2203    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s350_D1000_F2_
p10-3/g_Hpos1_r_s350_d1000_F2_p10-3.txt 
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X               6642    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge/Hpos1_histone_s
450_s400.txt 
 
X       X       8933    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge/Hpos1_histone_s
450_s400.txt|/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s
350_D1000_F2_p10-3/g_Hpos1_r_s350_d1000_F2_p10-3.txt 
 
rm 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450_s400.txt; 
 
mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450_s400_s350.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s300_D1000_F2_
p10-3/g_Hpos1_r_s300_d1000_F2_p10-3.txt 
>/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone
_s450_s400_s350_s300.txt 
 
        X       2653    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s300_D1000_F2_
p10-3/g_Hpos1_r_s300_d1000_F2_p10-3.txt 
 
X               8278    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge/Hpos1_histone_s
450_s400_s350.txt 
 
X       X       9489    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge/Hpos1_histone_s
450_s400_s350.txt|/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/reg
ion_s300_D1000_F2_p10-3/g_Hpos1_r_s300_d1000_F2_p10-3.txt 
 
rm 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450_s400_s350.txt; 
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mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450_s400_s350_s300.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s250_D1000_F2_
p10-3/g_Hpos1_r_s250_d1000_F2_p10-3.txt 
>/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone
_s450_s400_s350_s300_s250.txt 
 
        X       3517    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s250_D1000_F2_
p10-3/g_Hpos1_r_s250_d1000_F2_p10-3.txt 
 
X               10044   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge/Hpos1_histone_s
450_s400_s350_s300.txt 
 
X       X       10363   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge/Hpos1_histone_s
450_s400_s350_s300.txt|/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFile
s/region_s250_D1000_F2_p10-3/g_Hpos1_r_s250_d1000_F2_p10-3.txt 
 
rm 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450_s400_s350_s300.txt; 
 
mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450_s400_s350_s300_s250.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_sauto_D1000_F2
_p10-3/g_Hpos1_r_sauto_d1000_F2_p10-3.txt 
>/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone
_s450_s400_s350_s300_s250_sauto.txt 
 
        X       4266    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_sauto_D1000_F2
_p10-3/g_Hpos1_r_sauto_d1000_F2_p10-3.txt 
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X               12705   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge/Hpos1_histone_s
450_s400_s350_s300_s250.txt 
 
X       X       11206   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge/Hpos1_histone_s
450_s400_s350_s300_s250.txt|/Users/admin/NGSanalysis_JuliaW/ChIP/Pea
kFiles/region_sauto_D1000_F2_p10-3/g_Hpos1_r_sauto_d1000_F2_p10-
3.txt 
 
 
rm 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450_s400_s350_s300_s250.txt; 
 
#Hpos2 
 
mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/histone_F2/0309_Hpos2
_histone.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s450_D1000_F2_
p10-3/g_Hpos2_r_s450_d1000_F2_p10-3.txt > 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450.txt 
 
        X       3494    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s450_D1000_F2_
p10-3/g_Hpos2_r_s450_d1000_F2_p10-3.txt 
 
X               3017    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/histone_F2/0309_Hpos2
_histone.txt 
 
X       X       9612    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/histone_F2/0309_Hpos2
_histone.txt|/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s
450_D1000_F2_p10-3/g_Hpos2_r_s450_d1000_F2_p10-3.txt 
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mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s400_D1000_F2_
p10-3/g_Hpos2_r_s400_d1000_F2_p10-3.txt > 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400.txt; 
 
        X       2638    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s400_D1000_F2_
p10-3/g_Hpos2_r_s400_d1000_F2_p10-3.txt 
 
X               5470    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450.txt 
 
X       X       10646   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450.txt|/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s400_
D1000_F2_p10-3/g_Hpos2_r_s400_d1000_F2_p10-3.txt 
 
rm 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450.txt; 
 
 
mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s350_D1000_F2_
p10-3/g_Hpos2_r_s350_d1000_F2_p10-3.txt 
>/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone
_s450_s400_s350.txt 
 
        X       2503    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s350_D1000_F2_
p10-3/g_Hpos2_r_s350_d1000_F2_p10-3.txt 
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X               7745    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400.txt 
 
X       X       10993   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400.txt|/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_
s350_D1000_F2_p10-3/g_Hpos2_r_s350_d1000_F2_p10-3.txt 
 
rm 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400.txt; 
 
 
mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s300_D1000_F2_
p10-3/g_Hpos2_r_s300_d1000_F2_p10-3.txt 
>/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone
_s450_s400_s350_s300.txt 
 
        X       2390    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s300_D1000_F2_
p10-3/g_Hpos2_r_s300_d1000_F2_p10-3.txt 
 
X               10234   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350.txt 
 
X       X       10990   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350.txt|/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/re
gion_s300_D1000_F2_p10-3/g_Hpos2_r_s300_d1000_F2_p10-3.txt 
 
rm 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350.txt; 
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mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350_s300.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s250_D1000_F2_
p10-3/g_Hpos2_r_s250_d1000_F2_p10-3.txt 
>/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone
_s450_s400_s350_s300_s250.txt 
 
        X       4626    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_s250_D1000_F2_
p10-3/g_Hpos2_r_s250_d1000_F2_p10-3.txt 
 
X               11416   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350_s300.txt 
 
X       X       12185   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350_s300.txt|/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFil
es/region_s250_D1000_F2_p10-3/g_Hpos2_r_s250_d1000_F2_p10-3.txt 
 
rm 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350_s300.txt; 
 
 
mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350_s300_s250.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_sauto_D1000_F2
_p10-3/g_Hpos2_r_sauto_d1000_F2_p10-3.txt 
>/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone
_s450_s400_s350_s300_s250_sauto.txt 
 
        X       4933    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/region_sauto_D1000_F2
_p10-3/g_Hpos2_r_sauto_d1000_F2_p10-3.txt 
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X               14762   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350_s300_s250.txt 
 
X       X       13443   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350_s300_s250.txt|/Users/admin/NGSanalysis_JuliaW/ChIP/Pe
akFiles/region_sauto_D1000_F2_p10-3/g_Hpos2_r_sauto_d1000_F2_p10-
3.txt 
 
rm 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350_s300_s250.txt; 
 
 
#Strategy1_merge2 (combination of both peak files) 
 
mergePeaks 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450_s400_s350_s300_s250_sauto.txt 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350_s300_s250_sauto.txt > 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/strategy1_merg
e2.txt 
 
 X       26803   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos2_histone_
s450_s400_s350_s300_s250_sauto.txt 
 
X               21806   
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450_s400_s350_s300_s250_sauto.txt 
 
X       X       6277    
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/Hpos1_histone_
s450_s400_s350_s300_s250_sauto.txt|/Users/admin/NGSanalysis_JuliaW/C
hIP/PeakFiles/merge2/Hpos2_histone_s450_s400_s350_s300_s250_sauto.tx
t 
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>>54886 peaks in total 
 
 
#strategy2_merge2 (only overlapping peaks) 
 
cd /Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/ 
 
mergePeaks -prefix g 
Hpos1_histone_s450_s400_s350_s300_s250_sauto.txt 
Hpos2_histone_s450_s400_s350_s300_s250_sauto.txt  
 
 X       26803   Hpos2_histone_s450_s400_s350_s300_s250_sauto.txt 
 
X               21806   
Hpos1_histone_s450_s400_s350_s300_s250_sauto.txt 
 
X       X       6277    
Hpos1_histone_s450_s400_s350_s300_s250_sauto.txt|Hpos2_histone_s450_
s400_s350_s300_s250_sauto.txt 
 
 
 
mv 
g_Hpos1_histone_s450_s400_s350_s300_s250_sauto.txt_Hpos2_histone_s45
0_s400_s350_s300_s250_sauto.txt strategy2_merge2.txt 
#Annotation 
 
cd /Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/ 
 
annotatePeaks.pl strategy1_merge2.txt hg19 -d 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Gneg1_trimmed_hg19 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Gneg2_trimmed_hg19 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Gpos1_trimmed_hg19 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-go 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/strategy1_merg
Appendix 
263 
e2_GeneOnt -genomeOntology 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/strategy1_merg
e2_GenomeOnt -gene /Users/admin/NGSanalysis_JuliaW/ChIP/GE_info.txt 
> strategy1_merge2.ann.txt 
 
 
 
genomic position Annotation      Number of peaks Total size (bp) Log2 
Enrichment 
 
                3UTR    589.0   21944102        0.598 
                miRNA   1.0     48690   0.211 
                ncRNA   239.0   5148687 1.388 
                TTS     962.0   28108010        0.948 
                pseudo  35.0    1865590 0.081 
                Exon    1414.0  34376480        1.213 
                Intron  24531.0 1194960999      0.211 
                Intergenic      21419.0 1773347320      -0.554 
                Promoter        5223.0  31343091        3.232 
                5UTR    465.0   2505007 3.387 
                snoRNA  0.0     119     -15.744 
                snRNA   0.0     105     -15.744 
                rRNA    0.0     10999   -15.744 
 
genomic features Annotation      Number of peaks Total size (bp) Log2 
Enrichment 
 
                3UTR    589.0   21944102        0.599 
                Other   3.0     3962446 -4.549 
                Unknown?        0.0     18108   -15.744 
                RNA     5.0     115354  1.290 
                miRNA   1.0     48690   0.213 
                ncRNA   239.0   5148687 1.389 
                TTS     962.0   28108010        0.949 
                LINE    4850.0  625086598       -1.192 
                LINE?   1.0     10448   2.433 
                srpRNA  2.0     255222  -1.177 
                SINE    6742.0  381200056       -0.003 
                RC      4.0     443678  -0.975 
Appendix 
264 
                tRNA    10.0    93275   2.597 
                DNA?    4.0     265124  -0.232 
                pseudo  35.0    1865590 0.082 
                DNA     1064.0  96207793        -0.680 
 
                Exon    1414.0  34376480        1.215 
                Intron  14818.0 634436369       0.398 
                Intergenic      11650.0 904233348       -0.460 
                Promoter        5221.0  31343091        3.232 
                5UTR    463.0   2505007 3.383 
                snoRNA  0.0     119     -15.744 
                LTR?    1.0     21177   1.414 
                scRNA   2.0     116995  -0.052 
                CpG-Island      1349.0  9368574 3.022 
                Low_complexity  152.0   15514766        -0.855 
                LTR     4863.0  260567553       0.075 
                Simple_repeat   377.0   24952436        -0.230 
                snRNA   4.0     323087  -0.518 
                Unknown 21.0    1252703 -0.080 
                SINE?   1.0     43187   0.386 
                Satellite       38.0    12902670        -2.589 
                rRNA    1.0     182734  -1.695 
 
 
annotatePeaks.pl strategy2_merge2.txt hg19 -d 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Gneg1_trimmed_hg19 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Gneg2_trimmed_hg19 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Gpos1_trimmed_hg19 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg1_trimmed_hg19 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hneg2_trimmed_hg19 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos1_trimmed_hg19 
/Users/admin/NGSanalysis_JuliaW/ChIP/TagDir/HMGN5_Hpos2_trimmed_hg19 
-go 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/strategy2_merg
e2_GeneOnt -genomeOntology 
/Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/strategy2_merg
e2_GenomeOnt -gene /Users/admin/NGSanalysis_JuliaW/ChIP/GE_info.txt 
> strategy2_merge2.ann.txt 
 
Appendix 
265 
 
 
genomic position Annotation      Number of peaks Total size (bp) Log2 
Enrichment 
 
                3UTR    60.0    21896602        0.406 
                miRNA   0.0     48690   -12.616 
                ncRNA   38.0    5106375 1.847 
                TTS     138.0   27943868        1.255 
                pseudo  8.0     1831063 1.079 
                Exon    248.0   34274169        1.806 
                Intron  2174.0  1190135564      -0.179 
                Intergenic      1620.0  1718905554      -1.134 
                Promoter        1791.0  31179196        4.795 
                5UTR    199.0   2495214 5.269 
                snoRNA  0.0     119     -12.616 
                snRNA   0.0     105     -12.616 
                rRNA    0.0     10999   -12.616 
 
genomic features Annotation      Number of peaks Total size (bp) Log2 
Enrichment 
 
                3UTR    60.0    21896602        0.406 
                Other   1.0     3945746 -3.028 
                Unknown?        0.0     17982   -12.616 
                RNA     1.0     115110  2.071 
                miRNA   0.0     48690   -12.616 
                ncRNA   38.0    5106375 1.848 
                TTS     138.0   27943868        1.256 
                LINE    219.0   618432922       -2.545 
                LINE?   0.0     10448   -12.616 
                srpRNA  1.0     254103  0.929 
                SINE    314.0   378546582       -1.317 
                RC      0.0     439839  -12.616 
                tRNA    4.0     92339   4.389 
                DNA?    1.0     264912  0.869 
                pseudo  8.0     1831063 1.080 
                DNA     61.0    95742637        -1.698 
                Exon    248.0   34274169        1.807 
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                Intron  1412.0  632193295       0.112 
                Intergenic      1055.0  863261291       -0.758 
                Promoter        1791.0  31179196        4.796 
                5UTR    197.0   2495214 5.255 
                snoRNA  0.0     119     -12.616 
                LTR?    0.0     21177   -12.616 
                scRNA   0.0     116686  -12.616 
                CpG-Island      468.0   9275326 4.609 
                Low_complexity  28.0    15301963        -0.176 
                LTR     194.0   256011178       -1.448 
                Simple_repeat   35.0    24458261        -0.531 
                snRNA   1.0     320159  0.595 
                Unknown 1.0     1249709 -1.369 
                SINE?   0.0     42649   -12.616 
                Satellite       1.0     11207736        -4.534 
                rRNA    0.0     179404  -12.616 
 
 
cd /Users/admin/NGSanalysis_JuliaW/ChIP/PeakFiles/merge2/ 
 
cp strategy1_merge2.txt /Users/admin/Dropbox/JuliaW_Laengst/ 
 
cp strategy2_merge2.txt /Users/admin/Dropbox/JuliaW_Laengst/ 
 
> create bed files for UCSC 
 
cp strategy1_merge2.ann.txt /Users/admin/Dropbox/JuliaW_Laengst/ 
 
cp strategy2_merge2.ann.txt /Users/admin/Dropbox/JuliaW_Laengst/ 
 
cp strategy1_merge2_GeneOnt/geneOntology.html 
/Users/admin/Dropbox/JuliaW_Laengst/strategy1_merge2_GeneOntology.ht
ml 
cp strategy2_merge2_GeneOnt/geneOntology.html 
/Users/admin/Dropbox/JuliaW_Laengst/strategy2_merge2_GeneOntology.ht
ml 
cp strategy1_merge2_GenomeOnt/GenomeOntology.html 
/Users/admin/Dropbox/JuliaW_Laengst/strategy1_merge2_GenomeOntology.
html 
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cp strategy2_merge2_GenomeOnt/GenomeOntology.html 
/Users/admin/Dropbox/JuliaW_Laengst/strategy2_merge2_GenomeOntology.
html 
 
####motif analysis with strat2_merge2 peak file (annotated) 
 
cd /Volumes/Storage2/HMGN5_0817/ 
 
mkdir ChIP_oldAnalysis 
 
cd C:\Users\JuliaWimmer\Dropbox\Share 
 
pscp.exe 
C:\Users\JuliaWimmer\Dropbox\Collaborations\L‰ngst\HMGN5\ChIP-
seq\strategy2_merge2.ann.txt admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/ChIP_oldAnalysis/strategy
2_merge2.ann.txt  
 
#Run 'findMotifsGenome.pl' on hg19 genome, assume 1000bp size (peaks 
of varying size (200/250/300/350/400/450/500bp) were stitched into 
regions if closer than 1000bp - alignemnt viz showed broad regions 
of enrichment with several peaks within this region) 
 
findMotifsGenome.pl 
/Volumes/Storage2/HMGN5_0817/ChIP_oldAnalysis/strategy2_merge2.ann.t
xt hg19 /Volumes/Storage2/HMGN5_0817/ChIP_oldAnalysis/motifs_s1000 -
size 1000 -p 20 
 
#also test '-size 200' (smallest peak finding size) and compare 
 
findMotifsGenome.pl 
/Volumes/Storage2/HMGN5_0817/ChIP_oldAnalysis/strategy2_merge2.ann.t
xt hg19 /Volumes/Storage2/HMGN5_0817/ChIP_oldAnalysis/motifs_s200 -
size 200 -p 20 
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9.3.2 CLIP-seq analysis command lines. 
 
A detailed description of the command lines used for CLIP-seq analysis and output is 
indicated in the following script. Brief descriptions of the command lines are indicated 
after “##”. Output and explanation of usage are described after”#”. 
 
 
##Detailed analysis bowtie, homer 
 
wget --no-check-certificate  
https://sourceforge.net/projects/bowtie-
bio/files/bowtie/1.2.1.1/bowtie-1.2.1.1-macos-x86_64.zip 
wget --no-check-certificate 
ftp://ftp.ccb.jhu.edu/pub/data/bowtie_indexes/GRCh38_no_alt.zip 
 
/Volumes/Storage2/HTS_software/bowtie-1.2.1.1/bowtie 
 
-best -chunkmbs 512 -n 1 -S -M 100.  
mkdir /Volumes/Storage2/HMGN5_0817/CLIP/bowtie 
mkdir /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-1 
mkdir /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-2 
mkdir /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-3 
mkdir /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-1 
mkdir /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-2 
mkdir /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-3 
 
mv /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
1/GCA_000001405.15_GRCh38_no_alt_analysis_set.1.ebwt 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/ 
mv /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
1/GCA_000001405.15_GRCh38_no_alt_analysis_set.2.ebwt 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/ 
mv /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
1/GCA_000001405.15_GRCh38_no_alt_analysis_set.3.ebwt 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/ 
mv /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
1/GCA_000001405.15_GRCh38_no_alt_analysis_set.4.ebwt 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/ 
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mv /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
1/GCA_000001405.15_GRCh38_no_alt_analysis_set.rev.1.ebwt 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/ 
mv /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
1/GCA_000001405.15_GRCh38_no_alt_analysis_set.rev.2.ebwt 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/ 
cd /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/ 
/Volumes/Storage2/HTS_software/bowtie-1.2.1.1/bowtie --best --
chunkmbs 512 -n 1 -S -M 100 -p 8 
GCA_000001405.15_GRCh38_no_alt_analysis_set 
/Volumes/Storage2/HMGN5_0817/CLIP/rawdata_Project_S145/Sample_GFP1/G
FP1_GCACTA_L002_R1_001.fastq.gz 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-1.bowtie.sam 
 
# reads processed: 26530237 
# reads with at least one reported alignment: 16153689 (60.89%) 
# reads that failed to align: 5411828 (20.40%) 
# reads with alignments sampled due to -M: 4964720 (18.71%) 
#Reported 16153689 alignments to 1 output stream(s) 
 
/Volumes/Storage2/HTS_software/bowtie-1.2.1.1/bowtie --best --
chunkmbs 512 -n 1 -S -M 100 -p 8 
GCA_000001405.15_GRCh38_no_alt_analysis_set 
/Volumes/Storage2/HMGN5_0817/CLIP/rawdata_Project_S145/Sample_GFP2/G
FP2_ACCTCA_L002_R1_001.fastq.gz 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-2.bowtie.sam 
/Volumes/Storage2/HTS_software/bowtie-1.2.1.1/bowtie --best --
chunkmbs 512 -n 1 -S -M 100 -p 8 
GCA_000001405.15_GRCh38_no_alt_analysis_set 
/Volumes/Storage2/HMGN5_0817/CLIP/rawdata_Project_S145/Sample_GFP3/G
FP3_GTGCTT_L002_R1_001.fastq.gz 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-3.bowtie.sam 
/Volumes/Storage2/HTS_software/bowtie-1.2.1.1/bowtie --best --
chunkmbs 512 -n 1 -S -M 100 -p 8 
GCA_000001405.15_GRCh38_no_alt_analysis_set 
/Volumes/Storage2/HMGN5_0817/CLIP/rawdata_Project_S145/Sample_HMGN51
/HMGN51_AACCAG_L002_R1_001.fastq.gz 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-1.bowtie.sam 
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/Volumes/Storage2/HTS_software/bowtie-1.2.1.1/bowtie --best --
chunkmbs 512 -n 1 -S -M 100 -p 8 
GCA_000001405.15_GRCh38_no_alt_analysis_set 
/Volumes/Storage2/HMGN5_0817/CLIP/rawdata_Project_S145/Sample_HMGN52
/HMGN52_TGGTGA_L002_R1_001.fastq.gz 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-2.bowtie.sam 
 
# reads processed: 33310255 
# reads with at least one reported alignment: 16298962 (48.93%) 
# reads that failed to align: 4750503 (14.26%) 
# reads with alignments sampled due to -M: 12260790 (36.81%) 
#Reported 16298962 alignments to 1 output stream(s) 
 
/Volumes/Storage2/HTS_software/bowtie-1.2.1.1/bowtie --best --
chunkmbs 512 -n 1 -S -M 100 -p 8 
GCA_000001405.15_GRCh38_no_alt_analysis_set 
/Volumes/Storage2/HMGN5_0817/CLIP/rawdata_Project_S145/Sample_HMGN53
/HMGN53_AGTGAG_L002_R1_001.fastq.gz 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-3.bowtie.sam 
 
# reads processed: 24727981 
# reads with at least one reported alignment: 16265546 (65.78%) 
# reads that failed to align: 3232836 (13.07%) 
# reads with alignments sampled due to -M: 5229599 (21.15%) 
#Reported 16265546 alignments to 1 output stream(s) 
 
 
##Uniquely mapped reads 
 
samtools flagstat /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
1.bowtie.sam 
#21118409 + 0 mapped (79.60%) 
samtools flagstat /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
2.bowtie.sam 
#16050306 + 0 mapped (68.95%) 
samtools flagstat /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
3.bowtie.sam 
#18191290 + 0 mapped (77.13%) 
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samtools flagstat /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
1.bowtie.sam 
#17519792 + 0 mapped (84.70%) 
samtools flagstat /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
2.bowtie.sam 
#28559752 + 0 mapped (85.74%) 
samtools flagstat /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
3.bowtie.sam 
#21495145 + 0 mapped (86.93%) 
 
 
##Converting to bam format & indexing for IGV visualization 
 
wget --no-check-certificate 
ftp://ftp.sanger.ac.uk/pub/gencode/Gencode_human/release_26/gencode.
v26.primary_assembly.annotation.gtf.gz 
cd /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/ 
samtools view -bh -o GFP-1.bowtie.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-1.bowtie.sam 
samtools view -bh -o GFP-2.bowtie.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-2.bowtie.sam 
samtools view -bh -o GFP-3.bowtie.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-3.bowtie.sam 
samtools view -bh -o HMGN5-1.bowtie.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-1.bowtie.sam 
samtools view -bh -o HMGN5-2.bowtie.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-2.bowtie.sam 
samtools view -bh -o HMGN5-3.bowtie.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-3.bowtie.sam 
samtools sort -o GFP-1.bowtie.sorted.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-1.bowtie.bam 
samtools sort -o GFP-2.bowtie.sorted.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-2.bowtie.bam 
samtools sort -o GFP-3.bowtie.sorted.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-3.bowtie.bam 
samtools sort -o HMGN5-1.bowtie.sorted.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-1.bowtie.bam 
samtools sort -o HMGN5-2.bowtie.sorted.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-2.bowtie.bam 
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samtools sort -o HMGN5-3.bowtie.sorted.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-3.bowtie.bam 
samtools index GFP-1.bowtie.sorted.bam 
 
samtools index GFP-2.bowtie.sorted.bam 
samtools index GFP-3.bowtie.sorted.bam 
samtools index HMGN5-1.bowtie.sorted.bam 
samtools index HMGN5-2.bowtie.sorted.bam 
samtools index HMGN5-3.bowtie.sorted.bam 
 
cd C:\Users\JuliaWimmer\Dropbox\Share 
pscp.exe admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
1.bowtie.sorted.bam C:\Users\JuliaWimmer\ 
pscp.exe admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
2.bowtie.sorted.bam C:\Users\JuliaWimmer\ 
pscp.exe admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
3.bowtie.sorted.bam C:\Users\JuliaWimmer 
pscp.exe admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
1.bowtie.sorted.bam C:\Users\JuliaWimmer 
pscp.exe admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
2.bowtie.sorted.bam C:\Users\JuliaWimmer 
pscp.exe admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
3.bowtie.sorted.bam C:\Users\JuliaWimmer 
pscp.exe admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
1.bowtie.sorted.bam.bai C:\Users\JuliaWimmer 
pscp.exe admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
2.bowtie.sorted.bam.bai C:\Users\JuliaWimmer\ 
pscp.exe admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
3.bowtie.sorted.bam.bai C:\Users\JuliaWimmer\ 
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pscp.exe admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
1.bowtie.sorted.bam.bai C:\Users\JuliaWimmer\ 
pscp.exe admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
2.bowtie.sorted.bam.bai C:\Users\JuliaWimmer\ 
pscp.exe admin@pc1011202646b.uni-
regensburg.de:/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
3.bowtie.sorted.bam.bai C:\Users\JuliaWimmer\ 
 
bedtools bamtobed -i /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
1.bowtie.bam > /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
1.bowtie.bed 
bedtools bamtobed -i /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
2.bowtie.bam > /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
2.bowtie.bed 
bedtools bamtobed -i /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
3.bowtie.bam > /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
3.bowtie.bed 
bedtools bamtobed -i /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
1.bowtie.bam > /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
1.bowtie.bed 
bedtools bamtobed -i /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
2.bowtie.bam > /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
2.bowtie.bed 
bedtools bamtobed -i /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
3.bowtie.bam > /Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
3.bowtie.bed 
 
 
 
##Motif analysis with homer 
 
  
cd /Users/admin/Homer/ 
sudo mv configureHomer.pl configureHomer_v4.1.pl 
cp /Volumes/Storage2/HTS_software/homer_v4.9/configureHomer.pl 
/Users/admin/Homer/configureHomer_v4.9.pl 
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perl /Users/admin/Homer/configureHomer_v4.9.pl -install homer 
perl /Users/admin/Homer/configureHomer_v4.9.pl -list 
perl /Users/admin/Homer/configureHomer_v4.9.pl -install hg38 
 
 
##Creating tag directory 
 
mkdir /Volumes/Storage2/HMGN5_0817/CLIP/homer 
cd /Volumes/Storage2/HMGN5_0817/CLIP/homer 
 
makeTagDirectory /Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP1_tagdir 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-1.bowtie.bam 
makeTagDirectory /Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2_tagdir 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-2.bowtie.bam 
makeTagDirectory /Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP3_tagdir 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-3.bowtie.bam 
makeTagDirectory 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-1.bowtie.bam 
makeTagDirectory 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-2.bowtie.bam 
makeTagDirectory 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-3.bowtie.bam 
makeTagDirectory 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2+3_tagdir 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-2.bowtie.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-3.bowtie.bam 
makeTagDirectory 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51+2+3_tagdir 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-1.bowtie.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-2.bowtie.bam 
/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-3.bowtie.bam 
 
makeUCSCfile /Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP1_tagdir -o 
auto -strand separate 
makeUCSCfile /Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2_tagdir -o 
auto -strand separate 
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makeUCSCfile /Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP3_tagdir -o 
auto -strand separate 
makeUCSCfile /Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir -
o auto -strand separate 
makeUCSCfile /Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir -
o auto -strand separate 
makeUCSCfile /Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir -
o auto -strand separate 
 
 
##Identify HMGN5-specific peaks (GFP as input) 
 
 
findPeaks /Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir -
style factor -o auto -i 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2+3_tagdir 
 
 #Expected tags per peak = 0.068200 (tbp = 0.000304) 
 
Threshold       Peak Count      Expected Peak Count     FDR 
 
                4       13729.000       15.243  0.001110 
                3       25933.000       897.104 0.034593 
                2       62357.000       39688.484       0.636472 
                1       281180.000      1177261.018     4.186859 
                0       281180.000      17857142.857    63.507870 
 
        #0.10% FDR Threshold set at 5.0 (poisson pvalue ~ 1.16e-08) 
        #8532 peaks passed threshold 
        #Differential Peaks: 3534 of 8532 (41.42% passed) 
        #Local Background Filtering: 3246 of 3534 (91.85% passed) 
        #Clonal filtering: 3216 of 3246 (99.08% passed) 
        #Total Peaks identified = 3216 
        #Centering peaks of size 224 using a fragment length of 61 
 
 
findPeaks /Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir -
style factor -o auto -i 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2+3_tagdir 
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#Expected tags per peak = 0.065731 (tbp = 0.000307) 
 
                Threshold       Peak Count      Expected Peak Count     
FDR 
 
                4       14822.000       13.794  0.000931 
                3       28336.000       842.213 0.029722 
                2       67531.000       38651.984       0.572359 
                1       294228.000      1189099.809     4.041423 
                0       294228.000      18691588.785    63.527566 
 
        #0.10% FDR Threshold set at 4.0 (poisson pvalue ~ 7.38e-07) 
        #14822 peaks passed threshold 
        #Differential Peaks: 5754 of 14822 (38.82% passed) 
        #Local Background Filtering: 5444 of 5754 (94.61% passed) 
        #Clonal filtering: 5340 of 5444 (98.09% passed) 
        #Total Peaks identified = 5340 
        #Centering peaks of size 214 using a fragment length of 61 
 
findPeaks /Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir -
style factor -o auto -i 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2+3_tagdir 
 
 #Expected tags per peak = 0.105069 (tbp = 0.000370) 
 
                Threshold       Peak Count      Expected Peak Count     
FDR 
 
                5       11588.000       1.377   0.000119 
                4       19579.000       65.764  0.003359 
                3       38149.000       2516.984        0.065978 
                2       89141.000       72505.915       0.813385 
                1       89141.000       1404753.908     15.758786 
                0       89141.000       14084507.042    158.002569 
 
        #0.10% FDR Threshold set at 5.0 (poisson pvalue ~ 9.78e-08) 
        #11588 peaks passed threshold 
        #Differential Peaks: 3054 of 11588 (26.35% passed) 
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        #Local Background Filtering: 2689 of 3054 (88.05% passed) 
        #Clonal filtering: 2686 of 2689 (99.89% passed) 
        #Total Peaks identified = 2686 
        #Centering peaks of size 284 using a fragment length of 60 
 
 
findPeaks /Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51+2+3_tagdir 
-style factor -o auto -i 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2+3_tagdir 
 
 #Expected tags per peak = 0.253292 (tbp = 0.001481) 
 
                Threshold       Peak Count      Expected Peak Count     
FDR 
 
                5       90790.000       164.668 0.001814 
                4       172508.000      3278.805        0.019007 
                3       203752.000      52457.332       0.257457 
                2       203752.000      634928.800      3.116184 
                1       203752.000      5234131.229     25.688735 
                0       203752.000      23391812.865    114.805317 
 
        #0.10% FDR Threshold set at 6.0 (poisson pvalue ~ 2.95e-07) 
        #76939 peaks passed threshold 
        #Differential Peaks: 34969 of 76939 (45.45% passed) 
        #Local Background Filtering: 30533 of 34969 (87.31% passed) 
        #Clonal filtering: 30458 of 30533 (99.75% passed) 
        #Total Peaks identified = 30458 
        #Centering peaks of size 171 using a fragment length of 60 
 
 
 
##Finding motifs  
 
##Against whole hg38 in individual HMGN5vsGFP2+3 peaks 
 
findMotifsGenome.pl 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/peaks.txt hg38 
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/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/motifvshg38 -
rna -p 10 
findMotifsGenome.pl 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/peaks.txt hg38 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/motifvshg38 -
rna -p 10 
findMotifsGenome.pl 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/peaks.txt hg38 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/motifvshg38 -
rna -p 10  
 
 
 
##against whole hg38 in overlapping HMGN5vsGFP2+3 peaks (from all 
three HMGN5 samples) 
 
mkdir 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3 
cd 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3 
sudo cp 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/peaks.txt 
HMGN51.txt 
sudo cp 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/peaks.txt 
HMGN52.txt 
sudo cp 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/peaks.txt 
HMGN53.txt 
mergePeaks -d given HMGN51.txt HMGN52.txt -prefix overlap 
sudo mv overlap_HMGN51.txt_HMGN52.txt HMGN512.txt 
mergePeaks -d given HMGN512.txt HMGN53.txt -prefix overlap 
sudo mv overlap_HMGN512.txt_HMGN53.txt HMGN5123.txt 
findMotifsGenome.pl 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3/
HMGN5123.txt hg38 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3/
motifvshg38 -rna -p 10  
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##against whole hg38 in HMGN5vsGFP2+3 peaks from combined tag 
directory 
 
findMotifsGenome.pl 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51+2+3_tagdir/peaks.txt 
hg38 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51+2+3_tagdir/motifvshg3
8 -rna -p 10 
 
###Annotate the resulting peak file (annotatePeaks.pl) 
 
##Configure homer to annotate peaks on the basis of human genome 
information 
 
perl /Users/admin/Homer/configureHomer_v4.9.pl -list 
 
perl /Users/admin/Homer/configureHomer_v4.9.pl -install hg38 
 
sudo perl /Users/admin/Homer/configureHomer_v4.9.pl -install human-o 
 
sudo perl /Users/admin/Homer/configureHomer_v4.9.pl -install human-p 
 
sudo perl /Users/admin/Homer/configureHomer_v4.9.pl -install human-
mRNA 
 
sudo perl /Users/admin/Homer/configureHomer_v4.9.pl -install human-
mRNA-5UTR 
 
sudo perl /Users/admin/Homer/configureHomer_v4.9.pl -install human-
mRNA-3UTR 
 
 
 
##Usage 
 
% annotatePeaks.pl <peak/BED file> <genome> <other options> > 
<output file> 
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##Options 
 
-d <tag dir1> #Adds tag information from listed tag directories 
-go <output dir> #Adds gene ontology analysis 
-genomeOntology <output dir> #Adds genome ontology analysis 
 
cd /Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51+2+3_tagdir/ 
annotatePeaks.pl peaks.txt hg38 -d 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP1_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP3_tagdir/ -go 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51+2+3_tagdir/GeneOnt -
genomeOntology 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51+2+3_tagdir/GenomeOnt 
> HMGN51+2+3peaks.ann.txt 
 
 
cd 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3_
d100/ 
annotatePeaks.pl HMGN5123.txt hg38 -d 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP1_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP3_tagdir/ -go 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3_
d100/GeneOnt -genomeOntology 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3_
d100/GenomeOnt > HMGN5123_merged100_peaks.ann.txt 
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cd 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3_
d50/ 
annotatePeaks.pl HMGN5123.txt hg38 -d 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP1_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP3_tagdir/ -go 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3_
d50/GeneOnt -genomeOntology 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3_
d50/GenomeOnt > HMGN5123_merged50_peaks.ann.txt 
 
 
cd 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3/ 
 
annotatePeaks.pl HMGN5123.txt hg38 -d 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP1_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP3_tagdir/ -go 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3/
GeneOnt -genomeOntology 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/mergedPeaks_HMGN5overGFP2+3/
GenomeOnt > HMGN5123_mergedgiven_peaks.ann.txt 
 
 
cd /Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/ 
 
annotatePeaks.pl peaks.txt hg38 -d 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP1_tagdir/ 
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/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP3_tagdir/ -go 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/GeneOnt -
genomeOntology 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/GenomeOnt > 
HMGN51peaks.ann.txt 
 
cd /Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/ 
 
annotatePeaks.pl peaks.txt hg38 -d 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP1_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP3_tagdir/ -go 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/GeneOnt -
genomeOntology 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/GenomeOnt > 
HMGN52peaks.ann.txt 
 
cd /Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/ 
 
annotatePeaks.pl peaks.txt hg38 -d 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN51_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN52_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP1_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP2_tagdir/ 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/GFP3_tagdir/ -go 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/GeneOnt -
genomeOntology 
/Volumes/Storage2/HMGN5_0817/CLIP/homer/HMGN53_tagdir/GenomeOnt > 
HMGN53peaks.ann.txt 
 
 
 
##Differential gene expression analysis  
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source("http://bioconductor.org/biocLite.R") 
biocLite("TxDb.Hsapiens.UCSC.hg38.knownGene") 
library(GenomicFeatures) 
library(GenomicAlignments) 
library(TxDb.Hsapiens.UCSC.hg38.knownGene) 
 
 
setwd("/Volumes/Storage2/HMGN5_0817/CLIP/R_Analysis") 
 
outputDir <- 
file.path("/Volumes/Storage2/HMGN5_0817/CLIP/R_Analysis") 
 
 
#Genes for DGE analysis were extracted from 
TxDb.Hsapiens.UCSC.hg38.knownGene by 
txdb <- TxDb.Hsapiens.UCSC.hg38.knownGene # create transcription 
database based on hg38 known genes from ucsc 
eByg <- exonsBy(txdb, by="gene") # defines features to look for 
overlap later 
 
 
bfl <- 
BamFileList(c("/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
1.bowtie.sorted.bam", 
"/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
2.bowtie.sorted.bam", 
"/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/HMGN5-
3.bowtie.sorted.bam", "/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
2.bowtie.sorted.bam", "/Volumes/Storage2/HMGN5_0817/CLIP/bowtie/GFP-
3.bowtie.sorted.bam")) # list of bam files 
 
 
counteByg <- summarizeOverlaps(eByg, bfl, mode="Union", 
ignore.strand=FALSE, inter.feature=FALSE, singleEnd=TRUE) #creates 
an object including a matrix with all known UCSC genes and the 
corresponding read counts. Counting option is 'union according to 
HTseq-count: only reads mapping to unique features (i.e. not-
overlapping gene regions) are counted. 
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countDFeByg <- assays(counteByg)$counts #extracts read count table 
as matrix 
 
write.table(countDFeByg, file=file.path(outputDir, 
"countDFeByg_2+3.txt"), sep="\t") 
 
#list of Gene Symbols (downloaded from http://www.genenames.org/cgi-
bin/download [Curated by the HGNC > Approved Symbol // Downloaded 
from external sources > Entrez ID],  
 
# create data structures; DGEList object contains $counts (count 
matrix), $sample (sample information such as names, group, lib.size, 
norm.factors) 
 
library(edgeR) 
 
grp <- factor(c(1,1,1,2,2)) 
 
dge <- DGEList(counts=countDFeByg, genes=countDFeByg[,0], group=grp) 
#create data structure for normalisation, diff gene expr analysis 
and so on... (type 'dge' to look at structure) 
 
 
#Normalization 
 
dge_norm <- dge 
 
dge_norm <- calcNormFactors(dge_norm) # calculates a normalization 
factor based on the total number of Read Counts and inserts this 
into the sample information. 
 
 
##Data exploration 
 
pdf("plotMDS_dge_norm_2+3.pdf",width=7,height=5) 
 
plotMDS_dge_norm <- plotMDS.DGEList(dge_norm) 
 
dev.off() 
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## filter un-informative genes (with low CPM by threshold) (EdgeR 
UserGuide -2.6: usually a gene is required to have a count of 5-10 
in a library to be considered expressed in that library.  Users 
should also filter with count-per-million (CPM) rather than 
filtering on the counts directly, as the latter does not account for 
differences in library sizes between samples. 
 
 
mcpm_norm <- 1e6 * t(t(dge_norm$counts) / dge_norm$samples$lib.size) 
#Defines counts per million to be used as threshold for read counts 
in count matrix 
 
 
ridx5 <- rowSums(mcpm_norm > 5) >= 2 #keep only those genes for 
further processing that have at least 5 cpms in at least 2 samples 
(setting >2 samples is a simplified assumption that all 3 replicates 
have cpm >5) 
 
ridx20 <- rowSums(mcpm_norm > 20) >= 2  
 
dge_norm_f5<- dge_norm[ridx5,] #only genes with at least 3 samples 
with cpm >5 are further processed 
 
dge_norm_f20<- dge_norm[ridx20,] 
 
dim(dge_norm$counts) #returns dimension of the count matrix in the 
dge_s_norm data.set 
 
#[1] 24943     5 #all 24943 genes of initial count table 
 
dim(dge_norm_f5$counts) 
 
#[1] 10235    5 #only 10235 genes 'survive' 
 
dim(dge_norm_f20$counts) 
 
#[1] 4686    5 
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###Estimating dispersion ("The more the members of a collection 
differ to larger extents from each other, the more dispersed or 
spread-out the variation pattern is judged to be. This roughly 
describes the dispersion aspect of variation." > taken from 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373960/ >>> the smaller 
the better) 
Strictly speaking, it captures all sources of the inter-library 
variation between replicates, including perhaps contributions from 
technical causes such as library preparation as well as true 
biological variation between samples. (Extracted from EdgeR 
UserGuide) 
 
 
##Pairwise comparisons between two or more groups (classic): edgeR 
uses the quantile-adjusted conditional maximum likelihood (qCML) 
method for experiments with single factor (see chapter 2.9.1 of 
EdgeR UserGuide) 
 
#Overall level of biological variability  
 
dge_norm <- estimateCommonDisp(dge_norm, verbose=TRUE) 
 
Disp = 1.43326, BCV = 1.1972 #The square root of the common 
dispersion gives the coefficient of variation of biological 
variation 
 
dge_norm_f5 <- estimateCommonDisp(dge_norm_f5, verbose=TRUE) 
 
Disp = 0.87898, BCV = 0.9375 
 
dge_norm_f20 <- estimateCommonDisp(dge_norm_f20, verbose=TRUE) 
 
Disp = 0.3421 , BCV = 0.5849 
 
 
#>> Removing lowly expressed genes from the count table reduces the 
variability between individual samples. 
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#Repeating Data Exploration with filtered data 
 
pdf("plotMDS_dge_norm_f5_2+3.pdf",width=7,height=5) 
 
plotMDS_dge_norm_f5 <- plotMDS.DGEList(dge_norm_f5) 
 
dev.off() 
 
pdf("plotMDS_dge_norm_f20_2+3.pdf",width=7,height=5) 
 
plotMDS_dge_norm_f20 <- plotMDS.DGEList(dge_norm_f20) 
 
dev.off() 
 
 
#Gene-wise dispersion (applicable on datasets with a single factor design (such as 
here: GFP vs HMGN5) since it fails to  take  into  account  the  effects  from  multiple  
factors  in  a  more  complicated experiment. ) 
 
dge_norm <- estimateTagwiseDisp(dge_norm) 
dge_norm_f5 <- estimateTagwiseDisp(dge_norm_f5) 
dge_norm_f20 <- estimateTagwiseDisp(dge_norm_f20) 
 
 
##Differential Expression (EdgeR UsersGuide-2.9.2:  the exact test is only applicable 
to experiments with a single factor - such as here: GFP vs HMGN5)  
 
 
et_norm <- exactTest(dge_norm) 
 
et_norm_f5 <- exactTest(dge_norm_f5) #the (gene-wise) exact test is 
comparable to t-test 
 
et_norm_f20 <- exactTest(dge_norm_f20) 
 
tt_et_norm <- topTags(et_norm) 
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tt_et_norm_f5 <- topTags(et_norm_f5) #sorts entries of 
"et_s_norm_f5" > #The top DE tags have tiny p-values and FDR values, 
as well as large fold changes. 
tt_et_norm_f20_100 <- topTags(et_norm_f20, n=100) 
tt_et_norm_24943 <- topTags(et_norm, n=24943) 
tt_et_norm_f5_10235 <- topTags(et_norm_f5, n=10235) 
tt_et_norm_f20_4686 <- topTags(et_norm_f20, n=4686) 
 
 
#summary(de_norm <- decideTestsDGE(et_norm)) 
-1    17 
0  24925 
1      1 
 
#summary(de_norm_f5 <- decideTestsDGE(et_norm_f5)) 
-1    29 
0  10205 
1      1 
 
#summary(de_norm_f20 <- decideTestsDGE(et_norm_f20)) 
-1   28 
0  4657 
1     1 
 
 
write.table(tt_et_norm, file=file.path(outputDir, 
"tt_et_norm_2+3.txt"), sep="\t") 
write.table(tt_et_norm_f5, file=file.path(outputDir, 
"tt_et_norm_f5_2+3.txt"), sep="\t") 
 
 
 
write.table(tt_et_norm_f20_100, file=file.path(outputDir, 
"tt_et_norm_f20_2+3_100.txt"), sep="\t") 
 
 
tt_et_norm_100 <- topTags(et_norm, n=100) 
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tt_et_norm_f5_100 <- topTags(et_norm_f5, n=100) 
 
write.table(tt_et_norm_100, file=file.path(outputDir, 
"tt_et_norm_2+3_100.txt"), sep="\t") 
write.table(tt_et_norm_f5_100, file=file.path(outputDir, 
"tt_et_norm_f5_2+3_100.txt"), sep="\t") 
write.table(tt_et_norm_24943, file=file.path(outputDir, 
"tt_et_norm_2+3_24943.txt"), sep="\t") 
write.table(tt_et_norm_f5_10235, file=file.path(outputDir, 
"tt_et_norm_f5_2+3_10235.txt"), sep="\t") 
write.table(tt_et_norm_f20_4686, file=file.path(outputDir, 
"tt_et_norm_f20_2+3_4686.txt"), sep="\t") 
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